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achieved in understanding this key process, including results of structural, ensemble kinetic and single-
molecule studies. However, most of work has been focused on the pre-equilibrium states of this fast process,
leaving the real time dynamics, especially how EF-G interacts with the A-site tRNA in the pretranslocation
complex, not fully elucidated.
In this thesis, the kinetics of EF-G catalyzed translocation is investigated by both ensemble and single
molecule fluorescence resonance energy transfer studies to further explore the underlying mechanism. In the
ensemble work, EF-G mutants were designed and expressed successfully. The labeled EF-G mutants show
good translocation activity in two different assays. In the smFRET work, by attachment of a fluorescent probe
at position 693 on EF-G permits monitoring of FRET efficiencies to sites in both ribosomal protein L11 and
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while the EF-G:tRNA FRET proceeds from high to intermediate to low FRET values. Transition from
intermediate to low is the rate-limiting step with a small FRET change, whereas transition from high to
intermediate is fast, showing a large FRET change. In total, we capture a ~12 Ã? relative movement of A-site
tRNA away from EF-G during translocation. This indicates that EF-G:A-site tRNA distance increases
progressively during translocation, with our results providing the first good estimates of the timing of such
changes. This EF-G:tRNA smFRET measurement was applied to bifunctional rhodamine labeled EF-G
derivatives (BR-EF-G) and comparable kinetic results were obtained. FRET changes of BR-EF-G:Cy5-tRNA
pair are larger if the BR group is located closer to the EF-G hinge region, suggesting that parts of domain IV of
EF-G, which penetrate to the decoding region of the ribosome, move together with the A-site tRNA during
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ABSTRACT 
EF-G:tRNA DYNAMICS DURING THE ELONGATION CYCLE OF 
PROTEIN SYNTHESIS 
 
 
Rong Shen 
Barry S. Cooperman 
 
During polypeptide elongation cycle, prokaryotic elongation factor G (EF-G) 
catalyzes the coupled translocations on the ribosome of mRNA and A- and P-site bound 
tRNAs. Continued progress has been achieved in understanding this key process, 
including results of structural, ensemble kinetic and single-molecule studies. However, 
most of work has been focused on the pre-equilibrium states of this fast process, 
leaving the real time dynamics, especially how EF-G interacts with the A-site tRNA in 
the pretranslocation complex, not fully elucidated.  
In this thesis, the kinetics of EF-G catalyzed translocation is investigated by both 
ensemble and single molecule fluorescence resonance energy transfer studies to further 
explore the underlying mechanism. In the ensemble work, EF-G mutants were designed 
and expressed successfully. The labeled EF-G mutants show good translocation activity 
in two different assays. In the smFRET work, by attachment of a fluorescent probe at 
position 693 on EF-G permits monitoring of FRET efficiencies to sites in both 
ribosomal protein L11 and A-site tRNA. The EF-G:L11 FRET efficiency is constant 
vi 
 
during the entire EF-G occupancy on the ribosome, while the EF-G:tRNA FRET 
proceeds from high to intermediate to low FRET values. Transition from intermediate 
to low is the rate-limiting step with a small FRET change, whereas transition from high 
to intermediate is fast, showing a large FRET change. In total, we capture a ~12 Å 
relative movement of A-site tRNA away from EF-G during translocation. This indicates 
that EF-G:A-site tRNA distance increases progressively during translocation, with our 
results providing the first good estimates of the timing of such changes. This EF-
G:tRNA smFRET measurement was applied to bifunctional rhodamine labeled EF-G 
derivatives (BR-EF-G)  and comparable kinetic results were obtained. FRET changes 
of BR-EF-G:Cy5-tRNA pair are larger if the BR group is located closer to the EF-G 
hinge region, suggesting that parts of domain IV of EF-G, which penetrate to the 
decoding region of the ribosome, move together with the A-site tRNA during 
translocation. 
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CHAPTER I INTRODUCTION 
 
  
2 
 
1.1 The central dogma and ribosome-catalyzed translation  
Nucleotides are ubiquitous molecules with high structural diversity. Their polymeric 
forms, deoxyribonucleic acids (DNAs) and ribonucleic acids (RNA) are important in 
storage and expression of genetic information. As determined by James Watson and 
Francis Crick in 1953, the double helix structure of DNA is well known now. DNA in a 
parent cell is replicated through its double helix, propagating genetic information to the 
daughter cells (Watson et al., 1953a; Watson et al., 1953b). A great variety of enzymes 
are involved in DNA replication. Single-stranded parental DNA is used as the template to 
synthesize the complementary strand for both leading and lagging strands, with high 
fidelity. As DNA strand can only be extended from 5’ to 3’, for the lagging strand, semi-
discontinuous replication is performed and the DNA fragments are later joined together 
by DNA ligase. DNA polymerases (Pol) catalyze DNA strand extension (Caruthers et al., 
2002). In E. coli, Pol I and Pol III have both polymerase and exonulcease activities, and 
the latter functions as a proofreading mechanism which contributes to the high fidelity of 
DNA replication, with only one mismatching occurring per 10
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base pair replication 
(Rothwell et al., 2005).  
RNAs are classified according to their functions, including decoding RNA which is 
messenger RNA (mRNA) and non-decoding RNA. mRNA serves as the template for 
protein synthesis on the ribosome. Non-decoding RNA includes transfer RNA (tRNA), 
ribosomal RNA (rRNA), small interfering RNA (siRNA), micro RNA (miRNA), small 
nuclear RNA (snRNA), etc. tRNAs recognize the complementary triplet sequences of 
mRNA through codon-anticodon interactions and deliver specific amino acids that 
incorporate into nascent protein chains. tRNA has an L-shaped structure and is about 60 
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Å in length from its elbow region to the anticodon region (Fig 1.1). The amino acid is 
covalently attached to the CCA- end of tRNA, in a reaction catalyzed by an aminoacyl-
tRNA synthetase. There are two classes of aminoacyl-tRNA synthetases, denoted Class I 
and Class II, with both a catalytic and an editing site to ensure the accuracy of this 
process (Nureki et al., 1998). Another non-decoding RNA, denoted rRNAs account for ~ 
60% of the ribosome by weight.  
According to the central dogma (Fig 1.2), the base sequences of DNA are copied into 
mRNA during the transcription process (Crick et al., 1970). mRNA then directs protein 
synthesis by having the ribosome translate its nucleotide sequence into  an amino acid 
sequence. The transcription of DNA is carried out by RNA polymerases using nucleotides 
including adenine (A), cytosine (C), guanine (G) and uridine (U) (Cramer et al., 2002). 
Unlike DNA replication, RNA synthesis is initiated at a specific site called the promoter 
region and the single strand of mRNA is extended from 5’ to 3’. Posttranscriptional 
processing alters certain features of the primary transcript and the transcripts are 
subjected to several modifications, for instance, 5’ capping, poly (A) tail addition and 
splicing for eukaryotic mRNA transcripts (Black. et al., 2003; Nishikura et al., 2006; 
Wahl et al., 2009). The transcription process is rapid, with the in vivo rate of 20 to 50 
nucleotides per second at 37 °C. However, the accuracy of transcription is one out of 10
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mis-transcribed, which is much lower than replication. Three consecutive mRNA 
nucleotides code for a particular amino acid. Protein synthesis is carried out on the 
ribosome, which we will discuss in detail in Section 1.3.  
1.2 Ribosome components  
The ribosome is a ribonucleoprotein particle which is composed of a large and a 
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small subunit. The ribosome is built of two-thirds rRNA and one third ribosomal proteins 
(Table 1.). The E. coli ribosome, which has been extensively investigated, is a 2.5 MDa 
ribonucleoprotein assembly with a diameter of ~ 250 Å and a sedimentation coefficient of 
70S, where S stands for the Svedberg unit of sedimentation velocity. The complete 70S 
ribosome is formed from 50S and 30S subunits (Kaltschmidt et al., 1970). The 30S 
subunit consists of 16S rRNA (about 1500 nucleotides) together with 21 proteins. The 
50S contains 23S rRNA (about 3000 nucleotides), 5S rRNA and 34 proteins. Their 
eukaryotic counterparts are termed 60S and 40S, which together form an 80S ribosome.  
1.3 The prokaryotic translation cycle 
In bacteria, protein synthesis can be divided into three major stages including 
initiation, elongation and termination, which requires correlated movements among 
ribosomal proteins, rRNA, protein factors and tRNAs (Fig 1.3). 
1.3.1 Initiation of protein synthesis 
The initiation step requires mRNA, the initiator tRNA fMet-tRNA
fMet
 and initiation 
factors 1-3 (IF 1-3). In the initiation step, mRNA binds to the 30S subunit on the 
ribosome at the anti Shine-Dalgarno (SD) sequence of 16S rRNA that is complementary 
to an SD sequence in the mRNA. The initiator tRNA fMet-tRNA
fMet
, positioned in a P-
like site of the 30S subunit, forms codon-anticodon interactions with the start codon. The 
binding site of IF-1 partially overlaps with the decoding center, suggesting that IF-1 does 
not only assist IF-3 binding but also prevents the aminoacyl tRNA binding at this 
premature stage (Moazed et al., 1995). IF2 is a GTPase and it binds with GTP and fMet-
tRNA
fMet
 to form a ternary complex (Boelens et al., 2002; Tsai et al., 2012). IF3 helps to 
dissociate vacant 70S ribosomes resulting from protein synthesis termination and 
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prevents the premature docking of 50S subunit onto the 30S subunit. During the initiation 
process, IF3 first binds to the 30S subunit, followed by the association of mRNA, IF1, 
IF2, and initiator tRNA to form the 30S initiation complex (30SIC). The release of IF1 
and IF3 promotes the 30SIC and 50S subunit joining to form the 70S initiation complex 
(70SIC), followed by IF2 catalyzed GTP hydrolysis, Pi release, and IF2·GDP dissociation. 
This results in the initiator tRNA fMet-tRNA
fMet 
moving to the P-site of the 70S ribosome, 
ready for the next stage of the elongation reaction.  
1.3.2 Peptide elongation  
The elongation cycle can be divided into three stages, including decoding, peptide 
bond formation and translocation (Schmeing et al., 2009a). At the beginning of this cycle, 
the ribosome contains a peptidyl-tRNA in the P-site, with an empty A-site. EF-Tu 
delivers the cognate aminoacyl tRNA to the mRNA codon in the A-site of the ribosome in 
the form of ternary complex (TC: aa-tRNA·EF-Tu·GTP) (Pape et al., 1998; Rodnina et 
al., 1994). The TC complex first binds to the L7/L12 stalk and the anticodon of tRNA 
penetrates into the decoding center on the 30S subunit with the acceptor arm and EF-Tu 
interacting with the GTPase activation center on the 50S subunit (Schmeing et al., 
2009b).  As a result, tRNA is said to be in the A/T state, in which it displays a distorted 
conformation relative to the structure of tRNA bound within either a TC or free in 
solution. The cognate codon-anticodon interaction at the decoding center triggers 
conformational changes in both tRNA and the ribosome complex which are later 
transmitted to the interface of EF-Tu and tRNA (Voorhees et al., 2010). After fast GTP 
hydrolysis and Pi release, EF-Tu·GDP dissociates from the ribosome and the A/T tRNA is 
accommodated into the A/A site. Decoding is followed by fast peptide bond formation, 
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leaving deacylated-tRNA in the P site. Both structural work (Agirrezabala et al., 2008; 
Fu et al., 2011) and kinetic studies, including ensemble measurements (Dorner et al., 
2006) and single molecule experiments (Blanchard et al., 2004b; Blanchard et al., 2004a; 
Chen et al., 2011a; Fei et al., 2008) show that classic (A/A, P/P) and hybrid (A/P, P/E) 
tRNA binding states interconvert reversibly prior to EF-G·GTP binding. EF-G binds to 
the L7/L12 stalk on the ribosome, sharing the same binding site as EF-Tu (Gao et al., 
2009; Schmeing et al., 2009b). Upon EF-G·GTP binding, rapid GTP hydrolysis is 
triggered, followed by Pi release. The energy generated from this process promotes 
unidirectional movement of tRNAs, together with mRNA, from the A-, P- sites to the P-, 
E-sites, in a process that proceeds via at least two intermediates (Pan et al., 2007). This 
leaves an empty A-site, which is ready for the next cycle of elongation.  
1.3.3 Termination of protein synthesis  
The elongation cycle continues until a stop codon (UAA, UAG or UGA) moves into 
the A-site, signaling translation termination. RF1 (Class 1 release factor, recognizing 
UAA, UAG) or RF2 (Class 1 release factor, recognizing UAA, UGA) reads the stop 
codon, resulting in conformational changes of conserved bases (G530, A1492 and A1493) 
in the decoding center (Korostelev et al., 2008; Laurberg et al., 2008; Weixlbaumer et 
al., 2008). The conserved GGQ motif on RFs is positioned in the PTC and promotes the 
hydrolysis of peptidyl tRNA in the P-site, followed by peptide chain release from the 
ribosome (Laurberg et al., 2008; Weixlbaumer et al., 2008). RF3, a Class II RF binds to 
the ribosome in the GTP form and, accompanied by GTP hydrolysis (Zavialov et al., 
2002), destabilizes RF 1/2 binding, accelerating their dissociation from the ribosome. 
Then RF3 dissociates, leaving inactive mRNA and deacylated tRNA bound to the 
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ribosome. This inactive complex is recycled into 30S and 50S subunits, free mRNA and 
tRNA, assisted by ribosome recycling factor (RRF) and EF-G (Franckenberg et al., 2012; 
Hirashima et al., 1973). Then IF3 binds to the ribosome to the 30S subunit (Hirokawa et 
al., 2008; Karimi et al., 1999), ready for the next round of translation.  
1.4 Ribosome structure  
Elucidation of ribosome structure is a daunting task due to its size and lack of 
symmetry. The ribosome structure initially began to emerge via electron microcopy but 
with a low resolution (Hall et al., 1959). An early view of single particle reconstruction 
using cryo-EM came in 1986 (Frank et al., 1986) and structures with better resolution 
(below 10 Å) were reported by Valle et al. in 2003. With advanced experimental 
techniques and data refining methods, high resolution structure of 30S and 50S structures 
at atomic resolution, determined by X-ray crystallography study (~ 3 Å), were first 
reported in 2000 as the efforts from several groups (Ban et al., 2000; Carter et al., 2000; 
Harms et al., 2001; Schluenzen et al., 2000; Wimberly et al., 2000). In 2001, Noller 
group reported the first low resolution (5.5 Å) 70S ribosome structure from Thermus 
thermophilus containing mRNA, A-, P- and E-site tRNAs (Yusupov et al., 2001), 
showing that the core of the interface between 30S and 50S is mainly made up of RNA 
with protein located at the periphery. 
The 5’and 3’ domains of the 16S RNA are located in the body and head of the 30S 
subunit, respectively, with the central domain located in the platform region (Fig 1.4). 
There are three long helices in 30S subunits, h44, h16/17, and h7, with most of the small 
ribosomal protein located on the exterior side. The primary role of 30S is to bind mRNA 
and tRNA, providing the location for the decoding process, which occurs at the upper 
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part of 30S body and lower part of the head (Ban et al., 2000; Schluenzen et al., 2000; 
Wimberly et al., 2000) with nucleotides 1492 to 1498 and 1302 to 1408 of h44 forming 
parts of the A- and P- tRNA sites. 50S has a stable core structure with a strong mobility 
of the protuberances, for instance, the L7/L12 stalk and the L1 stalk (Fig 1.5, Fig 1.6). 
The six domains of 23S RNA are interwoven and the 5S RNA is located in the center of 
the protuberance (Harms et al., 2001). There are three tRNA binding sites on the 
ribosome: the A site for the incoming aminoacyl-tRNA, the P site for peptidyl-tRNA and 
the E site for the deacylated tRNA to exit from the ribosome after the elongation cycle 
(Schmeing et al., 2009a; Yonath et al., 2010). The tRNA binds at the 30S:50S interface, 
forming interactions with the decoding center of 30S and the peptidyl transferase center 
(PTC) on the 50S subunit, and moves through a tunnel from the A site located close to the 
L7/L12 stalk to the E site located close to L1 stalk in a stepwise manner during 
translocation (Fig 1.6). mRNA binds to the small unit between the platform and the head 
region with 5’ end of mRNA, forming contacts with the back of the platform, and wraps 
around the neck of 30S to place the nucleotides into A, P  and E sites (Yusupov et al., 
2001).  
High resolution (~ 3 Å) structures of 70S ribosome were obtained successfully by 
both Cate et al. and Ramakrishnan et al. in 2005 and 2006, separately (Schuwirth et al., 
2005; Selmer et al., 2006). Cate et al. reported two ribosome structures with a detailed 
view of the interface of 50S and 30S as well as the conformation of the PTC. By defining 
one structure as the standard, the comparison between the two structures indicated two 
types of motions of the 30S subunit, including swivelling of the head of 30S ribosome ~ 
6° and the rotation movement of 30S relative to 50S subunit (Fig 1.7). The 2006 paper 
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provided a detailed study of the ribosome interactions with mRNA, cognate A-, P- site 
tRNAs and non-cognate E-site tRNA, suggesting that a metal ion stabilized kink structure 
of mRNA is potentially important to prevent mRNA slippage. Since then, several high 
resolution X-ray and cryo-EM structures have been reported, focusing on revealing 
different aspects of translation, including mRNA decoding (Demeshkina et al., 2012; 
Jenner et al., 2010), translocation (Agirrezabala et al., 2008; Connell et al., 2008; Frank 
et al., 2007; Frank et al., 2000; Julián et al., 2008; Ratje et al., 2010) and termination 
(Korostelev et al., 2008; Laurberg et al., 2008).  
For mRNA decoding, by comparing the crystal structures of the ribosome with 
uncharged cognate tRNA, or with a near-cognate tRNA, or without the A-site tRNA, 
Yusupova and coworkers proposed a proofreading mechanism, suggesting that this 
process begins with monitoring the tRNA anticodon loop, followed by the elbow region 
of tRNA being examined by rRNA and ribosomal protein on the 50S subunit to decide if 
the acceptor end of tRNA is to be accommodated or not.  
During translocation, the ribosome undergoes a large scale conformational 
rearrangement. Frank et al. (2000) reported a cryo-EM structure of 70S ribosome from E. 
coli, showing that EF-G binding and GTP hydrolysis promote a ratchet-like rotation of 
30S relative to 50S (Frank et al., 2000; Zhang et al., 2009). This movement of the 
ribosome is believed to couple with the formation of hybrid state tRNAs but can be 
decoupled with the addition of antibiotics, e.g., viomycin. The L1 stalk undergoes a 
closure movement to form interactions with the deacylated P-site tRNA and such 
interaction persists throughout translocation (Fei et al., 2008). A spontaneous ribosome 
ratcheting movement (~ 8 to 10 degree) was observed with tRNAs in A/P, P/E hybrid 
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states by Julian et al. (2008) and Agirrezabala et al. (2008), separately. Ratje et al. (2010) 
presented two cryo-EM structures of EF-G-ribosomes complex from Thermus 
thermophilus and one of the characterized structures containing a partly translocated 
tRNA. A swivelling movement of 30S head stabilized by Domain IV of EF-G, was 
described and this movement was believed to be coupled with translocation and 
unratcheting of the 30S body(Ratje et al., 2010). This result provides a new insight into 
the structure of translocation intermediates.  
Concerning the termination process, Laurberg et al. reported a structure of 70S 
ribosome from Thermus thermophilus with release factor 1(RF1), P-, E- site tRNAs and 
mRNA containing stop codon UAA at 3.2 Å resolution, suggesting that RF1 interaction 
with the PTC is stabilized by the A-site of 30S, and repositioning of GGQ motif promotes 
hydrolysis of peptidyl-tRNA (Laurberg et al., 2008). Noller and coworkers (2008) 
obtained 70S ribosome with release factor 2 (RF2), P-, E- site tRNAs and mRNA 
containing a UAA stop codon. This high resolution structure (3 Å) supports the idea that 
the conformational changes transmitted from the decoding center to the PTC as the result 
of recognition of the stop codon promote the docking of GGQ motif into the PTC to 
catalyze peptidyl-tRNA hydrolysis (Korostelev et al., 2008).  
1.5 Prior results of special pertinence to work presented in this thesis 
Previous research has been heavily focused on the pre-equilibrium states of EF-G 
catalyzed translocation, leaving the real time dynamics, especially how EF-G first 
interacts with the A-site tRNA or with ribosomal protein in the GTPase associated center 
(GAC) within the pretranslocation complex, not fully elucidated. In my work, we want to 
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show how EF-G correlates its movements with tRNAs, and with ribosomal protein to 
promote different sub-steps of translocation. 
1.5.1 EF-G structures in solution or bound to the ribosome 
Of particular interest is the structure of EF-G under different conditions, including 
the structures of EF-G in solution (AEvarsson et al., 1994; al-Karadaghi et al., 1996; 
Czworkowski et al., 1994; Hansson et al., 2005), EF-G bound to the ribosome (Brilot et 
al., 2013; Chen et al., 2013b; Gao et al., 2009; Pulk et al., 2013; Ramrath et al., 2013; 
Tourigny et al., 2013; Zhou et al., 2013; Zhou et al., 2014) and of EF-G-2, a homolog 
of EF-G bound to the ribosome (Connell et al., 2008). In 1994, two crystal structures of 
EF-G from Thermus thermophilus, either lacking any guanine nucleotide (AEvarsson et 
al., 1994) or with GDP (Czworkowski et al., 1994) were reported separately. These two 
papers provided the fundamental information of EF-G structure. EF-G has overall 
dimensions of 50 × 60 × 118 Å and five domains. Its GTP binding domain has a core 
structure which is similar to those of other GTPases. EF-G has a unique inserted domain 
about 90 residues in length. The overall EF-G·GDP structure resembles the structure of 
the ternary complex, with Domains I, II resembling EF-Tu in the GTP form and Domains 
III, IV and V resembling tRNA. Al-karadaghi et al. reported another EF-G·GDP structure 
and compared this structure with nucleotide-free EF-G structure. The results imply that 
upon GDP release, the phosphate binding loop (P-loop) in the G domain of EF-G 
undergoes a conformational change which can be transmitted to other parts of EF-G and 
prepares EF-G for next round of GTP binding. Hansson et al., 2005 solved the structure 
of the T84A EF-G mutant, which is located in the G domain, bound with non-
hydrolysable GTP analogue GDPNP, providing the first structure of EF-G conformation 
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in the GTP form. With the improved experimental techniques, some well-ordered 
ribosome crystal structures were obtained and brought new insights into the structure of 
ribosome-bound EF-G. EF-G binds to the ribosome subunit interface: Domain I binds to 
the sarcin-ricin loop; Domains II and III bind to h15 of 16S rRNA and S12 of 30S; 
Domain IV binds to h23 of 16S rRNA and the mRNA; Domain V binds to L11 stalk of 
50S. Gao et al. (2009) presented a crystal structure of ribosome bound EF-G with the 
antibiotic fusidic acid (FA) in the posttranslocation state at 3.6 Å resolution. In this work, 
EF-G was trapped in an intermediate conformation between guanosine triphosphate and 
guanosine diphosphate states with loops I and II on G domain in a conformation similar 
to the GDP and GTP forms, respectively. In 2013, three ribosome-bound EF-G structures 
were published in Science. Cate and coworkers reported an EF-G-ribosome complex with 
non-hydrolyzable GTP analogue GDPCP at 3 Å. Binding of EF-G in the GDPCP state 
orders the switch regions in the GTPase associated center (GAC) compared to GDP state. 
Also, Domain II of EF-G moves about 7 Å toward Domain III and Domain IV is 
positioned into the A-site decoding center but without contacts with the 30S head, such 
that the presence of EF-G most likely precludes tRNA occupancy. EF-G-ribosome 
structure with a non-hydrolyzable GTP analog GDPCP and P/E tRNA was obtained at 2.9 
Å (Tourigny et al., 2013). Domain IV of EF-G was observed to be in an intermediate 
conformation which was between ribosome free EF-G and EF-G-ribosome in the post 
state. As was found by Pulk et al., an ordered structure stabilized by the sarcin-ricin RNA 
loop of 50S in the GAC was obtained and the conformation of conserved residues in the 
GTPase active site was different from both the ribosome-free and other ribosome-bound 
structures. Fusidic acid bound to EF-G in a position that overlapped with switch loop I of 
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G domain on EF-G in the GTP form and stabilized contacts between Domains I and II 
(Zhou et al., 2013). Although all these high resolution structures provide a detailed view 
of the ribosome bound EF-G structure, especially Domain I which catalyzes GTP 
hydrolysis and Domain IV which extends to the decoding center, all of them lack the A-
site tRNA and are from either the posttranslocation state or an intermediate state, leaving 
the pretranslocation state not fully elucidated. Since 2013, two papers have been 
published with EF-G-ribosome in a PRE-like state. Cryo-EM reconstruction of the 
pretranslocation complex was obtained with viomycin (VIO) and FA to increase the 
binding stability of the A-site tRNA. Although this structure is not of high resolution (7.6 
Å), a distinct EF-G conformation which is different from all previously characterized EF-
G structures was observed, suggesting that EF-G undergoes a structural rearrangement 
during translocation.  Domain IV of EF-G is outside the A-site of 30S and the tip of 
Domain IV makes an extensive contact with the anti-codon loop of the A-site tRNA. 
Compared with EF-G-ribosome complex in the posttranslocation state (Gao et al., 2009), 
the tip of Domain IV in this work is 20 Å farther from the A site, and a rotation about 20° 
around the sarcin-ricin loop was observed to avoid a steric clash of Domain IV with the 
A-site tRNA. A more recent published result (Zhou et al., 2014) improved the resolution 
of the EF-G-ribosome structure in a PRE-like state to 3.8 Å, but in the presence of 
antibiotics, with the deacylated P-site tRNA partly moving to a pe/E site and the A-site 
peptidyl tRNA to an ap/ap state, revealing how the rearrangement of rRNA promotes 
tRNA movements during translocation. 
1.5.2 Structural analogs of the active EF-G-ribosome structure 
As Domain IV of EF-G has a steric clash with the A-site tRNA, the stable structure 
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of EF-G-ribosome in a pretranslocation state in the absence of antibiotics is not fully 
characterized. Such a structure would be useful in choosing sites of fluorescent probe 
introduction into EF-G for FRET studies. Here, we will briefly discuss EF-Tu-ribosome 
and EF4-ribosome structures which can be considered as analogs of ribosome bound EF-
G. 
1.5.2.1 EF-Tu-ribosome structure 
EF-Tu is elongation factor Tu which delivers aminoacyl tRNA to the ribosome. EF-
Tu has three domains. Domain I contains a nucleotide binding site and catalyzes GTP 
hydrolysis. Domains II and III regulate the interaction of Tu with antibiotics and with EF-
Ts which catalyzes the exchange between GDP and GTP on EF-Tu. Aminoacyl tRNA 
binds to the interface of Domain I and II of EF-Tu, with the acceptor stem-loop 
contacting Domains I and II and the T-stem contacting Domain III (Nissen et al., 1995). 
In 2009, a high resolution (3.6 Å) EF-Tu-ribosome structure with kirromycin and 
paramomycin was reported (Schmeing et al., 2009b). This structure shows a detailed 
picture of the distortion of tRNA, which allows the tRNA to interact with both the 
decoding center at the 30S subunit and the binding site on EF-Tu. Another high resolution 
EF-Tu-ribosome structure (3.2 Å) was reported in 2010 with paramomycin and GDPNP 
(Voorhees et al., 2010). EF-Tu is in an active conformation with the switch loop I 
showing an ordered structure and the catalytic histidine positioned to attack the Ƴ-
phosphate, which provides a mechanism for GTPase activation on the ribosome.  
1.5.2.2 EF4-ribosome structure 
EF4 (Lep A) is a highly-conserved GTPase which competes with EF-G for binding 
to the PRE complex and leads to a transient inhibition of elongation (Liu et al., 2011; Liu 
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et al., 2010; Qin et al., 2006). E. coli EF4 protein is made up of 599 amino acid residues 
with a weight of 67 kDa.  EF4 exhibits a strong similarity with EF-G in structure, and the 
protein domains of EF4 are homologies of domains I, II, III, and V of EF-G, but neither 
G’ or Domain IV is found in EF4. EF4 has a unique C-terminus which contains two β-
strands and two helices. The lack of Domain IV makes the stable structure of the A site 
tRNA and EF4 on the ribosome possible. In 2008, Spahn et al. and Steitz et al. reported 
EF4 structure free of the ribosome (Evans et al., 2008) or bound to the ribosome 
(Connell et al., 2008), separately. The direct comparison between EF-G and EF4 
structure indicates that the orientations of Domains III and V in EF4 are different from 
EF-G (~ 10° rotation relative to structure of H573A EF-G mutant), suggesting that the 
hinge region of Domains III, IV, and V on EF-G undergoes a large movement during 
translocation (Evans et al., 2008; Laurberg et al., 2000). With EF4, a tRNA state which 
has not been characterized before was obtained and denoted A/L tRNA.  The anticodon 
loop of the A/L tRNA extends to the decoding center in a similar position as A/A tRNA. 
However, it deviates from the A/A tRNA conformation, pivoting around the anticodon 
loop with the largest distance displacement about 14 Å in T-loop and 13 Å in 5’-end 
(Connell et al., 2008).  
1.5.3 Ensemble kinetic studies of EF-G catalysis of translocation 
Ensemble kinetic studies of the ribosome primarily rely on site-specific labeling of 
different translation components. As translocation is of great importance to my work, 
here we will focus on discussing the ensemble kinetic studies of the EF-G catalyzed 
translocation process (Fig 1.8). The commonly used methods including introduction of 
fluorescently labeled ribosome components, GTP hydrolysis assays, peptide formation 
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assays and puromycin reactivity assays (Pan et al., 2007; Rodnina et al., 1997; 
Savelsbergh et al., 2003). EF-G·GTP binds to L7/L12 stalk on the ribosome (Diaconu el 
al., 2005), followed by a rapid GTP hydrolysis with a rate constant ~ 150 s
-1
. Addition of 
the antibiotic viomycin, which inhibits translocation, does not slow down GTP hydrolysis, 
suggesting that GTP hydrolysis precedes translocation. A slower step with a rate constant 
of 25 s
-1 
measured by the fluorescence change of proflavin (prf) labeled A-site tRNA 
which is attributed to ribosome conformational changes termed the unlocking process 
(Savelsbergh et al., 2003) limits rates of mRNA-tRNA movement on the ribosome as 
well as Pi release. The substitution of GTP with its non-hydrolysable analog (i.e., 
GDPNP) largely reduces the rate constant of this process (50 fold slower, Rodnina et al., 
1997; 6 fold slower, Zavialov et al., 2003; 5 fold slower, Pan et al, 2007). The intact 
structure and flexibility of Domain IV is of crucial importance as EF-G variants with 
Domain IV truncated, or with a Domain I-V cross-linked EF-G which limits the motions 
of Domain IV, induce only slow translocation and catalyze only single turnover 
(Savelsbergh et al., 2000). Although both mRNA-tRNA movement and Pi release are 
limited by unlocking, these two processes are independent of each other. This is 
confirmed by antibiotic studies, such as those showing that viomycin inhibits mRNA-
tRNA movement, but allows Pi release (Peske et al., 2000; Savelsbergh et al., 2003). 
Both mRNA-tRNA movement and Pi release have to occur to allow subsequent steps, 
including relocking of the ribosome before EF-G·GDP dissociation. The dissociation 
process is important for multiple rounds of translocation. Substitution of GTP with 
GDPNP only allows single round translocation by preventing EF-G dissociation. 
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1.5.4 Single molecule FRET studies of elongation cycle 
Protein synthesis is a highly dynamic process that involves multi-components. 
Although as we discussed above, the ensemble measurement provides great insights 
concerning the mechanism of translation, it is limited by ensemble averaging in bulk 
solution which may make it difficult to detect important intermediates or conformational 
changes of ribosome components. Measurement at the single molecule level provides a 
powerful tool as it can reveal the population distribution for heterogeneous species 
without averaging over all populations. As my work is based on single molecule 
fluorescence studies, we will focus on discussing single molecule fluorescence or 
fluorescence resonance energy transfer (FRET) results applied to the ribosome complexes 
during translation. Single molecule fluorescence experiments can reveal the movements 
of ribosome components or protein factors based on the fluorescence intensity differences 
in different local environments. As well, changes in FRET efficiency between two 
fluorophores attached to two ribosomal complex components can be used to monitor 
relative movement between the two components.  
In 2004, two papers were reported by Puglisi and coworkers, focusing on tRNA 
dynamics on the ribosome. By using Cy3 labeled P-site fMet-tRNA
fMet
 and Cy5 labeled 
A-site Phe-tRNA
Phe
, direct tRNA - tRNA FRET was observed, showing three FRET 
states, which are assigned to the codon recognition, GTPase-activated and accommodated 
states. Comparisons of FRET values reveal differences in intermediate state sampling 
upon cognate or near-cognate tRNA binding (Blanchard et al., 2004a). The same 
fluorescent labels were introduced to elucidate tRNA dynamics. The A-site tRNA was 
observed to fluctuate between the classic and hybrid states. Peptide bond formation 
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modulates the fluctuation of tRNA between these two states, favoring the hybrid state 
(Blanchard et al., 2004b). The effects of different experimental conditions (e.g., Mg2+ 
concentration, acylation or not of aminoacyl-tRNA in the A-site tRNA) on tRNA 
equilibrium between classic and hybrid states were characterized, showing that when A-
site tRNA is not acetylated, Mg
2+
 concentration does not shift the equilibrium, while if it 
is acetylated, the classic state is stabilized by a high Mg
2+
 concentration (Kim et al., 
2007). A new hybrid intermediate state was identified by Blanchard and coworkers with 
A/A, P/E site tRNAs and expanded previous reported tRNA states (Munro et al., 2007). 
FRET studies of ribosome dynamics and correlating ribosome tRNA movements have 
been carefully investigated since 2007. By engineering extended rRNA hairpins, which 
allows site-specific hybridization of fluorescently labeled oligonuleotides, 30S and 50S 
were labeled to monitor ribosome intersubunit rotations (Chen et al., 2013b; Marshall et 
al., 2008b; Marshall et al., 2008a). L1 stalk motions during translocation were later 
characterized. Interestingly, L1 stalk shows equilibrium between open and closed 
conformations, and only interacts with the P/E site tRNA in the closed conformation. EF-
G binds to the hybrid state and shifts L1 equilibrium to favor the closed form, 
collaborating allosterically with L1 to direct tRNA movements along the translocation 
trajectories (Fei et al., 2009; Fei et al., 2008). In contrast to Fei’s results that EF-G only 
binds to tRNAs in the hybrid state, Chen from our group monitored tRNA-tRNA and 
tRNA-L11 FRET, and these FRET results suggest that EF-G binds to both hybrid and 
classic tRNAs, which is later confirmed by work from Puglisi group in 2013. Chen et al. 
(2011) also observed that translocation starting with classic tRNAs proceeds via a 
transient intermediate hybrid state (lifetime~ 80 ms), in agreement with the ensemble 
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results of Pan et al. (2007).  
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Figure 1.1 Overview of tRNA tertiary structure. (Adapted from Jenner et al., 2010) 
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Figure 1.2 Central dogma of molecular biology. (Adapted from Crick et al., 1970). 
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Ribosome/subunit 70S 50S 30S 
Molecular weight (kD) 2520 1590 930 
rRNA components 
 
23S, 16S 5S 23S and 5S 16S 
Number of nucleotides in 
rRNA 
4566 
23S, 2904 nts 
16S, 1542 nts 
5S, 120 nts 
rRNA molecular weight 
(kD) 
1664 1104 560 
Number of ribosomal 
proteins 
55 34 21 
Protein molecular weight 
(kD) 
857 487 370 
 
 
Table 1.1 Components of E. coli ribosomes. This table is adapted from Voet et al., 2006 
 
 
 
 
 
 
Figure 1. 3 Overview of bacterial translation. (Adapted from Schmeing et al., 2009). 
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Figure 1.4 Stereo view of the tertiary structure of 16S RNA. H, head; Be, beak; N, 
neck; P, platform; Sh, shoulder; Sp, spur; Bo, body. 3’ and 5’ domain are colored yellow 
and red, respectively. (This figure is taken from Wimberly et al, 2000) 
 
 
 
 
 
Figure 1.5 The tertiary structure of rRNA on the large ribosomal subunit. The 
subunit particle is in its crown view.  (This figure is taken from Ban et al, 2000) 
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Figure 1.6 Overview of the ribosome structure. Ribosomal proteins and RNA of the 
small subunit (blue and gray) and large (green and yellow) subunits are showed in 
transparency. Three tRNAs (A-, P- E- site tRNAs) are colored in orange, red and blue. 
(Adapted from Jenner et al., 2010) 
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Figure 1.7 Overview of swiveling and ratcheting movements of 30S subunit. Two 
intermediate states I (left) and II (right) of 70S-EF-G-GDP-FAcomplex. The 30S subunit 
of intermediate states I and II (yellow) is compared with the 30S subunit of the POST 
(gray, Gao, et al., 2009) by aligning the respective 50S subunits. Arrows with numbers 
indicate the direction and magnitude of the head-swivel and inter-subunit rotation from 
the non-rotated state to the intermediate states I and II. (Adapted from Ratje, et al., 2010) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 
 
 
Figure 1.8 Kinetic model of EF-G catalyzed translocation. This figure is taken from 
Savelsbergh et al., 2003. 
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CHAPTER II MATERIALS AND METHODS 
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2.1 Materials 
2.1.1 Buffers 
All of the following buffers were prepared and the pH was adjusted at 25°C. Unless 
otherwise specified, experiments in Chapters 3-5 were performed in Buffers A (WB 
buffer) and TAM
15
, respectively.  
Buffer A (WB): 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2 and 
1 mM DTT. 
TAM
15 
buffer: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 15 mM MgCl2 and 
1 mM DTT. 
Polyamine buffer: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 15 mM MgCl2 5 
mM putrescine 1 mM spermidine and 1 mM DTT. 
Buffer B: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2 and 1 mM 
DTT, 100 μM GTP, 2 mM phosphoenolpyruvate, 100 μg/mL pyruvate kinase. 
Buffer C: 20 mM Tris-HCl pH 7.6, 200 mM NH4Cl, 10 mM MgAc2. 
IF3 lysis buffer: 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 10 mM 2-mercaptoethanol, 0.2 
mM PMSF. 
IF3 purification buffer A: 10 mM Tris-HCl pH 8.0, 200 mM NaCl, 5% glycerol, 1 mM 2-
mercaptoethanol. 
IF3 purification buffer B: 10 mM Tris-HCl pH 8.0, 500 mM NaCl, 5% glycerol, 1 mM 2-
mercaptoethanol. 
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L11 dialysis buffer A: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 6 mM 2-
mercaptoethanol, 10 mM NaCl. 
L11 lysis buffer: 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 0.5 mM Imidazole, 0.5 mM 2-
mercaptoethanol 
L11 purification buffer A: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 6 mM 2-
mercaptoethanol, 10 mM NaCl, 10 mM MgCl2. 
L11 purification buffer B: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 6 mM 2-
mercaptoethanol, 400 mM NaCl, 10 mM MgCl2. 
L11 labeling buffer: 25 mM Tris-HCl pH 7.0, 100 mM NaCl, 2 mM EDTA. 
EF-G washing buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl. 
EF-G washing buffer A: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 5 mM Imidazole. 
EF-G washing buffer B: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 125 mM Imidazole. 
EF-G elution buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 300 mM Imidazole. 
EF-G labeling buffer (M-labeling buffer): 25 mM Tris-HCl pH 7.0, 100 mM NaCl, 2 mM 
EDTA. 
EF-G purification buffer A: 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 0.5 
mM EDTA.  
EF-G purification buffer B: 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1M KCl, 0.5 mM 
EDTA. 
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EF-G storage buffer: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2. 
TBE buffer: 45 mM Tris-HCl pH=8.0, 45 mM H3BO3, 1 mM EDTA pH=8.0. 
Hybridization buffer: 100 mM Tris-HCl pH 7.5, 1 M NaCl, 10 mM EDTA. 
Aminoacylation buffer A: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 20 mM MgCl2, 1 mM 
EDTA (pH 8.0), 7 mM 2-mercaptoethanol, 10 mM KCl, 0.01 unit/μL thermostable 
inorganic pyrophosphatase, 720 μM formyl donor (see section 2.2.2.1), 67 μM [
35
S]-fMet 
stock, 0.75 mg/mL E. coli aminoacyl- tRNA synthetases. 
Aminoacylation buffer B: 100 mM Tris-HCl pH 8.0, 10 mM ATP, 50 mM MgCl2, 2.5 
mM EDTA (pH 8.0), 3 mM 2-mercaptoethanol, 200 μM [
3
H]-Phe, 3 mg/mL yeast 
aminoacyl-tRNA synthetases. 
Aminoacylation buffer C: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 5 mM MgAc2, 250 μM 
EDTA (pH 8.0), 7 mM 2-mercaptoethanol, 150 μM [
3
H]-Phe, 1 μM E. coli Phe-tRNA 
synthetase. 
Aminoacylation buffer D: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 20 mM MgCl2, 1 mM 
EDTA (pH 8.0), 7 mM 2-mercaptoethanol, 0.005 unit/μL inorganic pyrophosphatase, 100 
μM [
3
H]Val or 67 μM [
3
H]-Arg or 100 μM [
3
H]-Lys, 3 mg/mL E. coli aminoacyl-tRNA 
synthetase. 
Aminoacylation buffer E: 30 mM Hepes-HCl pH 7.0, 30 mM KCl, 15 mM MgCl2, 5 mM 
DTT, 4 mM ATP, 100 μM [
3
H]-Val, 0.01 unit/μL thermostable inorganic pyrophosphatase, 
3 mg/mL of E. coli aminoacyl-tRNA synthetase. 
tRNA Phe purification buffer HPLC A: 20 mM NH4Ac (pH 5.0), 10 mM MgAc2 and 400 
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mM NaCl. 
tRNA Phe purification buffer HPLC B: 20 mM NH4Ac (pH 5.0), 10 mM MgAc2, 400 
mM NaCl, 30% EtOH. 
2.1.2 Reagents  
All the aqueous solutions and buffers were prepared using either double-deionized 
water (DDI) from Milli-A Water System (Millipore) and treated with a BioPak filter 
(Millipore) to remove the DNase, RNase and protease or diethyl pyrocarbonate DEPC-
treated water (Fisher BioReagents
TM
). Unless otherwise specified, all the concentrations 
mentioned are the final concentrations. 
The following materials were purchased from the indicated suppliers: E. coli 
tRNA
fMet
, E. coli tRNA
Phe
, E. coli tRNA
Val
, E. coli tRNA
Arg
, E. coli tRNA
Lys
, and yeast 
tRNA
Phe
 (Chemical Block). Cy3/Cy5 maleimide dye and Cy3/Cy5 hydrazide dye (GE 
Healthcare Amersham
TM 
); S. O. C. medium and Top 10 competent cells (Invitrogen); 
Fusidic acid, IPTG, GTP, GDPNP, streptomycin, puromycin, glucose, phenyl- 
methanesulfonylfluoride (PMSF), tris(2-carboxyethyl)phosphine hydrochloride (TCEP), 
N-hydroxysuccinimide ester, folinic acid, glutathione and proflavin salt (Sigma Aldrich); 
Talon Superflow Metal Affinity Resin, NAP-5 column and pETZ24a plasmid (GE 
Healthcare); phosphoenolpyruvate (PEP), pyruvate kinase (PK), RNase T1, catalase and 
bulk tRNA from E. coli. MRE600 cells (Roche); Phusion DNA polymerase and DpnI 
(New England Biolabs); DNA purification kit and Ni-NTA Superflow resin (QIAGEN); 
BL21(DE3) competent cells and QuickChange site-directed Mutagenesis Kit (Stratagene); 
ampicillin and trichloroacetic acid (TCA) (Fischer Scientific); AG 50W-X8 cation 
exchange resin(Bio-Rad); thermostable inorganic pyrophosphatase (New England 
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BioLabs); PEG-succinimidyl valerate (Laysan Bio); Amicon Ultra ultrafiltration units, 
Ultrafree centrifugal filter unit, and nitrocellulose filters (Millipore). 
2.2 Methods of preparation 
2.2.1 Proteins 
The cloned E. coli His-tagged proteins IF3 (N-terminal His-tagged), EF-G (C-
terminal His-tagged), EF-Tu (C-terminal His-tagged), and ribosomal protein L11 (N-
terminal His-tagged) were prepared, purified and labeled as previously reported (Pan et 
al., 2007; Seo et al., 2006).  
2.2.1.1 Purification of IF3  
All steps below were performed at 4 °C. 10 g of frozen BL21(DE3) IF3 cells were 
kept on ice for 10 min, and then resuspended in 30 mL of IF3 lysis buffer followed by 
French Press (12,000-14,000 psi) twice. The mixture was subject to centrifugation (10 K 
rpm, 30 min and SS-34 rotor) to pellet the cell debris. The supernatant was loaded onto a 
10 mL Ni-NTA column (18 mm in diameter, 15cm in height) which was pre-washed with 
60 mL of water and pre-equilibrated with 60 mL of IF3 lysis buffer. 
The column was then washed by 60 mL of IF3 purification buffer A followed by 30 
mL of IF3 purification buffer B. IF3 protein was eluted by using a hyperbolic imidazole 
gradient in IF3 purification buffer B (5 mM imidazole, 40 mL; 10 mM imidazole, 20 mL; 
20 mM imidazole, 10 mL; 300 mM imidazole, 50 mL) and collected in fractions. 
Fractions with large amounts of IF3 were identified by 15% SDS-PAGE gel and pooled 
for dialysis against buffer A (Fig 2.1). IF3 was concentrated by an Amicon Ultra 
ultrafiltration units [molecular weight cutoff (MWCO): 10,000] and the concentration 
was determined by Bradford assay (Bradford et al., 1976).  
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2.2.1.2 Purification and labeling of WT-L11 and L11 (C38S/S87C) 
L11 protein was grown and purified as previously reported (Seo et al., 2006). Wild-
type and (C38S/S87C) double mutant N-terminal E. coli His-tagged L11 cells were 
grown in LB medium in the presence of 100 µg ampicillin/mL at 37 °C. 1mM final 
concentration of IPTG was added to the medium and the cells were grown for another 4 
hours. The cell pellet was harvested by (10 K rpm, SS-34 rotor) centrifugation at 4 °C for 
20 minutes each cycle, then fast frozen and stored in a -80 °C refrigerator. 14 g of pellet 
was dissolved in 20 mL of L11 lysis buffer with 3 μL of DNase I (2000 U/mg) for an hour. 
Cells were broken by French press (12,000 - 16,000 psi) twice and centrifuged at 15 K 
rpm, SS-34 rotor at 4 °C for 30 min twice. 12 mL of Ni-NTA Superflow resin (Qiagen) 
were placed into a plastic flex column (18 mm in diameter, 15cm in height).  After the 
resin settled, the column was washed with water twice and pre-equilibrated with lysis 
buffer. The supernatant was loaded onto prepared Ni-NTA column and washed with 50 
mL each of L11 elution buffers A and B. Then L11 was eluted with 50 mL of elution 
buffer C and the product was collected. These procedures were repeated once. Elution 
product by buffer C was analyzed by 5-14% SDS-PAGE gel (Fig 2.2, Lane 5). The 
product was dialyzed against L11 dialysis buffer at 4 °C overnight and purification buffer 
A at 4°C for 3 hours. After concentration (1 mL) using Amicon Ultra ultrafiltration units 
(MWCO Molecular weight cut-off: 10,000), crude L11 product was purified by a 
MonoS™ (5/50 GL) FPLC column and pure L11 was eluted using a linear gradient from 
L11 purification buffer A to L11 purification buffer B (Fig 2.2, Lanes 1 and 2). Then an 
Amicon Ultra ultrafiltration unit (MWCO: 10,000) was used to remove the urea and 
replace the buffer with L11 storage buffer to allow the proper folding of L11 protein. The 
final concentration of L11 was determined by Bradford assay (Bradford et al., 1976) and 
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adjusted by multiplying by 0.6 as the conversion factor (Congdon et al., 1993). 
L11 labeling with either Cy3 or Cy5 was purified as reported (Chen et al., 2011a). 
Nap-5 column (bed volume 500 μL) was used to exchange buffer from L11 storage buffer 
to L11 labeling buffer. Nap-5 column was pre-washed by DDI water 6 times, then by L11 
labeling buffer 6 times. 500 μL of L11 protein was loaded to the column and eluted by 1 
mL of L11 labeling buffer. 100 μM L11 in 1 mL of labeling buffer was incubated with 
300 μM fresh prepared TCEP for 40 min to free disulfide bonds formed by two cysteines, 
followed by addition of 500 μM Cy3 or Cy5 maleimide and incubated at room 
temperature in dark for 3 hours. The reaction was quenched with 3 μL of 14.3 βMe and 
the mixture was loaded onto MonoS™ (5/50 GL, bed volume 500 μL, diameter 5 mm) 
FPLC column for further dye protein separation and purification. Labeled L11 was eluted 
by using a linear gradient from L11 purification buffer A to L11 purification buffer B. 
Pure dye came out in the first 2 - 4 tubes and labeled product was washed out in later 
fractions. Different FPLC fractions were pooled and determined by 5-14% SDS-PAGE 
gel (Fig 2.3). Fractions 19 - 20 were collected and combined. An Amicon Ultra 
ultrafiltration unit (MWCO: 10,000) was used to further concentrate the products. L11 
concentration was determined by Bradford assay as described above and corrected by 
multiplying a factor of 0.6. Dye concentration was determined by A550 for Cy3 and A650 
for Cy5 (Extinction coefficients: 150,000 and 250,000 M
-1
 cm
-1
 for Cy3 and Cy5, 
respectively). Typical dye/L11 ratio was 0.8 - 0.9. 
2.2.1.3 Purification and labeling of EF-G and the derivatives 
2.2.1.3.1 Purification of EF-G 
EF-G protein and its variants were grown and purified as previously reported in 
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published paper (Seo et al., 2006) and optimized conditions were explored. Expression 
vectors for C-terminal His-tagged E. coli EF-G were based on the pET-21a vector. EF-G 
plasmid (3 μL, 50-80 ng) was transformed into BL21 (DE3) competent cells (50 μL) and 
incubated on ice for 30 min. The cells were then incubated at 42 °C for 30 s, 250 μL of 
pre-warmed Super Optimal Broth (S.O.C.) medium were added, and the resulting mixture 
was maintained at 37 °C for one hour. The cell cultures were plated onto LB-Agar plate 
supplemented with 50 μg/mL of kanamycin and grown overnight at 37 °C. A single 
colony on the plate was picked and transferred to 5 mL LB medium containing 50 μg/mL 
kanamycin and incubated overnight at 37 °C. The cell culture was transferred to 100 mL 
of LB medium, then to 1L of LB medium at 37 °C in the presence of 50 μg/mL 
kanamycin (final concentration). Incubation was maintained until A600 was 0.4 larger than 
the initial value (generally A600 is ~0.4 - 0.6), followed by addition of 1 mM IPTG to 
induce over-expression of EF-G protein, and the incubation was continued for another 3 
hours. The cell pellet was harvested by centrifugation at 4 °C for 20 min (7 K rpm, GS3 
rotor). Cell pellets were fast frozen and stored at -80°C. 8 g of cell pellet was dissolved in 
15 mL of EF-G elution buffer with 3 μL of lysozyme (50 units/mL) for an hour at 4 °C. 
Cells were broken by two cycles of French press (12,000 - 16,000 psi) and centrifuged at 
15 K rpm with SS34 rotor at 4 °C for 30 min twice.  
The supernatant was loaded onto a prepared Ni-NTA column (18 mm in diameter 
and 15 cm in height) and washed by 50 mL of EF-G elution buffers A and B. The EF-G 
protein fractions eluted by 50 mL of elution buffer C were collected and this purification 
procedure was repeated once. Sample was collected to run 5-14% SDS-PAGE gel (Fig 
2.4, Lane 9) to confirm the presence of EF-G. The solution was dialyzed against EF-G 
36 
 
purification buffer A without MgCl2 at 4 °C overnight and buffer A with MgCl2 at 4 °C 
for four hours (MWCO Molecular weight cut-off dialysis membrane: 15,000). After 
concentration using Amicon Ultra ultrafiltration units (MWCO Molecular weight cut-off: 
30,000), EF-G was further purified by self packed Q-Sepharose FPLC column (bed 
volume 1 mL). Purified EF-G protein was eluted using a linear gradient from EF-G 
purification buffer A to purification buffer B (Fig 2.5). Fractions with EF-G band, as 
determined by 5-14% SDS-PAGE (Fig 2.4, lanes 2 - 8), were pooled and dialyzed against 
WB buffer overnight at 4 °C. After concentrating by Amicon Ultra ultrafiltration units 
(MWCO Molecular weight cut-off: 30,000), EF-G concentration was measured by 
Bradford assay without correction factor applied.  
2.2.1.3.2 Labeling of EF-G 
EF-G was labeled with Cy3 or Cy5 maleimide. Nap-5 column (bed volume 500 μL) 
was used to exchange buffer from WB to EF-G labeling buffer and remove βMe which 
reacted with maleimide dye. Nap-5 column was pre-washed with DDI water and with EF-
G labeling buffer 6 times separately. 500 μL of EF-G protein (334 μM) was loaded to the 
column and eluted by 1 mL of labeling buffer. The protein concentration after buffer 
exchange was measured by Bradford assay and diluted to 100 μM in 1 mL volume as the 
final concentration, which was incubated with a 5-fold molar excess of Cy3 or Cy5 
maleimide dye for 3 hours at 37 °C in dark and then quenched by 3 μL of 14.3 M βMe. 
The mixture was further purified by self packed Q-Sepharose FPLC column as previously 
described. Fractions were collected and examined by 5-14% SDS-PAGE (Fig 2.6). 
Fractions containing EF-G were pooled and dialyzed against 1L of WB buffer overnight 
at 4 °C (MWCO membrane: 15,000). Amicon Ultra ultrafiltration units (MWCO: 30,000) 
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were used to concentrate the EF-G protein and the final concentration was determined by 
Bradford assay without any conversion factor applied. Dye concentration was determined 
by A550 for Cy3 and A650 for Cy5 (Extinction coefficients: 150,000 and 250,000 M
-1
 cm
-1
 
for Cy3 and Cy5, respectively). Typical dye/EF-G ratio was 0.5 - 0.9, depending on 
which EF-G mutant was labeled. 
2.2.1.3.3 Mutants of EF-G 
2.2.1.3.3.1 PCR primer design 
The Stratagene QuikChange site-directed mutagenesis kit was used to construct EF-
G variants. The primers were designed according to the following principles (adapted 
from Stratagene QuikChange site-directed mutagenesis kit Manual):  
1) Both of the mutagenic primers must contain the desired mutation and anneal to the 
same sequence on opposite strands of the plasmid. 
2) Primers should be between 25 and 45 bases in length, with a melting temperature (Tm) 
of ≥78°C. Primers longer than 45 bases may be used, but using longer primers increases 
the likelihood of secondary structure formation, which may affect the efficiency of the 
mutagenesis reaction. The following formula is commonly used for estimating the Tm of 
primers: 
Tm=81.5 + 0.41(% GC) - 675/N-% mismatch 
For calculating Tm: 
• N is the primer length in bases 
• Values for % GC and % mismatch are whole numbers 
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For calculating Tm for primers intended to introduce insertions or deletions, use this 
modified version of the above formula: 
Tm=81.5 + 0.41(% GC) - 675/N  
where N does not include the bases which are being inserted or deleted.  
The designed primer sequences can be found in Fig 2.7 with the mutant sites colored in 
red. 
2.2.1.3.3.2 EF-G DNA purification 
Wild type EF-G cell pellet was harvested as described above. Plasmid DNA was 
purified by using the QIAprep Spin Miniprep Kit (QIAGEN). (Procedures were adapted 
from QIAprep Miniprep Handbook) 
1) Resuspend pellet bacterial cells in 250 μL Buffer P1 and transfer to a microcentrifuge 
tube. 
2) Add 250 μL Buffer P2 and mix thoroughly by inverting the tube 4 - 6 times. 
3) Add 350 μL Buffer N3 and mix immediately and thoroughly by inverting the tube 4 - 6 
times. 
4) Centrifuge for 10 min at 13,000 rpm (~17,900 x g) in a table-top microcentrifuge. 
5) Apply the supernatants from step 4 to the QIAprep spin column by decanting or 
pipetting. 
6) Centrifuge for 30 - 60 s. Discard the flow-through. 
7) Recommended: Wash the QIAprep spin column by adding 0.5 mL Buffer PB and 
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centrifuging for 30 - 60 s. Discard the flow-through. 
8) Wash spin column by adding 0.75 mL Buffer PE and centrifuging for 30 - 60 s. 
9) Discard the flow-through, and centrifuge at full speed for an additional 1 min to 
remove residual wash buffer. 
10) Place the QIAprep column in a clean 1.5 mL microcentrifuge tube. To elute DNA, 
add 50 μL Buffer EB (10 mM Tris-Cl, pH 8.5) or water to the center of each QIAprep 
spin column, let stand for 1 min, and centrifuge for 1 min. The concentration of purified 
DNA is measured by A260 (1 A260=50 ng/ μL) and about 50 -80 ng/ μL was obtained. 
2.2.1.3.3.3 PCR amplification  
Mutant strand synthesis reactions were performed by Thermal Cycler using the 
Stratagene QuikChange site-directed mutagenesis kit. 5 μL of 10× reaction buffer, 5 ng, 
10 ng, 20 ng, 50 ng of wild type EF-G plasmid, 125 ng of primer 1, 125 ng of primer 2 
(Fig 2.8), 1 μL of dNTP were mixed and double-distilled water (DDI H2O) was added to 
a final volume 50 µL, followed by addition of 1 μL of 2.5 U/μL PfuTurbo DNA 
polymerase. The PCR machine was programmed for two segments: 1) one cycle at 95 °C 
for 30 sec; 2) eighteen cycles at 95 °C for 30 sec, at 55°C (or 60 °C, or 62 °C, 65 °C) for 
1 min (annealing), and at 68 °C for 5.5 min (1min/kb of plasmid length). After the final 
cycle, the reaction was stopped and kept at 4 °C overnight. DpnI was added to digest the 
amplification products. 1 μL of 10 U/μL DpnI restriction enzyme, 4.5 μL of reaction 
buffer 4 and 40 μL of PCR amplification product were gently mixed at 37 °C for 1 hour 
to digest the parental supercoiled dsDNA. Nucleotides of dsDNA in EF-G were expected 
to be 5.2 Kb in length and final products were confirmed by 1% DNA Agarose gel in 
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TBE buffer, showing expected brand located between 5 Kb and 6 Kb (Fig 2.8). The 
desired PCR products were sequenced. The DNA plasmids confirmed by sequencing 
results were transformed and then purified as described in section 2.2.1.3.3.2.  
2.2.1.4 Purification of EF-Tu 
EF-Tu protein was expressed and purified as previous reported (Liu et al., 2014). 
Expression vectors for C-terminal His-tagged E. coli EF-Tu variants were based on the 
pET15b vector. EF-Tu plasmids (50 - 80 ng) were transformed into BL21(DE3) 
competent cells, and the strains was grown in Super Optimal Broth (S.O.C.) medium at 
37 °C for one hour. The cell cultures were plated onto LB-Agar plate with 100 μg/mL of 
ampicillin and grown overnight at 37 °C. Single colony on the plate was inoculated into 6 
mL of LB medium containing 100 μg/mL of ampicillin for overnight growth at 37 °C. 
The cell culture was transferred into 1 L of LB medium with 100 μg/mL of ampicillin for 
growth until A600 reached ~0.6 - 0.8. Protein expression was induced by addition of 1 mM 
IPTG and continued for another 3 hours at 37 °C. The cell pellet was harvested by 
centrifugation at 4 °C for 20 min each cycle (7 K rpm, GS3 rotor). The pellets were 
resuspended in 25 mL of EF-Tu purification buffer A and the mixture was magnetically 
stirred for 30 min at 4 °C. A second incubation at room temperature for 20 min was 
performed after addition of 3 μL of lysozyme (50 units/mL). Cell was broken by French 
press twice (12,000 - 14,000 psi) and centrifuged (4 °C, 20K rpm with SS34 rotor, 20 min) 
to remove the cell debris. The supernatant was mixed with Co(II)-Sepharose (Talon) resin 
(bed volume 3 mL), pre-washed twice with 30 mL of EF-Tu purification buffer A, and 
shaken at 4 °C for 1 hour. Resin bound with EF-Tu was collected by centrifugation (4 °C, 
5K rpm with SS34 rotor, 5 min), washed twice by 30 mL of EF-Tu purification buffer A, 
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and transferred to a small gravity column (18 mm in diameter, 4 cm in height). The 
column was washed with 10 mL of EF-Tu purification buffer A, 10 mL of EF-Tu 
purification buffer B and 10 mL of EF-Tu purification buffer C, respectively. EF-Tu was 
eluted by EF-Tu elution buffer and the collected fraction was examined by 5-14% SDS-
PAGE gel (Fig 2.9). Amicon Ultra ultrafiltration units (MWCO: 10,000) were used to 
concentrate the samples and replace the elution buffer with EF-Tu storage buffer. EF-Tu 
concentration was determined by Bradford assay without any conversion factor applied 
for correction. 
2.2.2 tRNAs 
2.2.2.1 Preparation of formyl donor 
Formyl donor was prepared as described (Dubnoff et al., 1971). 25 mg of folinic 
acid was dissolved in 2.0 mL of 50 mM 2-mercaptoethanol, followed by addition of 1.0 
M HCl 0.22 mL, and the mixture was reacted for 3 hours at room temperature. Some 
precipitation can occur during the reaction, which could be re-dissolved on gentle heating 
in a water bath set at 37 °C. Formyl donor concentration was determined by A355 (at 355 
nm, 1 μmol/mL = 25 A355). The product was then aliquoted for storage at -80 °C. Before 
being used for tRNA
fMet
 aminoacylation, the pH of formyl donor was activated by 
adjusting to its neutral pH with 1/4 volume of 1 M Tris-HCl, pH 8.0 and incubating at 
room temperature for 15 min. 
2.2.2.2 Formylaminoacylation of tRNA
fMet
 
Wild type commercial E. coli tRNA
fMet 
was formylated by formyl donor and charged 
by bulk E. coli tRNA synthetase, synthetase S-100 (Kirillov et al., 1981). 7 μL of [35 S]-
Met was mixed with 21 μL of 670 μM non-isotopic labeled Met and DDI water to form 
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Met stock in a total volume of 210 μL.  36 nmol of tRNA
fMet 
was incubated in 2 mL of 
aminoacylation buffer A (which contains formyl donor) at 37 °C for 45 min. The reaction 
was quenched by 200 μL, 20% (w/w) KAc (pH=5.0), aliquoted in four tubes. The 
reaction mixture was extracted with 1:1 (v/v) phenol (Tris-saturated, pH 4.3, Fisher) once 
and 1:1 (v/v) chloroform once. Each time, the reaction mixture was centrifuged at 8 K 
rpm for 5 min (Table centrifuge, Thermo Scientific Micro 17, 24×15/2.0 mL rotor) and 
the upper aqueous layer was taken for EtOH precipitation. After addition of 50 μL of 20% 
KAc (pH=5.0), 1400 mL of 99% ethanol was added to the reaction mixture, then stored at 
-80 °C for 40 min and centrifuged at 13 K rpm for 25 min (Table centrifuge, Thermo 
Scientific Micro 17, 24×15/2.0 mL rotor). 
The formylaminoacylated tRNA pellet was suspended in 1 mL of tRNA FPLC buffer 
A and further purified by FPLC using a self-packed column (bed volume, 1 mL) with Q-
Sepharose resin. The final product was eluted by a gradient from tRNA FPLC buffer A 
(30 mL) to tRNA FPLC buffer B (30 mL) and the product was collected as determined by 
both UV peak position and radioactivity. The pooled fMet-tRNA
fMet
 fractions were 
aliquoted in 500 μL, and 20% KAc pH 5.0 (50 μL) was added, followed by 1400 μL of 
ethanol. The reaction mixture was stored at -80 °C for 40 min and centrifuged at 13 K 
rpm for 25 min (Table centrifuge, Thermo Scientific Micro 17, 24×15/2.0 mL rotor). The 
resulting precipitate was collected and dissolved in 60 μL DEPC-treated water. The 
concentration of tRNA and charging efficiency was determined by A260 (1 unit A260 =1.8 
μM) and radioactivity. Typical aminoacylation stoichiometry was 1100 - 1300 pmol/A260. 
2.2.2.3 Aminoacylation of tRNA
Phe 
Commercial tRNA
Phe
 from yeast and E. coli was aminoacylated in the similar 
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procedures as in the preparation of fMet-tRNA
fMet
, except that for yeast tRNA
Phe
 and E. 
coli tRNA
Phe
, aminoacylation buffer A was replaced by aminoacylation buffers B and C, 
respectively. Typical aminoacylation stoichiometries were 550 - 700 pmol/A260, for both 
yeast and E. coli Phe-tRNA
Phe
. 
2.2.2.4 Aminoacylation of E. coli tRNA
Arg
, tRNA
Val 
Commercial tRNA
Arg
 and tRNA
Val
 from E. coli was aminoacylated in the similar 
procedures as above. Similar aminoacylation steps were applied expect that: 1) E. coli 
tRNA
Arg
, 2 mL of reaction mix was in aminoacylation buffer D and the typical 
aminoacylation stoichiometry was 500 - 650 pmol/A260; 2) E. coli tRNA
Val
, 2 mL of 
reaction mix was in aminoacylation buffer E and the typical aminoacylation 
stoichiometry was 1000 - 1200 pmol/A260. 
2.2.2.5 Proflavin labeling fMet-tRNA
fMet
 
E. coli fMet-tRNA
fMet 
was fluorescently labeled by proflavin followed the protocol 
reported by Pan et al., 2007. The dihydrouridine residues on the D-loop of tRNA were 
reduced by NaBH4 in 0.01 M KOH and replaced by proflavin. 32 nmol of  uncharged 
tRNA were incubated in 40 mM Tris-HCl pH 7.5 and rapidly mixed with 35.8 μL of 100 
mg/mL NaBH4 (final concentration, 10 mg/mL). The reaction mixture was maintained on 
ice for 1 hour, with H2 released every 10 min. The reduction reaction was quenched by 
adding 60 μL of 6 M HAc dropwise and three EtOH precipitations were performed to 
purify the tRNA pellet. After proper dilution, tRNA concentration was measured by A260 
and stored at -80 °C. Formylmethionylation and purification were performed as described 
above. Product pellet was resuspended in 100 μL of H2O and mixed with 1 mL of 0.52 
mg/mL proflavin in 0.1 M HCOONa (pH 3.7) at 37°C for 45 min. After incubation, the 
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solution was adjusted to pH 7.5 by addition of 1/10 volume of 1 M Tris, and extracted 
twice with 1:1(v/v) phenol (Tris-saturated, pH 6.5). Labeled tRNA was EtOH precipitated 
twice after addition of 1/10 volume of 20% KAc (pH 6.5). Charging and labeling 
efficiencies were generally obtained as follows: 700 - 900 pmol/A260 and 0.9 - 1.1 
prf/tRNA for tRNA
fMet
. 
2.2.2.6 tRNA
Phe
 labeling with Cy3 or Cy5 
Yeast tRNA
Phe
 was labeled with Cy3 (Pan et al., 2008; Pan et al., 2009) or Cy5 
(Kaur et al., 2011) as reported. tRNAPhe was reduced and aminoacylated as described 
above. Pellet from last EtOH precipitation was resuspended in 800 μL of HPLC buffer A 
and purified by phenyl RP-HPLC (RP-C18 column, 4.6 × 250 mm, Alltech) with a 
gradient of 0% to 30% ethanol in 20 mM NH4Ac (pH 5.0), 10 mM Mg(Ac)2 and 400 mM 
NaCl. Pooled fractions were combined and EtOH precipitated with 20% KAc (pH 5.0). 
The dried pellet was resuspended in 16 μL of 0.1 M HCOONa (pH 3.7) with 4.3 μL of 
300 mM fluorescence dye in DMSO to make the final concentration of dye 60 mM which 
was tested to be the best labeling condition. The reaction mixture was incubated at 37 °C 
for 2 hours, followed by lyophilizing the samples. The resulting solid was dissolved in 
100 μL of DEPC-treated water, and then 10 μL of 20% KAc (pH 6.5) was added followed 
by ethanol precipitation. The solution-precipitation step was repeated a total of three 
times. Phe-tRNA
Phe 
(Cy3 or Cy5) was obtained with an aminoacylation efficiency of 
~900 pmol/A260 and ~0.5 Cy3 or Cy5/tRNA. 
2.2.3 mRNA 022 
mRNA 022 was purified as reported (Pan et al., 2007). 100 µL of mRNA 022 
plasmid ( 2.9 µg/µL) from Wei Liu was linearized by incubating with Hind III enzyme 
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(30 µL, 100,000 units/mL), a type II restriction enzyme, 10 fold buffer 2, and DEPC 
water, all from Hind III-HF kit (New England BioLabs), at 37 °C overnight. Linearized 
mRNA plasmid was extracted once with 1:1 (v/v) phenol/chloroform and once with 
chloroform, followed by EtOH precipitation with 1/10 volume of 20% KAc (pH 5.0). The 
pellet was dried and dissolved by 100 μL of DEPC-treated water. Dilutions were 
performed to allow concentration of mRNA to be determined by A260 (0.1 - 1.0).  Plasmid 
(9 µL, 150 ng/μL) was mixed with the following materials from the EPICENTRE 
AmpliscribeT7-Flash Transcription Kit: 36 µL of NTPs (100 mM, initial concentration, 
for each of ATP, CTP, GTP and UTP), 40 µL of DTT (100 mM, initial concentration), 40 
µL of T7 enzyme (10,000 units/mL) and 127 μL RNase-free water in a total volume 400 
μL. Following incubation of the mixture at 42 °C for 2 hours, 40 μL of DNase I (1 
MBU/μL) was added and incubation was continued at 37 °C for 15 min. The reaction 
mixture was extracted by 400 μL of 1:1(v/v) phenol/ chloroform once and 400 μL of 
chloroform once. 400 μL of chilled 5 M LiCl was added to the upper aqueous layer and 
left on ice for 1hour, followed by centrifugation at 15 K for 20 min (Thermo Scientific 
Micro 17, 24×15/2.0 mL rotor in cold room). The mRNA pellet was resuspended in 200 
μL of DEPC water and further purified by EtOH precipitation (99-100% ethanol). The 
pellet was washed by 400 μL of 70% ethanol and subjected to centrifugation at 15 K rpm 
for 5 min (Thermo Scientific Micro 17, 24×15/2.0 mL rotor in cold room). The purified 
pellet was dried and resuspended by 200 μL of DEPC water, followed by another EtOH 
precipitation and the final product was resuspended in 200 μL of DEPC water. The 
concentration and purity of mRNA was determined by A260, assuming 0.04 mg/A260 and 
electrophoretic analysis on 2% Agarose gel, respectively (Fig 2.10).  
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2.2.4 70S ribosomal complexes 
The mutant 70S ribosomes lacking L11 from E. coli AM77 cells and tight coupled 
wild-type 70S ribosomes from E. coli MRE600 cells were prepared and purified as 
previously reported (Liu et al., 2010; Pan et al., 2007). 
2.2.4.1 Preparation of Cy3 or Cy5 labeled 70S ribosome  
The reconstitution of 70S ribosomes containing L11
Cy3 
or L11
Cy5
 were performed as 
described (Chen et al., 2011a). A two-fold molar excess of C38-L11Cy5 or C38S/S87C-
L11
Cy5 
was incubated with E. coli AM77 ribosome.  53 μL of 46 μM Cy5 labeled L11 
(2400 pmol) and 64 μL of 19 μM AM77 70S (1200 pmol) were incubated separately at 
37 °C for 5 min in WB buffer. Then the two solutions were mixed and continued 
incubating at 37 °C for 15 min. MgCl2 was added to the mixture to increase the final 
Mg
2+ 
concentration to 20 mM, and the mixture was subject to centrifugation through a 
sucrose cushion in WB buffer with 1.1 M sucrose, 1 mM DTT and 20 mM Mg
2+
 
(SORVALL S120-AT2 rotor, 110K rpm, 40 min, 4 °C) to pull down the labeled 70S 
ribosome. The pellet was resuspended in 100 μL of WB buffer. 70S concentration was 
determined by A260 and dye concentration was determined by A550 for Cy3 or A650 for Cy5, 
respectively. A typical labeling efficiency is 0.8 - 1.0 dye per 70S ribosome. 
2.2.4.2 Preparation of initiation complex 
For ensemble experiments, 70S initiation complex was formed by incubating 2 μM 
WT or labeled ribosomes with 8 μM mRNA, 3 μM IF1, 3 μM IF2, 3 μM IF3, 1 mM GTP 
and 3 μM [
35
S]-fMet-tRNA
fMet
 or 3 μM [
35
S]-fMet-tRNA
fMet
 (prf 20) for 25 min at 37°C 
in WB buffer. The mixture was centrifuged through a sucrose cushion in WB buffer with 
1.1 M sucrose and 1 mM DTT (SORVALL S120-AT2 rotor, 110K rpm, 40 min, and 4 °C) 
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to pull down 70S initiation complex and get rid of all unbound protein factors.  Initiation 
complex concentration was determined by ribosome-bound [
35
S]-fMet-tRNA
fMet
. The 
stoichiometry per ribosome of tRNA bound [
35
S]-fMet was typically ranged from 0.4-0.8, 
depending on ribosome preparation. 
 
For single molecule experiments, two unlabeled initiation complexes and two labeled 
initiation complexes were prepared by mixing 1 μM WT or labeled ribosome with 4 μM 
mRNA, 1.5 μM each of IF1, IF2, IF3, 1 mM GTP and 1.5 μM [
35
S]-fMet-tRNA
fMet
 for 25 
min at 37 °C in a total volume of 40 μL. IC-1 contains mRNA MVF and WT ribosomes; 
IC-2 contains mRNA MFK and WT ribosomes; IC-3 contains mRNA MFK and 
C38L11
Cy5
-ribosomes; IC-4 contains mRNA MFK and C38S/C87L11
Cy5
-ribosomes. The 
initiation complex was subjected to centrifuge through a sucrose cushion in WB with 1.1 
M sucrose and 1 mM DTT (SORVALL S120-AT2 rotor, 110K rpm, 40 min at 4 °C). 
2.2.4.3 Preparation of ternary complex 
Ternary complex was formed by incubating EF-Tu (4.5 - 6 μM) with 1 mM GTP, 1.5 
mM phosphoenolpyruvate (Roche Diagnostics), 0.005 mg/mL pyruvate kinase (Roche 
Diagnostics) in WB buffer for 5 min to activate EF-Tu. Then unlabeled or labeled Phe-
tRNA
Phe
 (3 μM), or unlabeled or labeled Val-tRNA
Val
, or unlabeled Arg-tRNA
Arg
, or 
unlabeled Lys-tRNA
Lys
 (3 μM) was added and incubated for another 5 min at 37 °C in 
WB buffer.  
2.2.4.4 Preparation of PRE complex 
PRE complex was formed as published preparation (Pan et al., 2007). Initiation 
complex (1 µM, final concentration) and ternary complex (2 µM, final concentration) 
were incubated at 37 ºC for 45 sec. The product was purified by ultracentrifugation 
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through a 1.1 M sucrose cushion in WB buffer with 20 mM Mg
2+
( SORVALL S120-AT2 
rotor, 110K rpm, 40 min, 4 °C). PRE complex concentration was determined from 
ribosome-bound fMet-[
3
H]-Phe-tRNA
Phe
, which typically varied from 0.6 - 0.8/ribosome. 
The stoichiometry per ribosome of tRNA bound [
3
H]-Phe was typically 0.6 - 0.7. In 
single molecule experiments of the A-site tRNA and EF-G interaction, two PRE 
complexes were used. PRE-I was formed by incubating IC-1 (0.4 - 1 pmol) with Cy5 
labeled Val-tRNA
Val 
ternary complex (0.8 - 2 pmol) on ice for 1 min. PRE-II was 
prepared similarly by incubating IC-2 with Cy5 labeled Phe-tRNA
Phe 
ternary complex. 
For single molecule experiments measuring L11
Cy5
 and EF-G
Cy3
 interaction, PRE-II
38-Cy5
 
was formed by incubating C38L11
Cy5
-IC-3 with wild type Phe-tRNA
Phe
 ternary complex 
and labeled PRE-II
87-Cy5
 was formed by incubating Cy5 C38S/C87L11 labeled IC-4 with 
wild type Phe-tRNA
Phe
 ternary complex on ice for 1 min. 
2.2.4.5 Preparation of POST complex 
POST complex was prepared by incubation of initiation complex (1 µM) and ternary 
complex (2 µM) at 37 ºC for 45 sec, followed by addition of 5 μM EF-G and 1 mM GTP 
at 37 ºC for 10 min, and ultracentrifugation through a 1.1 M sucrose cushion (SORVALL 
S120-AT2 rotor, 110K rpm, 40 min, 4 °C) in WB buffer. POST complex concentration 
was calculated from the amount of ribosome-bound fMet-[
3
H]-Phe-tRNA
Phe
. The 
stoichiometry per ribosome of tRNA bound [
3
H]-Phe was typically 0.6-0.7  
2.2.5 Ensemble fluorescence measurements 
All the ensemble experiments were measurements and associated incubation steps 
were performed at 25.0 °C.  
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2.2.5.1 Static fluorescence experiments 
Steady-state fluorescence was measured on a photon-counting instrument 
(Fluorolog-3 spectrofluorometer, Horiba Jobin Yvon). The Cy5 fluorophore was excited 
at 600 nm wavelength and the emission spectrum from 610 - 740 nm wavelength was 
recorded. The Cy3 fluorophore was excited at 514 nm wavelength and the emission 
spectrum from 530 - 750 nm wavelength was recorded.  
Solutions containing Cy3 labeled EF-G and wild type 70S or PRE complexes were 
excited at 514 nm and the emission was monitored from 530 to 750 nm wavelength. 
Solutions containing Cy3 labeled EF-G and L11
Cy5
-70S or L11
Cy5
-PRE complex were 
excited at 514 nm and the emission was monitored from 530 to 750 nm wavelength. 
Solutions containing wild type EF-G and L11
Cy5
-70S or L11
Cy5
-PRE complex were 
excited at 600 nm and the emission was monitored from 610 - 740 nm wavelength. The 
same wavelengths were utilized for experiments performed with fusidic acid. The four 
samples in each case differ only in the presence or absence of the donor (Cy3) or acceptor 
(Cy5) dyes, and they are designated D*A (donor-containing), D*A* (donor- and 
acceptor-containing), DA* (acceptor-containing), and DA (a blank sample without donor 
or acceptor dyes). Signal of DA was subtracted from those of D*A*, D*A and DA* to 
correct the light scattering and background fluorescence. Fluorescence of 
    
                 
                
 was subtracted from D*A* signal as a correction for donor leakage 
in the acceptor channel. Then DA* signal upon 514 nm excitation was subtracted from 
the corrected value of D*A* signal, yielding the extracted D*A (Cy5) fluorescence from 
energy transfer (Seo et al., 2006). 
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2.2.5.2 Kinetic experiments  
2.2.5.2.1 Stopped-flow fluorescence experiments  
Experiments were performed in an SX.18MV stopped-flow spectrofluorometer 
(Applied Photophysics) with excitation ranging from 500 to 600 nm. The dead time is 1 -
2 ms, giving sufficient time resolution for most of the fluorescence or FRET changes 
monitored. For the fluorescence experiments, Cy3 dye was excited at 530 nm and 
monitored with a 570 ± 10 nm band pass filter. Proflavin was excited at 462 nm and 
monitored with a 515 ± 15 nm band pass filter. For FRET experiments, Cy3 dye was 
excited at 530 nm and monitored with 670 ± 10 nm band pass filter for Cy5 signal. Slit 
widths were 2 nm for the excitation. For every independent experiment, signals from the 
initial 2 to 3 shots were not collected to make sure the two chambers were filled with 
reaction mixtures.  Collected fluorescence signals were averaged from at least 5 traces to 
make sure the abnormal traces were not counted and each experiment was repeated at 
least twice to make sure the results were reproducible. Apparent rate constants (kapps) 
were obtained by either single           
 
    
  or double exponential fitting 
          
 
    
       
 
    
  of each independent experiment using Origin 9.0 
(OriginLab).  
2.2.5.2.2 Puromycin assay 
Puromycin (puro) experiments were designed as reported in Pan et al, 2007 and 
optimized experimental condition was tested. Puromycin is an analog of 3’ end tyrosyl-
tRNA which has a 3000 fold greater reactivity with the P-site peptidyl tRNA than the A-
site peptidyl tRNA. All experiments were performed at 37 °C in WB buffer. For the 
control group, 20 μL of PRE complex was incubated with 20 μL of puro for 10 sec and 
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then quenched with 150 μL of 0.3 M NaAc (pH=5.2). In the real experiment, 20 μL of 
PRE complex was incubated with 2 μM wild type EF-G or Cy3 labeled EF-G derivatives 
for 20 s, followed by addition of 20 μL puro for 10 sec and quenched with 150 μL of 0.3 
M NaAc (pH=5.2). The quenched products were extracted by 600 μL of ethyl acetate and 
counted the radioactivity of [
35 
S]-fMet-tRNA
fMet
. 
2.2.6 Single molecule FRET experiments  
2.2.6.1 Temperature 
Single molecule experiments were performed at 21 °C. 
2.2.6.2 Microscope 
Microscope was set up as described in (Chen et al., 2011a). A custom-built 
objective-type total internal reflection fluorescence (TIRF) microscope was based on a 
commercial inverted microscope (Eclipse Ti, Nikon) with a 1.49 N.A. 100×oil immersion 
objective (Apo TIRF; Nikon, Tokyo, Japan). A Dual View splitter (Photometrics, Tucson, 
AZ) was used to separate fluorescence intensities of Cy3 channel (550-620 nm) from Cy5 
channel (660-720 nm). Cy3 fluorophore was excited by a 532 nm laser (CrystaLaser, Inc.) 
and Cy5 fluorophore was excited by a 640 nm laser (Coherent, Inc.). The FRET signal 
between Cy3 and Cy5 was measured by the corrected emission of Cy5 fluorophore.  
Fluorescence signals were recorded with an electron multiplying charge-coupled device 
(EM-CCD) camera (Cascade II, Photometrics) at either an 11 ms or a 35 ms integration 
time, the 11 ms integration time was achieved by cutting the exposure area down to 128 
pixels × 512 pixels without further binning and the 35 ms integration time was recorded 
by using the whole area (512 pixels × 512 pixels).  
Fluorescence data was collected and analyzed as described below (adapted from 
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Chen et al., 2011). Collected movies were analyzed by a custom-made software program 
developed as an Image J Plugin. Fluorescence spots were fitted by a two-dimensional 
Gaussian function within 9 pixels × 9 pixels area, matching the donor and acceptor spots 
using a variant of the Hough transform (Illingworth et al., 1988). The background 
subtracted central intensity of the two-dimensional Gaussian peak was used as raw 
fluorescence intensity I. Actual FRET efficiency was calculated by 
     
                     
      
  
  
                                                                                    (Equation 2.1) 
where ID is raw fluorescence intensity of donor, IA is raw fluorescence intensity of 
acceptor, and χ is the cross-talk of the donor emission into the acceptor channel.   
accounts for the differences in quantum yield and detection efficiency between the donor 
and the acceptor and is calculated as the ratio of change in the acceptor intensity (ΔIA) to  
change in the donor intensity (ΔID) upon acceptor photobleaching and transition between 
different FRET states (          . 
2.2.6.3. Preparation of PEG-coated slides  
PEG-coated slides were prepared as described in Chen et al, 2011. Glass slides and 
coverslips (Fisher Scientific) were sonicated in acetone for 10 min at 40 °C, then washed 
with water 3 times and the entire procedure was repeated once. The slides and coverslips 
were sonicated in 200 mM KOH for 20 min at 40 °C and dried at room temperature. 
Slides and coverslips were aminosilanized by 1% (v/v) 3-aminopropyltriethoxysilane 
(United Chemical Technologies, Inc.) and 5% (v/v) acetic acid in methanol, and then the 
containers were sealed in dark overnight under room temperature. The slides and 
coverslips were washed by DDI water and EtOH five time each, followed by incubation 
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with a polyethylene glycol mixture, which is 20% (w/v) 5000 MW PEG-succinimidyl 
valerate (Laysan Bio) and 0.25% (w/v) 5000 MW biotin-PEG-succinimidyl valerate 
(Laysan Bio) in 100 mM NaHCO3 solution for 3 hours in dark (Roy et al., 2008). The 
prepared sides and coverslips were dried, sealed and stored in a -20 °C refrigerator.  
2.2.6.4 Immobilizing the ribosome complex onto the slides 
All the smFRET studies were carried out at 21 °C in TAM
15 
buffer unless otherwise 
specified. 30 μL of 0.5 mg/mL streptavidin was added to the slides and the excess 
material was washed away by TAM
15 
buffer. Initiation complexes (0.4 - 1 pmol) 
containing a 5’-biotinylated mRNA (Dharmacon RNAi Tech) were mixed in a 1:2 ratio 
with ternary complexes (0.8 - 2 pmol) in 30 μL of reaction buffer for 1 min on ice to form 
PRE complexes, which were later immobilized onto a biotin/PEG-streptavidin coated 
glass surface and washed with buffer to remove unbound complexes. The washing buffer 
was composed of an enzymatic deoxygenation system of 3 mg/mL glucose, 100 μg/mL 
glucose oxidase, 40 μg/mL catalase, 1.5 mM 6-hydroxy-2,5,7,8-tetramethyl-chromane-2-
carboxylic acid (Trolox, Sigma-Aldrich) and 1 mM GTP to diminish fluorophore 
photobleaching and blinking. After quick injection of 5 to 10 nM Cy3 labeled EF-G 
derivatives, real-time Cy3 and Cy5 fluorescence signals were collected for 1 min, then 
the microscope was moved to another area of the slide for data collection.   
2.2.6.5 Data analysis of single molecule experiments 
2.2.6.5.1 FRET efficiency distribution 
FRET efficiency distribution was plotted in the range of -0.2 to 1.2 by collecting all 
the FRET traces and using 0.02 as the bin size. The FRET peaks were fitted by the 
Gaussian function. 
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 y=y0 + (
                   
      
 
  
      
   
 
)                                                                           (Equation 2.2) 
2.2.6.5.2 Dwell time distribution 
Dwell time distribution was plotted in a range of 0 to 220 frames (35 ms per frame) 
by collecting all the FRET traces and using 1 or 2 frames as the bin size, depending on 
the number of traces collected. The dwell time distribution was fitted by either single 
(Equation 2.3) or double exponential decay (Equation 2.4). The fitting result is mostly 
contributed from the fast components of the FRET recordings as the best fit is obtained in 
this region, whereas the slow component is not that well fitted. However, this fitting 
strategy is reasonable, for the slow component is likely to be inactive ribosome 
complexes, for instance, complexes with unchanged tRNA in the P-site or less active 
PRE complexes. To simplify the term, we denote our fitting result as dwell time, but 
precisely, it is the result of fitting the fast components of the FRET traces.  
           
 
    
                                                                                      (Equation 2.3) 
          
 
    
       
 
    
                                                                        (Equation 2.4) 
2.2.6.5.3 ΔFRET, Initial and Final FRET distributions 
FRET events which lasted longer than 6 frames were selected. The initial and final 
FRET was calculated as the averaged results of the first and last three frames, 
respectively. The global fitting results suggested that for some experiments, fast FRET 
change occurred soon after EF-G binding. For these events, only 4 frames were examined, 
with the first frame value defined as initial FRET and the last three averaged as the final 
FRET to avoid an averaging protocol that would miss the fast FRET change occurring 
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early in the event. Results were plotted as a two-dimensional transition density contour 
map. Similar selection criteria were applied and the transition density map was plotted by 
mapping the initial FRET value along the x axis and final FRET value along the y axis 
directly. In this way, the number of events with specific initial and final FRET values 
could be counted from the map. The FRET difference distribution, which was calculated 
by final FRET value minus initial FRET value, was plotted in the range of -0.8 to 0.8 
using 0.02 as the bin size. The initial FRET and final FRET distributions were plotted in 
the same way. 
2.2.6.5.4 Postsynchronized analysis 
Postsynchronized analysis was performed as reported in previous two papers (Chen 
et al., 2012; Chen et al., 2011a) in order to reduce the noise of the data collected. All 
FRET events were lined up at an identifiable trigger transition and averaged. To get equal 
durations, all individual traces were extended at the prior and subsequent segment ends. 
FRET traces were aligned at the beginning (pre-synchronization) or end (post-
synchronization). The averaged results revealed the dynamics of the molecules leading up 
to and following the transition and provided information which was previously hidden 
due to the noise of the collected data (Fig 2.11). The lifetime of any given state is equal to 
the reciprocal of transition rate of the given state and the apparent overall translocation 
rate is the reciprocal of the summed lifetimes of all states in translocation. Two kinetic 
models were built to study the transition rates by fitting the FRET efficiency. All the 
results were fitted by Scientist 3.0 (MicroMath) and the detail programs are as follows:  
Three-state model 1: Fitted by FRET  
Define:  
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T, time;  
Y1, FRET efficiency of pre-synchronization trace;  
Y2, FRET efficiency of post-synchronization trace;  
k1, k2, k3: transition rates;  
F1, F2, F3: FRET efficiencies of different complexes;  
A, B, C: concentrations of different complexes in pre-synchronization analysis; 
D, E, F: concentrations of different complexes in post-synchronization analysis. 
// Simulations 
IndVars: T 
DepVars: Y1, Y2 
Params: k1, k2, k3, F1, F2, F3 
Y1=F1*A+F2*B+F3*C 
A'=-k1*A 
B'=k1*A-k2*B 
C'=k2*B 
 
Y2=F3*D+F2*E+F1*F 
D'=-k3*D 
E'=k3*D-k2*E 
F'=k2*E 
// Parameter values and constrains 
//Initial conditions 
T=0 
A=1 
B=0 
C=0 
D=1 
E=0 
F=0 
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> 
Two-state model: Fitted by FRET 
Define:  
T, time;  
Y1, FRET efficiency of pre-synchronization trace;  
Y2, FRET efficiency of post-synchronization trace;  
k1, k2: transition rates;  
F1, F2: FRET efficiencies of different complexes;  
A, B: concentrations of different complexes in pre-synchronization analysis; 
D, E: concentrations of different complexes in post-synchronization analysis. 
// Simulations 
IndVars: T 
DepVars: Y1, Y2 
Params: k1, k2, F1, F2 
 
Y1=F1*A+F2*B 
A'=-k1*A 
B'=k1*A 
Y2=F2*D+F1*E 
D'=-k2*D 
E'=k2*D 
// Parameter values and constrains 
//Initial conditions 
T=0 
A=1 
B=0 
D 
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Figure 2.1 Electrophoretic analysis of IF3 by 15% SDS-PAGE gel. Protein 
concentration measured by Bradford is 180 µM, IF3 (21 KD). 
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Figure 2.2 Electrophoretic analysis of His-tagged L11 fractions. Lane 1, L11 (14.5 
kDa) after FPLC, 3µL; Lane 2, L11 after FPLC, 9µL; Lanes 3 and 4, L11 pellet debris 
after centrifugation and before Ni-NTA column purification; Lane 5, 2
nd
 flow through of 
L11 elution buffer C of Ni-NTA column purification; Lane 6, 1
st
 flow through of L11 
elution buffer A of Ni-NTA column purification; Lane 7, 2
nd
 flow through of L11 elution 
buffer A of Ni-NTA column purification; Lane 8, 1
st
 flow through of L11 elution buffer B; 
Lane 9, 2
nd
 flow through of L11 elution buffer B of Ni-NTA column purification.  
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Figure 2.3 Electrophoretic analysis of labeled L11 fractions after FPLC. Lanes 1 - 8 
corresponded to FPLC fractions 16 - 23.  Fractions 19 - 20 (lanes 4 and 5) were collected 
and combined. 
 
61 
 
 
Figure 2.4 Electrophoretic analysis of EF-G fractions of FPLC.  Lane 1, EF-G (74 
kDa) after final concentration by Amicon Ultra ultrafiltration units (after FPLC); Lanes 2 
- 8, different FPLC fractions of EF-G; Lane 9, EF-G protein eluted by EF-G elution 
buffer C after Ni-NTA column and before FPLC purification.  
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Figure 2.5 FPLC buffer gradient of EF-G purification. The second red peak (24 - 37 
mL) indicated the elution fraction of EF-G protein.  
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Figure 2.6 Electrophoretic analysis of labeled EF-G. The labeled product was purified 
product after FPLC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
Figure 2.7 Designed EF-G primers  
(The mutant sites were marked red).  
 
Primer 1 S453C (32- number of nucleotides) 
GG ACT GAC GAA GAA TGC AAC CAG ACC ATC ATC  
GAT GAT GGT CTG GTT GCA TTC TTC GTC AGT CC 
 
Primer 2 N454C (32) 
 CT GAC GAA GAA TCT TGC CAG ACC ATC ATC GCG  
CGC GAT GAT GGT CTG GCA AGA TTC TTC GTC AG 
 
Primer 3 Q455C (32) 
GAC GAA GAA TCT AAC TGC ACC ATC ATC GCG GG  
CC CGC GAT GAT GGT GCA GTT AGA TTC TTC GTC 
 
Primer 4 T456C (33) 
GAA GAA TCT AAC CAG TGC ATC ATC GCG GGT ATG  
CAT ACC CGC GAT GAT GCA CTG GTT AGA TTC TTC 
 
Primer 5 G484C (36) 
GTT GAA GCG AAC GTA TGC AAA CCGCAG GTT GCT TAC  
GTA AGC AAC CTG CGG TTT GCA TAC GTT CGC TTC AAC 
 
Primer 6 K485C (33) 
GAA GCG AAC GTA GGT TGC CCGCAG GTT GCT TAC  
GTA AGC AAC CTG CGG GCA ACC TAC GTT CGC TTC 
 
Primer Q487C (33) 
CG AAC GTA GGT AAA CCG TGC GTT GCT TAC CGT G 
C  ACG GTA AGC AAC GCA CGG TTT ACC TAC GTT CG 
 
Primer V488C (32) 
GTA GGT AAA CCG CAG TGC GCT TAC CGT GAA AC 
GT TTC ACG GTA AGC GCA CTG CGG TTT ACC TAC 
 
Primer A489C (33) 
GGT AAA CCG CAG GTT TGC TAC CGT GAA ACT ATC  
GAT AGT TTC ACG GTA GCA AAC CTG CGG TTT ACC 
 
Primer A690C (32) 
CTG AAG TAT GAT GAA TGC CCG AGT AAC GTT GC 
GC AAC GTT ACT CGG GCA TTC ATC ATA CTT CAG 
 
Primer S692C (34) 
G TAT GAT GAA GCG CCG TGC AAC GTT GCT CAG GCC 
GGC CTG AGC AAC GTT GCA CGG CGC TTC ATC ATA C 
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Primer N693C (31) 
GAT GAA GCG CCG AGT TGC GTT GCT CAG GCC G 
C GGC CTG AGC AAC GCA ACT CGG CGC TTC ATC 
 
For 231 C-E (36) 
GCA GCT GAA GCT TCT GAA GAG CTG ATG GAA AAA TAC  
GTA TTT TTC CAT CAG CTC TTC AGA AGC TTC AGC TGC 
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Figure 2.8 Electrophoretic analysis of PCR product of EF-G derivatives. This gel 
contains 1% agarose. Lanes 1, 4 and 8, A690C-EF-G DNA with annealing temperatures 
of 65 °C, 62 °C and 60 °C, respectively; Lanes 2 and 6, S692C-EF-G DNA with 
annealing temperatures of 65 °C and 62 °C respectively; Lanes 3 and 7, N693C-EF-G 
DNA with annealing temperatures of 65 °C and 62 °C respectively. Our experimental 
results confirmed the presence of dsDNA encoding EF-G protein, as it is expected to be 
5.2 kilobases in length. 
67 
 
 
 
Figure 2.9 Electrophoretic analysis of wild type EF-Tu. Product was purified by 
Co(II)-Sepharose resin and the presence of EF-Tu (43.2 kDa) is confirmed by 4-15% 
SDS-PAGE gel. 
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Figure 2.10 Electrophoretic analysis of mRNA.  mRNA 022 (63 nucleotides) is labeled. 
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Figure 2.11 Scheme of postsynchronized analysis. All FRET events are lined up at an 
identifiable trigger transition and averaged. To get equal durations, all individual traces 
are extended at the prior and subsequent segment ends. FRET traces are aligned at the 
beginning (pre-synchronization, black) or at the end (post-synchronization, red). 
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CHAPTER III EF-G MUTANT SCREENING AND ENSEMBLE 
FLUORESCENCE STUDIES OF TRANSLOCATION 
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Abstract 
Ribosomes are large ribonucleic particles with three tRNA binding sites. The main 
function of ribosomes is to carry out protein synthesis which can be divided into three 
basic processes: initiation, elongation and termination. EF-G, one of the two conserved 
translation elongation factors, catalyzes translocation of the A, P site tRNAs to the P, E 
sites. In this work, 15 different EF-G mutants in which a Cys residue replaced a wild type 
residue were designed with the help of two structural models, including EF-G bound to 
the ribosome in the presence of  fusidic acid (FA) (Gao et al., 2009) and EF4 bound to 
the ribosome (Connell et al., 2008). Of these 15 EF-G derivatives, 7 were expressed 
successfully and were labeled at the introduced Cys residue with 40 - 90 % labeling 
efficiency (Fig 3.1). Each of these EF-G derivatives showed translocation activity in two 
different assays, with apparent rate constants ranging from 1.4 - 2.5 s
-1
. In static 
experiments, all Cy3-EF-G derivatives showed FRET with large ribosomal protein L11 
(L11) in the presence of either FA and GTP or GDPNP, although the FRET efficiency was 
different under these two experimental conditions. Different L11:EF-G FRET efficiencies 
were also obtained in comparing vacant 70S ribosomes and pretranslocation (PRE) 
complexes, suggesting the importance of the A-site tRNA in studies of EF-G function in 
translocation. None of the Cy3-labeled EF-G variants studied showed significant FRET 
changes in ensemble kinetic experiments in which EF-G was rapidly mixed with PRE 
complex. However, in the presence of FA, sizable EF-G:L11
38-Cy5
 FRET changes were 
observed for EF-G
453-Cy3
, EF-G
655-Cy3
, and EF-G
693-Cy3
,
 
with apparent rate constants of 
0.14 - 0.29 s
-1
, suggesting that FA traps EF-G on the ribosome in a state that follows 
translocation. Preliminary single molecule fluorescence resonance energy transfer 
(smFRET) studies were carried out on these three mutants.  FRET with both the A-site 
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tRNA and L11 was only observed for the EF-G
693-Cy3
 mutant, so this mutant was picked 
to carry out the detailed smFRET studies described in Chapter 4. 
3.1 Introduction 
The detailed mechanism of EF-G catalyzed translocation during the elongation cycle 
is still unclear. A well accepted model is that after the peptide bond formation, the A-site 
tRNA oscillates between the classic (A/A) and hybrid states (A/P), and the 30S subunit is 
rotated counterclockwise about 6° relative to the 50S subunit as the ratcheted movement 
(Schuwirth et al., 2005; Zhang et al., 2009). EF-G.GTP first binds to the GTPase 
associated center (GAC) and the mobile C terminal domain (CTD) of L7/12 reaches into 
solution to promote this binding process. Compared to the isolated ribosome stalk, the 
CTD of L7/12 is close to N-terminal domain (NTD) of L11 and bridges the interaction of 
EF-G with L11 (Gao et al., 2009). EF-G hydrolyzes GTP immediately after binding to 
the ribosome, the rate of which is at least 5 fold faster than the translocation rate 
(Rodnina et al., 1997). By using a non-hydrolyzable GTP analogue GDPNP, a single 
round of translocation is promoted with a slower rate (Pan et al., 2007; Rodnina et al., 
1997; Zavialov et al., 2003). The relative movements between Domains I, II and 
Domains III, IV, V are of crucial importance as Domains I and V cross-linked EF-G was 
inactive in both translocation and turnover on the ribosome (Peske et al., 2000). Domain 
IV contains two loops at its tip region, loop I (496 - 509) and loop II (567 - 579) with two 
conserved glycines (502 and 503) located on loop I to facilitate a tight turn which allows 
loop I to be inserted into the minor groove (Gao et al., 2009). The Domain IV truncated 
EF-G protein retained GTPase activity but only promotes single round of translocation 
(Savelsbergh et al., 2000). Because of this great functional importance of Domain IV in 
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translocation, when we selected potential sites on EF-G for fluorescent label introduction, 
many positions within Domain IV were not considered, to avoid potential effects on EF-
G catalytic activity. 
3.2 Results 
3.2.1 Nomenclature 
Cy3-labeled EF-G mutants H655C, Q669C, S453C, Q455C, Q487C, S692C, and 
N693C are denoted EF-G
655-Cy3
, EF-G
669-Cy3
, EF-G
453-Cy3
, EF-G
455-Cy3
, EF-G
487-Cy3
, EF-
G
692-Cy3
, and EF-G
693-Cy3
, respectively. 70S ribosomes and pretranslocation complexes 
containing Cy5 labeled L11 at position 38 are denoted 70S
38-Cy5
 or PRE-II
38-Cy5
, 
respectively. PRE complexes containing Cy5 labeled A-site fMet-Phe-tRNA
Phe
(Cy5) are 
denoted PRE-II
tRNA-Cy5
.  
3.2.2 EF-G mutant screening  
Potential mutant sites on EF-G for introduction of a fluorescent label should meet the 
following criteria: 1) L11 or the A site tRNA are within FRET (Ro) range of a Cy3/Cy5 
pair (about 50 Å); 2) the labeling site should be exposed to the solvent instead of buried 
inside the structure; 3) the amino acid should not be conserved, and less likely to have 
functional importance. As we have material stocks and developed matured labeling 
strategies for position 38 on large ribosomal protein L11 and labeled tRNAs at the elbow 
region, the site of EF-G labeling was selected based on its distance to these two sites 
(Kaur et al., 2011; Seo et al., 2006). As there was no accessible structure of EF-G bound 
to the ribosome with A site tRNA in presence when we started the mutant selection, two 
structures were used to find proper mutant sites, including structure of EF-G bound 
ribosome complex containing P/P and E/E site tRNAs in the presence of FA (Gao et al., 
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2009) and EF4 (Lep A) bound ribosome structure containing A/L, P/P, E/E site tRNAs, 
and GDPNP (Connell et al., 2008). FA prevents EF-G release from the ribosome after 
GTP hydrolysis. FA traps EF-G in a stable intermediate conformation as it locks switch II 
of G domain in a conformation similar to the GTP form even after GTP hydrolysis. This 
prevents the transmission of conformational changes to Domains III and IV while switch 
I is in a conformation similar to the GDP form (Gao et al., 2009). EF4 competes with 
EF-G for binding to the PRE complex and leads to a transient inhibition of elongation 
(Liu et al., 2011; Liu et al., 2010; Qin et al., 2006). The protein domains of EF4 are 
homologous of Domains I, II, III, and V of EF-G but with a unique C terminus (Fig 3.2). 
The lack of Domain IV in EF4 allows formation of a stable complex in which the A-site 
tRNA and EF4 are bound to the ribosome simultaneously (Fig 3.3). 3 mutant sites were 
picked based on the first structure and another 12 mutants were selected based on the 
latter one. Of these 15 EF-G derivatives, 7 were expressed successfully and with 60 - 90 % 
labeling efficiency, except for Q669C-EF-G which showed a labeling efficiency of 40 % 
(Table 3.1). 
3.2.3 EF-G activity tests  
3.2.3.1 Puromycin activity 
Puromycin (Puro) is an analog of 3’ end tyrosyl-tRNA which has a 3000-fold greater 
reactivity as a peptidyl acceptor when peptidyl-tRNA is bound in the P-site than when it 
is bound in the A-site (Dorner et al., 2006; Pan et al., 2007; Semenkov et al., 1992; 
Sharma et al., 2004). Therefore, formation of peptidyl-puromycin  provides a quick way 
to determine if the mutant is active or not for translocation, as posttranslocation (POST) 
complexes have a much higher reactivity toward compared to PRE complexes. 70S 
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initiation complex (70SIC), in which fMet-tRNA
fMet
 is bound in the P-site while the A-
site is empty, also shows a high activity toward transferring fMet to puro. PRE complex 
in which peptidyl-tRNA occupies the A-site has a very low reactivity toward puro. 
Reaction products on incubating PRE complex with wild type EF-G or Cy3-EF-Gs 
should show comparable puro reactivity if the Cy3 labeled EF-G derivatives are fully 
functional. As the labeling efficiencies of EF-Gs are 40 - 90 % and the reaction takes 
about 30s, it is hard to determine if the reactivity toward puro reflects the real activity of 
labeled EF-Gs or unlabeled species. However, all these mutants are confirmed to be 
active. Experiments were performed as described in Chapter 2 and the same amount of 
wild type EF-G was studied together with all the labeled EF-G mutants as the positive 
control. In this assay puro reactivities of IC and of POST complex formed from PRE 
complex by addition of WT-EF-G were approximately equal and ~3 to 4 fold greater than 
PRE complex (Fig 3.4). POST complexes formed with each of seven labeled EF-Gs 
showed equivalent reactivities to that seen with WT-EF-G. To simplify our descriptions 
of experimental conditions, all concentrations mentioned for both static and kinetic 
experiments are based on final concentrations after mixing. 
3.2.3.2 Translocation rate constant  
The previous assay only measured the stoichiometry of EF-G-induced translocation. 
A more stringent test of EF-G derivative activity comes from measuring the rate of EF-G 
catalyzed translocation. The kinetic activities of labeled EF-G were measured by a 
translocation assay, monitored by using proflavin (prf) labeled tRNA programmed at the 
ribosomal A site. Prf can be used to label dihydrouridines within the elbow region (D-
loop) of tRNA. As reported by Pan et al., 2007, the prf fluorophore is sensitive to the 
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local environment. Yeast fMet-Phe-tRNA
Phe
(prf), labeled at positions 16/17 shows an 
increase in fluorescence intensity on translocation from the A- to the P-site and can be 
used to monitor the kinetics of translocation (Fig 3.5). Upon rapid mixing of prf labeled 
PRE complex with EF-Gs, all seven labeled EF-G mutants catalyzed translocation with a 
rate constant 40 - 70 % of that of wild type EF-G catalyzed translocation. The 
concentration of EF-G utilized (2 µM) is close to its Km value for translocation (Pan et 
al., 2007; Savelsbergh et al., 2003), so that for the highly labeled EF-G variants (S453C, 
Q455C, Q487C, S692C, N693C - see Table 3.1), the minor amounts of unlabeled EF-G in 
the reaction mixtures would not have been sufficient to account for the rates observed.   
However, the translocation rate constants for H655C-EF-G and Q669C-EF-G are 
somewhat ambiguous. For these mutants, the labeling efficiencies were only 60 % and 
40 %, respectively, so that the measured rates could reflect, at least in major part, the 
activities of the unlabeled EF-G mutants. 
3.2.4 Static FRET measurements  
3.2.4.1 Static measurement of EF-G:L11 FRET  
EF-G binds and dissociates from the ribosome dynamically even in the absence of 
the A-site bound tRNA. To monitor FRET between EF-G and L11 at equilibrium, either 
the antibiotic fusidic acid (FA) or GDPNP was added in order to trap Cy3-labeled EF-G 
on the ribosome.  
FA interacts with switch II of Domains I, II, III of EF-G and traps EF-G on the 
ribosome by preventing EF-G release after GTP hydrolysis. Previous study indicated that 
FA does not affect single-turnover GTPase but instead inhibits single-turnover Pi release 
(Bodley et al., 1970). In contrast, Seo et al. (2006) showed that FA inhibits translocation 
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moderately by a gradually halting translocation after a number of GTPase turnovers, with 
higher concentrations of FA showing more marked effects. As we want to trap EF-G on 
the ribosome to produce FRET with L11, we utilized a high concentration of FA (1 mM).  
GDPNP is a non-hydrolyzable GTP analogue, which catalyzes translocation at lower 
rate (50 fold slower, Katunin et al.; 6 fold slower, Zavialov et al., 2003; 5 fold slower, 
Pan et al., 2007) compared to GTP but without Pi release. In the presence of GDPNP, 
only single round translocation was promoted and there was, of course, no Pi release.  
FA and GTP or GDPNP were added to study the interaction between Cy3-EF-Gs and 
Cy5-L11 and determine if the Cy3-EF-G:Cy5-L11 pair was within the FRET distance. As 
EF-G binds to the ribosome even in the absence of the A-site tRNA, both 70S
38-Cy5
 and 
PRE-II
38-Cy5
 complexes were used to measure FRET with EF-G. To get an accurate 
measurement of the FRET efficiency, four differently labeled samples were employed for 
each EF-G mutant. They are designated D*A (donor-containing), D*A* (donor- and 
acceptor-containing), DA* (acceptor-containing), and DA (a blank sample without donor 
or acceptor dyes) and FRET efficiencies were calculated as described (Seo et al., 2006), 
with corrections for the labeling efficiencies of both EF-G and L11.  Briefly, signal of DA 
was subtracted from those of D*A*, D*A and DA* to correct the light scattering and 
background fluorescence. Fluorescence of     
                 
                
 was subtracted from 
D*A* signal as a correction for donor leakage in the acceptor channel. Then DA* signal 
upon 514 nm excitation was subtracted from the corrected value of D*A* signal, yielding 
the extracted D*A (Cy5) fluorescence from energy transfer. 
FRET efficiencies for EF-G interactions with vacant ribosomes (Fig 3.6) are listed in 
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Table 3.2. As the labeling efficiency of Q669C-EF-G was low, the mutant was not 
included in our study. All Cy3-EF-G derivatives showed FRET with 70S
38-Cy5
 in the 
presence of FA/GTP or GDPNP. For S453C-EF-G and N693C-EF-G, only minor FRET 
efficiency differences were obtained for FA/GTP vs. GDPNP. In contrast, significant 
decreases were seen for FA/GTP vs. GDPNP for EF-G
655-Cy3
 and EF-G
692-Cy3 
while EF-
G
487-Cy3
 showed a significant increase.  
The A-site tRNA has a steric clash with the tip region of Domain IV on EF-G, making 
it hard to obtain a stable structure with A-site tRNA and EF-G bound simultaneously. In 
previous publications, EF-G bound to the A-site unoccupied ribosome was studied a lot to 
decipher the information of EF-G interaction with PRE complexes (Gao et al., 2009; 
Zhou et al., 2013). However, it turned out that the presence of the A-site tRNA may be of 
great importance for EF-G and ribosome conformations. To further understand the effect 
of the A-site tRNA on Cy3-EF-G:Cy5-L11 FRET pair, the static FRET of six Cy3-EF-
Gs:PRE-II
38-Cy5
 pairs was studied in the similar way as described above in the presence of 
either FA/GTP or GDPNP (Figure 3.7 and Table 3.3). Large FRET differences between 
FA and GDPNP stabilized complexes were observed for EF-G
655-Cy3
, EF-G
455-Cy3
and EF-
G
692-Cy3
, with other EF-G derivatives showing no significant FRET efficiency differences. 
With or without the A-site tRNA do bring a conformational difference between the 
labeling sites on EF-G and L11. However, the effect was complicated as it is not in one 
direction and both decreased (FRET efficiencies for EF-G
487-Cy3 
with 70S or PRE
 
in the 
presence of GDPNP are 0.25 and 0.17, respectively) and increased FRET (FRET 
efficiencies for EF-G
455-Cy3
with 70S or PRE
 
in the presence of FA/GTP are 0.13 and 0.33, 
respectively) were obtained.  
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For S692C and N693C on Domain V, the presence of the A-site tRNA increased the 
FRET between Cy3-EF-G:Cy5-L11. For instance, FRET efficiencies in the presence of 
FA/GTP for 70S or PRE are 0.4 and 0.25 respectively, and FRET efficiencies in the 
presence of GDPNP for 70S or PRE are 0.22 and 0.07 for EF-G
692-Cy3
. Similar results 
were obtained for EF-G
693-Cy3
, which seemed to contradict to our prediction as the 
presence of the A-site tRNA should constrain EF-G movement toward the A-site and 
push EF-G toward L11. The possible explanation would be that with the A-site tRNA, 
EF-G had some inter-domain reorientation which resulted in a decreased FRET efficiency 
of Cy3-EF-G:L11
38-Cy5
. To sum up, FA stabilizes EF-G on the ribosome in a different 
confirmation compared to GDPNP. The occupancy of the A-site tRNA has an effect on 
the relative distances between ribosome protein L11 and EF-G, which could be due to the 
EF-G domain reorientation in the presence of the A-site tRNA. 
3.2.4.2 Static measurement of EF-G:tRNA FRET 
To monitor FRET between EF-G and tRNA at equilibrium, antibiotics FA and 
viomycin (VIO) were added to trap both Cy3 labeled EF-G and Cy5 labeled A-site tRNA 
on the ribosome. VIO is a cyclic peptide antibiotic that binds at the 16S and 23S 
ribosomal RNA interface and inhibits translocation by stabilizing tRNAs in the A and P 
sites (Modolell et al., 1977), although it does allow both EF-G binding and fast GTP 
hydrolysis (Ermolenko et al., 2007; Stanley et al., 2010).  
We confirmed that simultaneous addition of FA and VIO does not impair EF-G 
binding, by measuring static FRET between EF-G
693-Cy3
 and 70S
38-Cy5
 (Fig 3.8), a result 
that is in accord with recent published results of Salsi et al. (2014), which showed that 
EF-G bound to PRE complexes in the presence of both FA and VIO by observing FRET 
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between EF-G and protein S12 (Salsi et al., 2014). 
 Accordingly, we carried out static FRET experiments in which Cy3-labeled EF-Gs 
were added to PRE-II
tRNA-Cy5
 in the presence of FA/GTP or of FA/GTP plus VIO (Fig 3.9), 
in the expectation that a higher FRET signal would be seen in the presence of VIO than in 
its absence. However, none of the experiments gave an observable FRET signal. When a 
higher Mg
2+ 
concentration (15 mM) was employed so as to increase the fraction of PRE 
complex in the classic state (Chen et al., 2011a) which should decrease EF-G:tRNA 
distance, still no FRET signal was obtained. 
Our failure to detect FRET could result from neither of the two structures used for 
mutant selection being good models for EF-G interaction with the A-site tRNA in PRE 
state. As a result, the distances of labeled positions on A-site tRNA and EF-G would not 
be in the FRET range. However, the most recently published high resolution structure by 
Zhou et al. (2014) indicate that our selections are within FRET range to L11 and the A-
site tRNA (Table 3.4). We think it more likely that the failure stems from slow 
translocation occurring even in the presence of FA and VIO which we employ in our 
experiments, although we cannot exclude the possibility that the presence of both FA and 
VIO used in the work changes the confirmations of EF-G and/or ribosome and increases 
the relative distances of Cy3-EF-G:Cy5-tRNA FRET pair.  
3.2.5.1 Fast kinetic measurements of EF-G:L11 FRET 
3.2.5.1.1 Experiments with vacant ribosomes and PRE complexes with EF-G  ·GTP in 
the presence or absence of FA  
As described above, in the static measurement, we observed FRET between Cy3-EF-
G:Cy5-L11 in the presence of either FA/GTP or GDPNP. The next step was to study the 
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real time interaction between Cy3-EF-G:Cy5-L11 measured by stopped flow for six EF-
G derivatives. If position 38 of L11 is close enough to the labeled sites on EF-G used in 
this work, when EF-G binds to the ribosome, a FRET signal should be observed. As 
reported by Seo et al. (2006), the increase in FRET efficiency observed on addition of a 
Cy3-EF-G labeled at position 216 in domain G’, quite far from the positions labeled in 
this work, to vacant ribosomes containing Cy5-L11 was biphasic, with rate constants 
equal to 20 ± 3 s
-1
 and 0.23 ± 0.02 s
-1
 and with the larger FRET change observed in the 
fast phase. In the work by Seo, addition of FA/GTP did not change either the fast or slow 
rate constants, but the overall magnitude of FRET change contributed from the slow 
phase was enhanced.  
We used the same PRE and EF-G concentration as reported by Seo, so if FRET 
changes occurred they should have been observable within 0.5 s (fast phase) and/or 12 s 
(slow phase).  However, we observed little if any FRET change in this study over these 
time scales when the Cy3-labeled EF-Gs were rapidly mixed with either 70S
38-Cy5
 (data 
not shown) or PRE-II
38-Cy5
 (Fig 3.10).  
In the presence of FA, anti-correlated fluorescence changes were observed when 
three of Cy3-labeled EF-Gs, EF-G
644-Cy3
, EF-G
453-Cy3
,
 
and EF-G
693-Cy3 
were rapidly mixed 
with either 70S
38-Cy5
 (Fig 3.11) or PRE-II
38-Cy5
 (Fig 3.12) over 20 s time scale, however, 
when we zoomed in the initial 0.5 s time scale, no FRET change was observed. The 
FRET change occurred during 20 s time scale with apparent rate constants that varied 
from 0.15 - 0.30 s
-1
 which are much lower than the apparent translocation rate constants 
of 1.4 - 2.5 s
-1
 (Table 3.1).  It is therefore likely that these FRET changes arise from slow, 
FA-induced conformational rearrangements of EF-G that follow translocation, rather than 
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from translocation itself.  
3.2.5.1.2 Experiments with PRE complexes with GDPNP replacing GTP  
Seo et al. (2006) found that on substitution of GDPNP for GTP, the increase in FRET 
efficiency observed on addition of a Cy3-EF-G labeled at position 216 in domain G’, to 
vacant ribosomes containing Cy5-L11, but that the rate constants of both the fast and 
slow phases were reduced by about 100-fold and 30-fold to 0.20 ± 0.01 s
-1
 and 0.007 ± 
0.001 s
-1
, respectively.  However, when GDPNP was substituted for GTP we found no 
evidence for FRET change out to 100 s on rapid mixing of each of the six Cy3-EF-G 
labeled mutants with PRE-II
38-Cy5 
(data not shown).  
The possible explanations for not observing FRET change in the real-time kinetic 
measurement would be as follows: 1) FA traps EF-G on the ribosome in a state which is 
not an intermediate of EF-G catalyzed translocation. Therefore, even FRET was obtained 
in the static measurement, no FRET was observed in real time kinetic measurement, and 
no FRET change could be observed accordingly; 2) As FRET events happened at 
different times, at a single time point, only a small portion of EF-G bound to the 
ribosome and contributed FRET signal. The scarcity of EF-G binding and the averaged 
results in bulk solution covered the real FRET change signal. On the other hand, FA 
enhanced binding of Cy3-EF-Gs to the ribosome and FRET change was observed only 
with FA.  
3.2.5.2 Fast kinetic measurements of EF-G:tRNA FRET 
Although no FRET was observed between Cy3-EF-Gs and PRE-II
tRNA-Cy5
 in the 
static experiments in the presence of FA ± VIO (Figure 3.9), fast kinetic measurement by 
stopped flow were carried out to determine if an intermediate could be detected upon 
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rapid mixing of Cy3-EF-Gs and PRE-II
tRNA-Cy5
 in the absence of any antibiotics. 2 µM 
Cy3-EF-G was rapidly mixed with 0.1 µM PRE-II
tRNA-Cy5 
in TAM
15 
buffer and data was 
collected over a 1 s time scale, as the translocation rate constant ranged from  1.43 ± 0.01 
to 3.54 ± 0.02 s
-1 
as measured by prf labeled A site tRNA (Table 3.1). However, no FRET 
change was obtained on this time scale. In addition, in an effort to decrease background 
fluorescence which could make FRET detection difficult, the standard 2 µM Cy3-EF-G 
was lowered to 0.4 µM and data was collected over a 5 s time scale instead of the 1 s time 
scale used at 2 µM Cy3-EF-G. However, neither of these changes resulted in detectable 
FRET changes.  
3.3 Discussion 
FA traps EF-G on the ribosome by preventing its dissociation and halts translocation 
after a number of GTPase turnovers (Seo et al., 2006). GDPNP functions similarly, but 
the effect is more stringent as only single turnover of translocation was allowed (Rodnina 
et al., 1997). The equilibrium FRET results displayed in Table 3.2 show a clear between 
the FA stabilized EF-G-70S structure and the GDPNP stabilized EF-G-70S structure, 
which suggests that EF-G-ribosome complexes stabilized by FA or GDPNP are in two 
different states. As the structure of the A-site tRNA bound to an EF-ribosome complex is 
not stable, a lot of efforts have been made to characterize EF-G-ribosome structure with 
an empty A-site to elucidate structural insights of the pretranslocation complex (Chen et 
al., 2013b; Pulk et al., 2013; Ramrath et al., 2013). However, by comparing FRET 
results in Tables 3.2 and 3.3, it is clear that the presence of the A-site tRNA does have 
effects on EF-G and/or ribosome structures. Interestingly, for both EF-G
692 
and EF-G
693 
mutants, decreased FRET between EF-G and L11 was observed for PRE vs. 70S. As the 
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presence of the A-site tRNA restricts the spatial movements of EF-G, FRET between EF-
G and L11 protein is expected to increase. The decreased FRET efficiency between EF-G 
and L11 for PRE vs. 70S observed in our experiment suggests that reorientation of EF-G 
occurred when the A-site tRNA bound.  
The results obtained in the ensemble rapid kinetic experiments are summarized in 
Table 3.5. FRET change was only observed under the experimental conditions of mixing 
Cy3-EF-Gs with 70S
Cy5 
or PRE-II
Cy5 
and 1mM FA/GTP, but with a rate constant much 
slower (0.15 - 0.30 s
-1
) than the translocation rate constant (3.5 s
-1
). A possible 
explanation for not observing FRET change in the real-time kinetic measurement in the 
absence of FA would be that during EF-G occupancy on the ribosome, EF-G has constant 
FRET with L11 and tRNA. However, the single molecule FRET (smFRET) experiments 
reported in Chapter 4 demonstrate changes in EF-G:tRNA FRET efficiency during 
translocation. A more likely explanation, consistent with the smFRET results, is that at 
any single time point, only a small portion of ribosomes contained bound EF-G capable 
of producing a FRET change, which would be difficult to detect in an ensemble 
experiment. The slow ensemble FRET change seen in the presence of FA is evidence that 
FA traps EF-G on the ribosome in a state which is not an intermediate of EF-G catalyzed 
translocation. 
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Figure 3.1 EF-G structure with mutant sites labeled. EF-G structure is adapted from 
2WRI (PDB) (Thermus thermophilus) and the potential mutants are showed as sphere. 
The number of the mutant sites is base on the sequence of EF-G protein in E. coli. 
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Figure 3.2 Comparison of EF-G and EF4 structures. A. Structure of EF-G (colored 
orange) bound with A-site tRNA (colored purple) and the structure of EF-G was 
superimposed on the cryo-EM density of EF4 (gray mesh); B. EF4 structure with the 
individual domains colored blue (I), green (II), yellow (III), orange (V) and red (CTD). 
 
 
 
 
 
   
 
Figure 3.3 EF-G-ribosome and EF4-ribomse complexes. A. EF-G bound to the 
ribosome with P/P E/E site tRNAs, mRNA, GTP and FA (Gao et al, 2009); B. EF4 bound 
ribosome complex, containing  A/L, P/P, E/E site tRNAs, mRNA and GDPNP (Connell et 
al., 2008). 
A B
… 
A B 
87 
 
 
 
Figure 3.4 Puromycin reactivity tests of Cy3-EF-Gs. All concentrations mentioned are 
based on final concentrations after mixing. Background, no reactants was added; IC-
complex, 10 µL of 0.3 µM IC was mixed with 10 µL WB buffer and incubated with 5mM 
puro at 37 °C for 20 sec and then quenched with 150 µL of 0.3 M NaAc (pH=5.2). PRE-
complex, 20 µL of 0.3 µM PRE was incubated with 5mM puro at 37°C for 20 sec and 
then quenched with 150 µL of 0.3 M NaAc (pH=5.2). WT or EF-G
Cy3
, 20 µL of 0.3 µM 
PRE was incubated with 2 µM wild type EF-G or Cy3-EF-Gs with 1 mM GTP for 1 min, 
followed by incubation with 5mM puro for 20 sec and then quenched with 150 µL of 0.3 
M NaAc (pH=5.2). All the quenched products were extracted by 600 µL ethyl acetate and 
counted the radioactivity of [
35
S]-fMet-tRNA
fMet
. A second measurement was carried for 
some mutants and the error bar is within 5% which confirms the reliability of our 
measurement. 
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Figure 3.5 EF-G derivatives catalyzed fast translocation as measured by stopped 
flow fluorescence change. All the results were obtained by mixing 400 µL of 0.1 µM 
prf-tRNA-PRE with 400 µL of 2 µM EF-G and 1mM GTP in WB buffer at 37 °C. The 
latter concentration is close to the Km value for EF-G (Pan et al., 2007; Savelsbergh et al., 
2003). Both raw traces and fitted results of each trace are plotted.  
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Table 3.1 Test of Cy3 labeled EF-G derivatives catalyzed fast translocation by 
stopped flow. 400 µL of 0.1 µM prf-tRNA-PRE was rapidly mixed with 2 µM EF-G and 
1mM GTP in the same volume in WB buffer at 37 °C. Two independent determinations 
were performed to some mutants with the error listed. 
 
 
 
 
 
 
 
 
 
 
EF-G  derivatives 
(Domain) 
 
Puromycin activity 
(CPM) 
Prf-tRNA 
translocation activity 
(s
-1
) 
Labeling 
efficiency 
 
 
WT 840 ± 25 3.5 ± 0.8  
H655C(V) 780 1.7 ± 0.4 0.60 
Q669C(V) 820 2.1 ± 0.4 0.40 
S453C(III) 810 2.2 ± 0.7 0.92 
Q455C(III) 850 ± 40 1.4 ± 0.3 0.93 
Q487C (III) 790 ± 20 2.0 ± 0.7 0.77 
S692C (CTD) 880 ± 20 1.8 ± 0.5 0.82 
N693C (CTD) 890 2.5 ± 0.6 0.90 
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Figure 3.6 Static FRET of EF-G
Cy3
:70S
38-Cy5
. Samples were prepared at 25 °C in WB 
buffer, containing 70S (0.4 µM), EF-G (0.5 µM) and either 1 mM FA/GTP (left) or 1mM 
of GDPNP (right) for all EF-G derivatives.  
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EF-G derivatives 
(Domain) 
 
Experimental 
conditions 
 
Labeling efficiency EF-G:L11 FRET 
efficiency  
Ecorr 
H655C(V) 70S, FA 0.60 0.30 
 70S, GDPNP 0.60 0.10 
S453C(III) 70S, FA 0.92 0.062 
 70S, GDPNP 0.92 0.077  
Q455C(III) 70S, FA 0.93 0.13 
 70S, GDPNP 0.93 0.049 
Q487C (III) 70S, FA 0.77 0.024 
 70S, GDPNP 0.77 0.25 
S692C (CTD) 70S, FA 0.82 0.40 
 70S, GDPNP 0.82 0.22 
N693C (CTD ) 70S, FA 0.90 0.30 
 70S, GDPNP 0.90 0.25 
 
Table 3.2 Summary of static FRET of EF-G
Cy3
:70S
38-Cy5 
pair. All static FRET 
measurements were performed in WB at 25 °C. Samples were prepared containing 70S 
(0.4 µM) with EF-G (0.5 µM) and either 1mM FA and GTP or 1mM of GDPNP. FRET 
efficiencies are calculated as described in Seo et al., 2006. 
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Figure 3.7 Static FRET of EF-G
Cy3
:PRE
38-Cy5
. Samples were prepared at 25 °C in WB 
buffer, containing PRE-II (0.4 µM), EF-G (0.5 µM) and either 1 mM FA/GTP (left) or 
1mM of GDPNP (right) for all EF-G derivatives.  
 
  
95 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.3 Summary of static FRET of EF-G
Cy3
:PRE-II
38-Cy5
. All Static FRET 
measurements were performed in WB at 25 °C. Samples were prepared containing PRE-
II (0.4 µM) with EF-G (0.5 µM) and either 1mM FA/GTP or 1mM of GDPNP. FRET 
efficiencies are calculated as described in Seo et al., 2006. 
 
 
  
EF-G derivatives 
(Domain) 
 
Experimental 
conditions 
 
Labeling 
efficiency 
EF-G:L11 
FRET 
efficiency 
Ecorr 
H655C(V) PRE, FA 0.60 0.29 
 PRE, GDPNP 0.60 0.09 
S453C(III) PRE, FA 0.92 0.09 
 PRE, GDPNP 0.92 0.11 
Q455C(III) PRE, FA 0.93 0.33 
 PRE, GDPNP 0.93 0.03 
Q487C (III) PRE, FA 0.77 0.11 
 PRE, GDPNP 0.77 0.17 
S692C (CTD) PRE, FA 0.82 0.25 
 PRE, GDPNP 0.82 0.07 
N693C (CTD) PRE, FA 0.90 0.10 
 PRE, GDPNP 0.90 0.06 
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Figure 3.8 Test of EF-G binding to the ribosome with both FA and VIO. Samples 
were prepared at 25 °C in WB buffer, containing 70S
38-Cy5 
(0.4 µM), EF-G
693-Cy3
 (0.5 µM), 
1 mM FA, 1 mM GTP and 5 µM viomycin. 
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Figure 3.9 Static FRET of EF-G
Cy3
:PRE-II
tRNA-Cy5
. Samples were prepared at 25 °C in 
WB buffer, containing PRE-II
tRNA-Cy5
 (0.4 µM), Cy3-EF-G (0.5 µM), 1 mM FA/GTP and 
with or without 5 µM viomycin. 
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Structure Distances (Å) 
EF-G L11 tRNA 
H655C(V) 24.8 80.3 
S453C(III) 53.9 66.6 
Q455C(III) 53.9 71.4 
Q487C (III) 51.5 67.3 
S692C (V) 48.4 54.9 
N693C (V) 51.0 55.7 
 
Table 3.4 Summary of distances. Distances of EF-G mutants to L11 and tRNA were 
calculated based on the ribosome structure containing ap/ap pe/E site tRNAs, mRNA, 
GTP and FA. (Zhou et al., 2014) 
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Figure 3.10 Fast kinetic of EF-G
Cy3
 and PRE-II
38-Cy5
. Experiments were performed at 
25 °C in WB buffer. All the results were obtained by mixing 400 µL of PRE-II
38-Cy5 
(0.5 
µM) with 400 µL of EF-G
Cy3
 (0.75 µM). Cy3 (left, red) and Cy5 (right, green) signal 
collected from both short time (0.5 s) and long time scales (12 s) are plotted and no anti-
correlated Cy3/Cy5 signals with comparable rate constants are obtained.  
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Figure 3.11 Fast kinetic measurements of EF-G
Cy3
 with 70S
38-Cy5
. Experiments were 
performed at 25 °C in WB buffer. All the results were obtained by mixing 400 µL of 
70S
38-Cy5 
(0.5 µM) with 400 µL of 0.75 µM Cy3-EF-G (EF-G
453-Cy3
, EF-G
655-Cy3
 or EF-
G
693-Cy3
), FA (1 mM) and GTP (1 mM). Cy3 (left, red) and Cy5 (right, green) signal 
collected from both short time scale (0.5 s) and long time scale (20 s) are plotted and anti-
correlated Cy3/Cy5 signals are obtained for results on 20 s time scale.  
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Figure 3.12 Fast kinetic measurements of EF-G
Cy3
 with PRE-II
38-Cy5
. Experiments 
were performed at 25 °C in WB buffer. All the results were obtained by mixing 400 µL of 
PRE-II
38-Cy5 
(0.5 µM) with 400 µL of 0.75 µM Cy3-EF-G (EF-G
453-Cy3
, EF-G
655-Cy3
 or 
EF-G
693-Cy3
), FA (1 mM) and GTP (1mM). Cy3 (left, red) and Cy5 (right, green) signal 
collected from both short time (0.5 s) and long time scale (20 s) are plotted and anti-
correlated Cy3/Cy5 signals are obtained for results of 20 s time scale.  
 
  
106 
 
Kinetic Exp 
EF-G
655-
Cy3 
EF-G
453-
Cy3
 
EF-G
455-
Cy3
 
EF-G
487-
Cy3
 
EF-G
692-
Cy3
 
EF-G
693-
Cy3
 
Cy3-EF-G : 70S38-Cy5 (GTP) 
0.5 s,  12s 
NO NO NO NO NO NO 
Cy3-EF-G : 70S38-Cy5 (FA, GTP) 
0.5 s 
NO NO NO NO NO NO 
Cy3-EF-G : 70S38-Cy5 (FA, GTP) 
20 s 
YES YES NO NO NO YES 
Cy3-EF-G : PRE-II38-Cy5 (GTP) 
0.5 s 
NO NO NO NO NO NO 
Cy3-EF-G : PRE-II38-Cy5 (FA,GTP) 
20 s 
YES YES NO NO NO YES 
Cy3-EF-G : PREII38-Cy5 (GDPNP) 
5 s,  100 s 
NO NO NO NO NO NO 
Cy3-EF-G : PREIItRNA-Cy5 (GTP) 
1 s   
NO NO NO NO NO NO 
 
Table 3.5 Summary of ensemble rapid kinetic FRET experiments.  Experiments were 
performed at 25 °C in WB buffer. All the results were obtained by mixing 400 µL of 
70S
38-Cy5
 (0.5 µM) or PRE-II
38-Cy5
 (0.5 µM) with 400 µL of 0.75 µM Cy3-EF-Gs, or 
PRE-II
tRNA-Cy5
 (0.1 µM) with 400 µL of 2 µM Cy3-EF-Gs, with GTP (1 mM) or GDPNP 
(1 mM) or GTP (1 mM) and FA (1 mM). Yes or No indicates whether FRET change was 
observed over the time ranges indicated. 
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CHAPTER IV SINGLE MOLECULE FRET STUDIES OF 
TRANSLOCATION 
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Abstract 
Prokaryotic elongation factor G (EF-G) catalyzes the coupled translocations on the 
ribosome of mRNA and A- and P-site bound tRNAs during the polypeptide elongation 
cycle. However, the kinetic pathway of this important step has not been fully elucidated. 
Here, we describe the application of single molecule fluorescence resonance energy 
transfer (smFRET) to probe the mechanism of this key process in real time. Attaching a 
fluorescent probe within domain IV of EF-G permits monitoring of FRET efficiencies to 
sites in both ribosomal protein L11 and A-site tRNA. Two different sites on L11, position 
38 or position 87, as well as two different A-site tRNAs, Phe-tRNA
Phe
 or Val-tRNA
Val
, 
were labeled with Cy5. The EF-G:L11 FRET efficiency is constant during EF-G 
occupancy on the ribosome (300 - 400 ms), whereas EF-G:tRNA FRET proceeds from 
high to intermediate to low FRET values. This indicates that the EF-G:A-site tRNA 
distance increases progressively during translocation, with our results providing the first 
good estimates of the timing of such changes. For both tRNAs, the EF-G:tRNA pair 
spends most of its time in the intermediate FRET state, with shorter lifetimes in the high 
and low FRET states. Each transition in the FRET value corresponds to a relative 
distance change of about 5 to 7 Å, so in total, we capture a 12 Å relative movement of A-
site tRNA away from EF-G during translocation. EF-G:A-site tRNA FRET is sensitive to 
buffer conditions, with high Mg
2+
 and polyamines stabilizing the high FRET state. In 
addition, the translocation inhibitors viomycin and spectinomycin block formation of the 
low FRET state, although spectinomycin allows more movement between EF-G and 
tRNA than viomycin. 
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4.1 Introduction 
Bacterial translation can be dissected into three major stages, including initial, 
elongation and termination, which requires the correlated movements among the 
ribosome, tRNAs, as well as important ribosomal factors, e.g., elongation factor G (EF-G) 
and elongation factor Tu (EF-Tu) (Schmeing et al., 2009a). In the elongation cycle, EF-
G, a GTPase works dynamically on the ribosome, promoting translocation of tRNAs and 
mRNA by precisely one codon. Continued progress has been achieved in understanding 
this key process, including results of structural (Agrawal et al., 2000; Cate et al., 2013; 
Tourigny et al., 2013; Zhou et al., 2013) ensemble (Dorner et al., 2006; Pan et al., 
2007; Savelsbergh et al., 2003; Wilden et al., 2006) and single-molecule studies (Chen 
et al., 2011a; Chen et al., 2013a; Fei et al., 2009; Munro et al., 2010; Munro et al., 
2007). However, most of the work has been focused on the pre-equilibrium states of this 
fast process, leaving the real time dynamics, especially how EF-G first interacts with the 
A-site tRNA in the pretranslocation complex not fully elucidated (Scheme 4.1). In this 
work, we studied how EF-G correlated its movement with tRNAs, ribosomal proteins to 
promote different sub-steps of translocation. 
EF-G comprises five domains, the overall structure mimics the structure of the 
ternary complex, with Domains I-III resemble EF-Tu structure and Domain IV 
corresponds to the anti-codon region of the tRNA (AEvarsson et al., 1994; Czworkowski 
et al., 1994). After peptidyl transfer, a peptide chain is formed in the A-site, leaving a 
deacylated tRNA in the P site. The A- and P-site tRNAs were observed to fluctuate 
between the non-rotated (A/A, P/P) and rotated states (A/P, P/E), and adding EF-G 
promoted translocation of the A, P-site tRNA to the P, E-sites respectively. While some 
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previous studies showed that EF-G·GTP bound to the rotated state of the ribosome and 
promoted translocation of tRNAs only from the hybrid states (Fei et al., 2008), the most 
recent single molecule FRET experiments indicated that EF-G can bind to both rotated 
and non-rotated ribosomes to promote translocation (Chen et al., 2011a; Chen et al., 
2013a). It was proposed that EF-G made its initial contact with the L7/L12 stalk and L10 
protein which comprised EF-G binding sites on the large subunit (Savelsbergh et al., 
2005). While the intrinsic hydrolysis rate of EF-G·GTP is very low (less than 10
-5 
s
-1
), 
binding to the ribosome largely enhances the hydrolysis activity of EF-G (at least 5 fold 
faster than translocation) and the energy released from this process further drives tRNA 
movements (Rodnina et al., 1997). Upon EF-G binding, it functions allosterically with 
ribosomal protein L1, located near the exit tunnel, to control the delivery of tRNAs. 
Domain IV of EF-G reaches out to the A-site decoding center (Gao et al., 2009), 
preventing back movements of tRNAs, then EF-G finally dissociates from the ribosome 
in the GDP form after translocation (Fei et al., 2009).  
4.2 Results  
4.2.1 The Design of the experiment 
Two FRET pairs, EF-G:L11 and EF-G:tRNA, were studied in the experiment. 
Ribosomal protein L11 or the A-site tRNA were labeled with Cy5 fluorescence dye. For 
EF-G:L11 pair, L11
Cy5
-initiation complex (IC) was pre-incubated with WT-ternary 
complex (TC) to form pretranslocation complex (PRE). For EF-G:tRNA pair, WT-IC was 
incubated with tRNA
Cy5
-TC. Cy5 labeled PRE was then attached to the slide surface via a 
single biotin labeled mRNA (Fig 4.1). As TAM
15 
buffer has been used extensively in 
single molecule studies of ribosomes, both in our laboratory (Chen et al., 2011a) and 
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others (Munro et al., 2010), we chose TAM15 as the standard buffer condition. Also, 100 
nM next TC was added simultaneously with EF-G
Cy3 
for two reasons. First, both PRE and 
POST complexes (posttranslocation complex) were formed in our system and EF-G 
bound to both complexes without showing a difference in the binding affinity. As we are 
only interested in characterizing the EF-G interaction with PRE, we want to block EF-G 
binding to the POST which blurs the results of PRE. TC shares the same binding site with 
EF-G and competes with EF-G for binding to the POST. Therefore, 100 nM TC was 
added. As POST complex had a higher affinity to TC compared to EF-G, and the 
concentration of TC applied was 100 nM, which was about 10 to 20 fold of EF-G 
concentration (5nM to 10 nM) used in the experiments, the addition of 100 nM TC 
should effectively block EF-G binding to the POST. Second, in case EF-G binds, with 
100 nM next TC, the second round of translocation would be promoted. The A-site 
labeled tRNA would move to the E-site, which was far from EF-G
Cy3
 after two cycles of 
translocation. In this way, we were able to mitigate the contribution of FRET from the P-
site labeled tRNA and focus on studying FRET of tRNA translocation from the A-site to 
the P-site. Unless otherwise mentioned, all experiments were performed under the 
standard experimental condition, which is TAM
15 
in the presence of 100 nM next round 
TC. All single molecule experiments were performed at 21°C.  
4.2.2 EF-G mutants  
4.2.2.1 EF-G mutant selection  
The relative movements between EF-G:tRNA and EF-G:L11 were studied to reveal 
how EF-G works cooperatively with different ribosomal components. The potential 
mutant sites on EF-G for introduction of a fluorescent label should meet the following 
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criteria: 1) The distances between the mutant site and either ribosomal protein L11 or the 
A site tRNA are within FRET (Ro) range of a Cy3/Cy5 pair (about 53 Å); 2) the site 
should be exposed to the solvent instead of buried inside the structure; 3) the amino acid 
should not be conserved, and less likely to have functional importance. As we have 
material stocks and developed matured labeling strategies for both C38 and S87C on 
large ribosomal protein L11 and labeled tRNAs at the elbow region, the site of EF-G 
labeling was selected based on its distance to these three sites (Seo et al., 2006). As there 
was no accessible structure of EF-G bound to the ribosome in the presence of A site 
tRNA when we started the mutant selection, the EF4 (Lep A) bound ribosome structure 
was used to find proper mutant sites. Here, cryo-EM structure of EF4, with A/L (Connell 
et al., 2008) and P/P site tRNAs on ribosomes was selected as the structural model of 
EF-G bound to PRE.  
Three Cy3-labeled EF-G mutants, containing Cys at positions 453, 655, and 693, 
show L11:EF-G FRET changes in the presence of FA (Section 3.2.5 ). Preliminary single 
molecule FRET experiments were performed by adding each of these labeled mutants to 
PRE-II
tRNA-Cy5
 in the absence of antibiotics. Only EF-G
693-Cy3 
showed an observable 
FRET with the A-site tRNA. Accordingly, EF-G
693-Cy3 
was selected for detailed smFRET 
studies on two FRET pairs, EF-G:L11 and EF-G:tRNA. 
4.2.2.2 Ensemble FRET events confirmed the activity of EF-G
693-Cy3
 
The kinetic activity of EF-G
693-Cy3
 was measured by a translocation assay, proflavin 
(prf) labeled Phe-tRNA
prf-Phe
 programmed at the ribosomal A site at 25 °C in WB buffer. 
Prf substitution of dihydrouridine group was attached within the elbow region of the A 
site tRNA and translocation of the A site tRNA to the P site leads to an increase of prf 
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fluorescence intensity (Pan et al., 2007). Upon rapid mixing of prf labeled PRE with the 
same concentration of WT-EF-G or EF-G
693-Cy3 
in stopped-flow, a single exponential 
increase of prf fluorescence was observed in both experiments. In the presence of EF-
G
693-Cy3
, the fitted rate constant was 2.5 ± 0.6 s
-1 
at 25 °C, which was about 70% of rate 
constant in the presence of WT-EF-G (3.5 ± 0.8 s
-1 
), indicating the competency of Cy3 
labeled EF-G
693 
in catalyzing fast translocation (see Section 3.2.3.2).  
4.2.3 Characterization of EF-G:L11 FRET interaction 
L11
38-Cy5 
or L11
87-Cy5 
IC was pre-incubated with WT-TC to form PRE and denoted 
PRE-L11
38-Cy5
 or PRE-L11
87-Cy5
, followed by addition of EF-G
693-Cy3
. The experiment 
was performed by using a total internal reflection fluorescence (TIRF) microscope as 
described in Chapter 2 and green laser (532 nm) was illuminated to excite Cy3 
fluorophore directly. The results in both cases are similar to one another, showing FRET 
between PRE-L11
Cy5
 and EF-G
693-Cy3
 upon initial excitation.
 
All the observed FRET 
events presented an increase of Cy3 and Cy5 signals simultaneously, indicating that EF-G 
binds to the ribosome with a conformation showing detectable FRET to the labeled sites 
on L11 (Fig 4.2). Dwell time of the FRET events was about 200 - 400 ms with only one 
fitted peak for both N-terminal (position C38) and C-terminal (position C87) labeled L11. 
The FRET efficiencies were equal to 0.41 ± 0.01 and 0.67 ± 0.01 for PRE-L11
38-Cy5
 and 
PRE-L11
87-Cy5
, respectively (Fig 4.3). All the FRET events lasted until EF-G
693-Cy3
 
dissociation from the ribosome, with a simultaneous decrease of Cy3 and Cy5 
fluorescence. 
4.2.3.1 FRET efficiency between Cy3-labeled EF-G and Cy5-labeled L11 
(C38S/S87C variant) is constant during EF-G occupancy of the ribosome  
FRET events between EF-G
693-Cy3 
and C-terminal labeled L11
87-Cy5
 were collected 
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and further analyzed. Dwell time was fitted by a single exponential function y = Aexp(-
kt), with a fitted value equal to 250 ± 5 ms under standard experimental condition (Fig 
4.3). FRET efficiency was fitted by Gaussian function y=y0 + (
                   
      
 
  
      
   
 
), 
showing a single peak value of 0.67 ± 0.01. Averaged FRET values as a function of time 
were calculated by lining up all FRET events either to the same starting time point or end 
time point to generate one pre-synchronization trace and one post-synchronization trace 
(Chen et al., 2012; Chen et al., 2011a). Synchronized FRET efficiency was plotted as a 
function of time and showed a constant value for both pre-synchronization and post-
synchronization (Fig 4.4, A), implying that there was only single FRET state over the 
entire dwell time of EF-G on the ribosome.  
This result was further confirmed by FRET difference distribution and transition 
density map. FRET events which lasted longer than 6 frames with duration longer than 
210 ms (35 ms per frame) were selected. The first and last three frames were averaged 
separately, defined as initial and final FRET. Difference between the final and initial 
FRET was calculated and the distribution was plotted, showing a symmetrical ΔFRET 
distribution relative to x = 0 (Fig 4.4, B). Some FRET events showed an increased FRET 
efficiency after translocation (located in the regions x > 0), while some showed decreased 
efficiency (located in the regions x < 0), but the majority of events presented similar or 
unchanged FRET efficiency. As similar numbers of events with increased or decreased 
FRET were observed, it implied that those events showing changes were mostly due to 
the noise, instead of being attributable to the relative distance changes between EF-G
693-
Cy3
 and L11
87-Cy5
 during EF-G residence on the ribosome. Additionally, the initial and 
final FRET values were plotted as a transition density map. Events located on the 
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diagonal line on the map presented exactly same initial and final FRET values. The 
transition density contour map showed a symmetrical pattern relative to the diagonal line 
with the majority of traces located in the region where ΔFRET was between -0.1 to 
0.1(Fig 4.4 C), indicating that most events had similar initial and final FRET values. 
4.2.3.2 FRET efficiency between Cy3-labeled EF-G and Cy5-labeled L11 (C38) 
behaves similarly as Cy5-labeled L11 (C38S/S87C variant)  
The FRET results between EF-G
693-Cy3
 and N-terminal domain labeled L11
38-Cy5
 are 
similar to those of EF-G
693-Cy3
:L11
87-Cy5
 pair, with dwell time equal to 327 ± 5 ms and a 
lower FRET efficiency of 0.41 ± 0.01 (Fig 4.3, C, D). A single FRET state was observed 
during EF-G residence on the ribosome, as confirmed by postsynchronized analysis, 
FRET difference distribution and transition density map (Fig 4.4 D, E, F). Protein L11 is 
located at the base of the L7/L12 protein stalk and has significant structural flexibility on 
the ribosome (Agrawal et al., 2000; Agrawal et al., 2001). Previous study showed that 
C-terminal (CTD) and N-terminal domains (NTD) of L11 are connected by a linker 
which is composed of two proline amino acids. Two L11 structures were compared 
(Agrawal et al., 2001; Wimberly et al., 1999) and an inter-domain conformational 
change by an approximate 7Å shift and 40° rotation between CTD and NTD was 
observed, which is due to the movement in the linker region. Only a single FRET state 
was obtained in our work for both N-terminal and C-terminal labeled EF-G, implying that 
EF-G interacted with C-terminal and N-terminal domains of L11 in a similar manner and 
that such interaction occurred without L11 inter-domain conformational change. 
The EF-G
693
:L11
38
 and EF-G
693
:L11
87
 FRET efficiencies of 0.41 and 0.67, 
respectively, correspond to approximate distances of 56 Å and 47 Å, respectively, 
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assuming a Förster Ro value of 53 Å (Seo et al., 2006). These distances are in qualitative 
accord with the coordinates from a recently published structure (Zhou et al., 2014) in 
which EF-G and A-site peptidyl-tRNA are bound simultaneously to the ribosome, albeit 
in the presence of fusidic acid and neomycin, in which the  distances between Cβ of 
N693C and Cβ of C38L11 or S87L11 are 51Å and 37Å, respectively (Fig 4.5). That the 
FRET distances of EF-G with either L11 or tRNA measured in our work are somewhat 
larger could be explained by three reasons: 1) the fluorophore-fluorophore distance 
measured in our work could be considerably greater than α-C-α-C distances calculated 
from the reported structure; 2) the structure was obtained from Thermus thermophilus and 
our experiments were based on the ribosome from E. coli; 3) fusidic acid (FA) was 
applied in the structural work which could result in a relative conformational change 
between EF-G and the ribosome/tRNA (Sections 3.2.4.1 and 3.2.5.1).  
4.2.4 Characterization of EF-G:tRNA FRET interaction showing relative distances 
changes during translocation under standard conditions 
4.2.4.1 Overview  
To monitor the relative movements between EF-G and the A-site tRNA, the Cy3-
labeled EF-G mutant used in the previous L11 experiment, EF-G
693-Cy3
, was utilized. Two 
different A-site tRNAs, Val-tRNA
Val
 at dihydrouridine position 17 and Phe-tRNA
Phe 
at 
dihydrouridine positions 16/20 were labeled with Cy5 hydrazide dye (Kaur et al., 2011). 
PRE-I contains Val-tRNA
Val-Cy5 
and PRE-II contains Phe-tRNA
Phe-Cy5
. By immobilizing 
pretranslocation complexes onto the surface of the slide in a pre-incubation step, and then 
quickly injecting Cy3 labeled EF-G together with 100 nM wild type next ternary complex, 
the real-time kinetics of translocation can be monitored. The synchronization analysis of 
all FRET events showed a small FRET decrease as a result of translocation, indicating 
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that there were relative distance changes between EF-G
693-Cy3 
and the A-site tRNA
Cy5
 
(Detailed discussion in section 4.2.4.3). In this section, both FRET and kinetic results are 
described as follows: Sections 4.2.4.2 - 4.2.4.6, FRET results, including 4.2.4.2, 
characterization of FRET; 4.2.4.3, FRET segmentation; 4.2.4.4, initial and final FRET 
distributions; 4.2.4.5, FRET of POST complexes; 4.2.4.6, proposed explanations for two 
different groups of traces. Section 4.2.4.7, kinetics of translocation for Group I trace. 
4.2.4.2 EF-G
693-Cy3
: tRNA FRET characterization of all FRET results 
Single molecule FRET experiments between Cy5 labeled PRE and EF-G
693-Cy3 
were 
carried out under standard experimental conditions, as described above. Upon EF-G 
binding, a simultaneous increase of Cy3 and Cy5 fluorescence was observed, similarly to 
what was seen in the EF-G:L11 experiment, indicating that EF-G binding to the ribosome 
gives rise to a detectable FRET signal (Fig 4.6). The dwell time of FRET for PRE-I was 
424 ± 9 ms and FRET efficiency distribution was fitted by two peaks with values of 0.18 
± 0.01 and 0.37 ± 0.02, respectively. Similarly, the dwell time for PRE-II was equal to 
457 ± 8 ms and FRET distribution was fitted by two peaks, having values of 0.22 ± 0.01 
and 0.36 ± 0.03 (Fig 4.7). Importantly, these average dwell times are consistent with the 
overall ensemble rate constant for translocation of 2.5 ± 0.6 s
-1
, allowing for the 
somewhat lower temperature at which the single molecule experiments are performed 
(ensemble, 25 
o 
C, smFRET, 21 
o 
C). 
4.2.4.3 Partial resolution of traces showing EF-G:tRNA FRET into two groups 
More than one FRET state was observed over the entire FRET events, demonstrated 
by the results of postsynchronized analysis, FRET difference distribution and transition 
heat contour map. As discussed in Chapter 2, if there were no relative distance changes 
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between two labeled positions, pre- and post- synchronization traces should show a single 
constant FRET value, as what was observed in EF-G:L11 experiments. However, a 
decrease of final FRET efficiency of EF-G:tRNA FRET pair was obtained, implying 
there was more than one FRET state during translocation (Fig 4.8). The FRET difference 
distribution of PRE-I was plotted to study the details of the changes. Interestingly, 
although the majority of the events still presented no significant FRET changes during 
translocation, the distribution was not symmetrical, in contrast to what was seen in the 
EF-G:L11 interaction. A larger proportion of events was observed located in x < 0 region 
with a negative FRET change (Fig 4.9, A). The transition heat contour map further 
confirmed our observation by showing a large proportion of events under the line of 
identity (Fig 4.9 B, C). To determine if these results suggested that the tRNA:EF-G 
interaction was heterogeneous and could be further segmented by FRET efficiency 
changes during translocation, a manually selected ΔFRET cutoff value (- 0.1 for PRE-I 
and - 0.12 for PRE-II ) was applied to further segment the traces into two groups, without 
confirming whether the two groups are really different from each other or not. For PRE-II, 
essentially similar results were obtained from postsynchronized analysis, FRET 
difference distributions and transition heat contour maps (Fig 4.8 B, Fig 4.9 D, E, F).  
Traces with large decreased FRET changes (ΔFRET < - 0.1 for PRE-I and ΔFRET < 
- 0.12 for PRE-II) were placed in Group I, and all other traces (ΔFRET > - 0.1 for PRE-I 
and ΔFRET > - 0.12 for PRE-II) were placed in Group II.  Group I traces constitute 15 -
40 % of the total population depending on different experimental conditions (Detailed 
discussion in section 4.2.5). Dwell time analysis provided an indication that these two 
groups represented two different types of EF-G:tRNA interactions. The dwell times 
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averaged 555 ± 10 ms (PRE-I) and 543 ± 19 ms (PRE-II) for Group I, which were 1.25 - 
1.5 fold longer than the dwell times of Group II (374 ± 13 ms, PRE-I; 435 ± 10 ms, PRE-
II). Thus, these two Groups not only had different ΔFRET values during EF-G binding, 
but also showed a difference in FRET signal duration (Fig 4.10). This suggested that the 
two Groups were different and could be at least partially resolved.  
4.2.4.4 Initial and Final FRET distributions for the EF-G:tRNA pair under standard 
conditions 
In this section we focused on FRET efficiencies measured between EF-G
693-Cy3
 and 
the A-site tRNA
Cy5
 upon the first binding of EF-G to the PRE complex or just before EF-
G departing from the ribosome, as a prelude to the discussion of the kinetics of EF-
G:tRNA FRET efficiency changes during translocation (Section 4.2.4.7).   
Initial and final FRET values were calculated as the average values of the first three 
and last three frames of the FRET events, respectively. For PRE-I, the initial FRET 
distribution showed two major peaks, with FRET efficiency values of 0.23 ± 0.01 and 
0.42 ± 0.01,  and relative areas of 0.45 and 0.55, respectively (Fig 4.11, top, left). The 
initial FRET distribution was broad, which indicated that tRNAs were in a variety of 
states when EF-G bound to the ribosome. The final FRET distribution also had two peaks 
with approximately the same values as the initial FRET distribution (0.22 ± 0.01 and 0.41 
± 0.01) but with very different relative areas (0.65 and 0.35, respectively) (Fig 4.11, top, 
right), indicating that 36% ((0.55-0.35)/0.55=0.36) of the PRE complexes with an initial 
high FRET efficiency successfully converted to the low FRET state. 
The results for the PRE-II complex were qualitatively similar but, for the most part, 
quantitatively different. The initial FRET distribution showed two major peaks, with 
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FRET efficiencies of 0.27 ± 0.01 and 0.45 ± 0.05 and with relative areas of 0.70 and 0.30 
(Fig 4.11, bottom, left). The corresponding final values were 0.25 ± 0.01 and 0.40 ± 0.04 
for the FRET efficiencies and 0.80 and 0.20 for the relative areas (Fig 4.11, bottom, 
right). One quantitatively similar result was obtained in the percentage of traces in PRE-
II having initial high FRET efficiency that was successfully converted to the low FRET 
state (33% vs. 36% in PRE-I). 
As EF-G:L11 interaction indicated that the EF-G:L11 FRET pair only presented a 
single FRET value, the differences in EF-G:tRNA FRET efficiencies and distributions 
between PRE-I and PRE-II are likely due to differences in the binding of different 
peptidyl-tRNAs [tRNA
Val
 (PRE-I) vs. tRNA
Phe
 (PRE-II )] at the A-site. PRE-I with Val-
tRNA
Val-Cy5
 showing a higher preference for the high FRET efficiency state compared to 
PRE-II with A site Phe-tRNA
Phe-Cy5
, which is consistent with the results from Chen et al. 
(2011).    
It is reasonable to assume that the initial FRET distribution was determined by both 
the equilibrium states of the A-site tRNA before EF-G binding and the binding affinity of 
EF-G to the corresponding states. Chen et al. (2011) reported that at equilibrium in the 
same buffer condition, the classic and hybrid populations of tRNAs in the absence of EF-
G were in 1:1 ratio for PRE-II complex. In our experiments, the relative populations of 
high and low FRET states on EF-G addition, which correspond to class and hybrid tRNA 
states (Detailed discussion in Section 4.2.6.1) was 0.3:0.7, implying the binding affinity 
of EF-G to the hybrid FRET state was approximately two fold of that to the classic state. 
The initial FRET distribution plots were broad for PRE-I and PRE-II, suggesting the 
possibility that EF-G bound to different states of tRNAs which were located along the 
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translocation trajectories between classic and hybrid states. This result is consistent with 
Fischer et al. (2010) study which showed that while classic and hybrid tRNAs were the 
two most abundant populations, tRNA possessed a number of different conformations 
along the translocation trajectories that could be captured by EF-G (Fischer et al., 2010). 
 Initial FRET distributions of Group I and Group II were plotted separately for both 
PRE-I and PRE-II (Figure 4.12). For Group I, most of the initial FRET events displayed 
high FRET values for both PRE-I and II, but with a broad distribution (Fig 4.12 A, C). 
This further supported that multiple high FRET states existed at the beginning of 
translocation that could be captured by EF-G. For Group II, the initial FRET values were 
dominated by the lower FRET values in both PRE complexes, but still a certain 
proportion of high FRET state was observed. Since Group II is characterized by traces 
showing similar initial and final FRET values, this distribution of initial FRET states 
suggests that Group II includes both translocation events that start from low FRET states 
and non-productive binding events to the high FRET states (Fig 4.12 B, D). 
4.2.4.5 Binding of EF-G 
693-Cy3 
to POST Complex  
Characterizations of FRET between EF-G
693-Cy3 
and PRE
Cy5 
were the focus of this 
study. However, after one cycle of translocation, Cy5 labeled peptidyl tRNA in the P-site 
gives rise to FRET signals with EF-G
693-Cy3 
that could affect the interpretation of our 
results. Although 100 nM next TC was added to lessen such a FRET contribution, still 
there is certain possibility that FRET between EF-G
693-Cy3 
with POST
Cy5 
were counted. 
Therefore, binding of EF-G
693-Cy3 
to POST
Cy5
 complexes was studied as negative controls. 
WT-EF-G was added to the pre-formed PRE to produce post translocation complex 
(POST) in TAM
15 
buffer. POST complexes formed by PRE-I and PRE-II were denoted 
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POST-I and POST-II, respectively. Each POST complex was formed after one cycle of 
translocation and active peptidyl-tRNA
Cy5
 was translocated to the P site. POST was 
attached to the slide surface by using the same single biotin labeled mRNA as previously 
described, followed by addition of EF-G
693-Cy3
 in the absence of next TC. EF-G
693-Cy3 
bound and dissociated from the ribosome, resulting in a FRET between EF-G
693-Cy3 
and P 
site peptidyl-tRNA
Cy5
. FRET efficiency distribution of POST-I had lower values 
compared to the results of EF-G binding to the PRE complex, giving values of 0.14 ± 
0.01 and 0.22 ± 0.01 (Fig. 4.13, A), which correspond to distances of 72 Å and 65 Å, 
respectively. Zhou et al. (2014) reported tRNA in the pe/E site showing a distance of 88 
Å to the position 693 on EF-G, which is larger but comparable to the calculated result of 
72 Å. Therefore, 0.14 ± 0.01 may correspond to the FRET of Cy5-P-site tRNA: Cy3-EF-
G pair and 0.22 ± 0.01 may be attributed to FRET between the inactive tRNA in the A/P 
site and EF-G. Also, the dwell time of the POST complex was 301 ± 6 ms, significantly 
shorter than for EF-G interaction with the PRE complex (Fig. 4.13, B). A single FRET 
state over the entire duration was obtained, demonstrated by postsynchronized analysis 
which showed only one constant value for both pre- and post-synchronizations, indicating 
that, unlike in PRE, there were no relative distance changes between the P-site tRNA
Cy5
 
in POST-I and EF-G
693-Cy3 
(Fig 4.13, C). The ΔFRET distribution of POST-I further 
confirmed this conclusion (Fig 4.14). Unlike in PRE, the distribution of delta FRET for 
POST showed a symmetrical pattern relative to x = 0. The Group I population was 
largely suppressed in POST-I complexes, suggesting that Group I can be attributed to 
translocation, which involves movements of tRNAs and mRNA by one codon. Similar 
results were obtained for POST-II complexes. FRET efficiencies were equal to 0.16 ± 
123 
 
0.01 and 0.29 ± 0.02, respectively with a dwell time of 275 ± 3 ms (Fig. 4.13, D, E).  A 
constant FRET value was obtained in postsynchronized analysis and Group I traces were 
again not present (Fig. 4.13, F and Fig 4.14).  
4.2.4.6 Proposed explanations of Group I and Group II traces  
Previous studies showed that EF-G binding to the ribosome could be both productive, 
catalyzing active translocation, and non-productive, with EF-G dissociation occurring 
prior to translocation (Chen et al., 2013a; Munro et al., 2010). For the reasons cited 
above (longer residence time of EF-G, reflecting the longer time needed to complete the 
translocation process, and decreases in FRET during the residence time, expected as a 
result of peptidyl-tRNA movement from the A- to the P-site ) we conclude that  Group I 
traces reflect largely productive, translocation events. On the other hand, we believe that 
Group II traces comprised both translocation events starting from lower FRET states and 
non-productive binding events during which EF-G binds and dissociates from the same 
state without completing translocation. Here, it is noteworthy that high FRET events (E > 
0.4) in Group II had much shorter dwell times (112 ± 2 ms for PRE-I and 169 ± 6 ms for 
PRE-II) than events started with high FRET in Group I (Fig 4.15)  
4.2.4.7 Translocation kinetics of Group I 
Synchronization analysis was applied to extract FRET efficiencies and durations of 
FRET events in Group I and characterize the kinetics of tRNA translocation (Chen et al., 
2011a). The postsynchronized traces were calculated from the averaged FRET values as a 
function of time. All FRET events were lined up at an identifiable trigger transition and 
averaged. To get equal durations, all individual traces were extended at the prior and 
subsequent segment ends. FRET traces were aligned at the beginning (pre-
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synchronization) or end (post-synchronization). The fitted results of synchronization 
analysis of Group I traces showed three FRET states, with the conversion of the 
intermediate FRET state to the low FRET state constituting the rate limiting step.  
4.2.4.7.1 Group I traces show three FRET states 
PRE and post synchronization traces were each fitted with a single exponential 
function. The apparent overall translocation rate is the reciprocal of the summed lifetimes 
of all the states. Both two- and three- state models were applied to the two PRE 
complexes. The three state model turn out to show better fitting results to the raw data for 
both PRE complexes (Fig 4.16, Fig 4.17). Therefore, the three-state model will be applied 
in our following kinetic analysis. 
For PRE-I, FRET events started with a high FRET value of 0.47 ± 0.01, via an 
intermediate FRET 0.25 ± 0.01, and finally disappeared with a low FRET of 0.24 ± 0.01, 
corresponding to a distance change from about 54.1 Å to 63.6 Å and then to 64.2 Å. 
These values agree reasonably well with the average distance between Cβ of N693C in 
EF-G and C4 of positions 16/20 of the A-site bound N-acetyl-Val-tRNA
Val  
in
 
the 
 
recent 
structure of Zhou et al. (2014). The transitions from 0.47 to 0.25 and 0.24 to zero 
proceeded with rate constants of 18.0 ± 0.4 s
-1
, 18.4 ± 1.8 s
 -1
 respectively, while the 
conversion from 0.25 to 0.24 was slower, with a rate constant of 1.8 ± 0.1 s
-1 
(Table 4.4 
and Fig 4.17, A). For PRE-II, essentially similar results were obtained. FRET events 
started with a high FRET value of 0.49 ± 0.01, via an intermediate FRET of 0.31 ± 0.01, 
and finally disappeared with a low FRET of 0.26 ± 0.01, corresponding to a distance 
change from about 53.7 Å to 60.6 Å and then to 63.1 Å.  The transitions from 0.49 to 
0.31 and 0.26 to zero proceeded with rate constants of 24.4 ± 1.1 s
-1
, 12.6 ± 1.1 s
-1
 and 
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the conversion from 0.31 to 0.26 proceeded more slowly, with a rate constant of 1.6 ± 0.1 
s
-1 
(Table 4.4 and Fig 4.17, B).  
4.2.4.7.2 Transition from INT to Low is the rate determining step 
As described above, for both PRE complexes, transition from intermediate FRET 
(INT) to low FRET (Low) is the rate limiting step but with a small FRET change, and 
from high FRET (High) to intermediate FRET (INT) is not rate limiting but shows a large 
FRET change. As Group II also contains active translocation events which only give rise 
to a small FRET change, it is likely that transition from INT to Low FRET is included in 
Group II. Such transitions should have a longer duration as they correspond to the rate-
limiting step in translocation. To further examine this point, the timing of translocation 
events with an initial FRET value of 0.35 to 0.27 and final FRET of 0.27 to 0.21 in Group 
II was analyzed. The average dwell time of this group for PRE-I complexes was 
determined to be 670 ± 43 ms (Fig 4.18, A), considerably longer than the dwell time of 
the total population 424 ± 9 ms (Fig 4.7), consistent with the notion that FRET 
conversion from INT to Low was the rate determining step. Similar results were found 
for PRE-II, with an average dwell time of the selected traces equal to be 630 ± 30 ms (Fig 
4.18, B), suggesting that different tRNAs have similar translocation trajectories.  
4.2.4.7.3 Choosing different FRET cutoffs does not substantially alter the kinetics 
of Group I traces 
By definition, Group I and Group II are two types of events with different ΔFRET 
values. As the 0.1 cutoff value was selected somewhat arbitrarily, several different cutoff 
values were applied to test the robustness of our interpretation of the results (Table 4.2). 
We want to examine how many traces were placed in Group I when different cutoff 
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values applied, but the noise was counted in our measurement which complicated the 
results. To get rid of the noise, the number of traces in corresponding positive ΔFRET 
regions was used as the benchmark value of noise (for instance, number of traces with 
FRET > + 0.10 was counted as noise for the traces with FRET < - 0.10), for the noise 
should present a normal distribution as a function of ΔFRET. Therefore, a larger cutoff 
value (absolute value) would reduce noise counted in Group I (for instance, for PRE-I 
complexes, the numbers of traces with FRET > + 0.10 and FRET > + 0.20 were 522 
and 67, respectively). Global fitting was applied to Group I with different cutoff values to 
test the robustness of our results. Transition rates were fitted with the cutoff values 
between - 0.12 and - 0.20. The fitted transition rates were little affected, confirming the 
robustness of the three-state model. Similar results were found for PRE-II (Table 4.2 a, b).  
4.2.5 Characterization of EF-G:tRNA FRET interaction showing relative distances 
changes during translocation under non-standard conditions 
4.2.5.1 Ternary complex concentration effect on 
 
translocation kinetics  
Elongation factor Tu (Tu) is believed to bind to the ribosome at L7/L12, sharing the 
same binding site with EF-G. As there are two copies of L7/L12 dimer per E. coli 
ribosome, it is possible, even likely, that Tu and EF-G could bind to the ribosome 
simultaneously at some point. Therefore, ternary complex (TC) binding may have three 
possible effects on EF-G catalyzed translocation: 1) binding to the A-site - expected to be 
codon dependent; 2) binding to L7/L12 - expected to be codon independent 3) uncharged 
tRNA (present within TC preparations) binding to the E-site - expected to be codon 
independent (Lill et al., 1987). As explained above, we added 100 nM of the next 
cognate TC as part of the standard reaction mixture for studying EF-G:peptidyl-tRNA 
interaction during translocation. To further examine the effect of TC complex on 
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translocation, here we examine the effects of either eliminating the next cognate TC (0 
nM TC) or of increasing the TC concentration to 500 nM. TC was added along with EF-
G
693-Cy3
 to both PRE-I and PRE-II. As compared with adding 100 nM TC, eliminating TC 
did not alter FRET efficiency distribution, while adding 500 nM TC shifted the high 
FRET peak to an even higher value for both PRE-I and PRE-II (Fig 4.19). The total dwell 
time of FRET events was unchanged for PRE-I and was shorter for PRE-II in the absence 
of TC. Interestingly, the total dwell time was reduced to half of its value with the addition 
of large concentration (500 nM) TCs (Table 4.4) for both PRE-I and PRE-II. Further 
analysis was applied to Groups I and II traces, respectively. For PRE-I, a similar trend of 
dwell time change at different TC concentrations was observed for Groups I and II, with 
unchanged dwell time at 0 nM TC and half reduced dwell time at 500 nM TCs. For PRE-
II, under 0 nM TC, dwell time of both Groups I and II was reduced and similar reduction 
in dwell time was obtained for 500 nM TCs condition. To test whether this effect was 
codon dependent or not, 500 nM non-cognate Arg-tRNA
Arg 
was applied and showed a 
similar dwell time reduction (Total dwell times are 202 ± 4 ms for PRE-I and 249 ± 5 ms 
for PRE-II), implying that this effect was not codon dependent and could be attributed to 
either the binding effect of EF-Tu to L7/L12 on the 50S subunit or of deacylated tRNA to 
the E-site. Either of these possibilities could decrease the affinity of EF-G on the 
ribosome and promote its release. While eliminating TC did not change the transition 
rates for PRE-I, 500 nM TC did reduce the transition rate from High to INT (k1 from 18.1 
± 0.4 s
-1
 to 15.7 ± 1.2 s
-1
 for PRE-I and from 24.4 ± 1.1 s
-1
 to 12.8 ± 0.5 s
-1
 for PRE-II) 
and increased the dissociation of EF-G (k3 from 18.4 ± 1.8 s
-1
 to 38.6 ± 18.7 s
-1
 for PRE-I 
and  from 12.6 ± 1.1 s
-1
 to 20.9 ± 3.6 s
-1
 for PRE-II ), leaving the transition rate constant 
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from INT to Low unchanged (Table 4.4). The possible explanation for the decreased 
transition rates from High to INT for PRE-I and PRE-II would be that with high 
concentration of TC complexes, uncharged tRNA within the TC preparation, bound to the 
E-site non-specifically, favoring the classic state position for A-site tRNA and extending 
the life-time of the high FRET state. 
4.2.5.2 Buffer effect on translocation kinetics  
Our standard conditions employed 15 mM Mg
2+
 in the absence of polyamines. We 
determined the effects of both reducing Mg
2+
 and adding polyamines on translocation 
kinetics, as reflected in the measurement of FRET values, dwell times and kinetics (Table 
4.6, Fig 4.21 and Fig 4.22).  For PRE-I, the high FRET proportion was increased in both 
polyamine buffer and by reducing Mg
2+ 
to 7 mM, with the effect being more marked in 
the presence of polyamine. By contrast, for PRE-II the overall FRET efficiency 
distribution was essentially unchanged by reduced Mg
2+ 
concentration or addition of 
polyamine (Table 4.5).  
Decreasing Mg
2+ 
from 15 mM to 7 mM resulted in shorter dwell times for both PRE-
I and PRE-II, with reduced values for both Groups I and II. For PRE-I, the transition rate 
constant (k1) from High to INT was slightly increased (from 18.1 ± 0.4 s
-1 
to 21.6 ± 1.1   
s
-1
), while the rate constants from INT to Low (k2) was increased by a factor of two (from 
1.8 ± 0.1 s
-1 
to 3.9 ± 0.1 s
-1
). Similar fitting results were obtained for PRE-II, except that 
the transition rate constants from Low to dissociation was unchanged and from High to 
INT was slightly decreased (Table 4.6).  
Addition of polyamines did not much change overall dwell times. For PRE-I, a 
decrease in the dwell time of Group II was offset by an increase on the dwell time of 
129 
 
Group I, while for PRE-II added polyamine had little effect on either overall dwell time 
or the dwell times for Groups I and II.  For PRE-I, adding polyamine significantly 
decreased the transition rates (from 18.1 ± 1.8 s
-1 
to 10.2 ± 0.5 s
-1 
for k1, from 1.8 ± 0.1 s
-1 
to 1.1 ± 0.3 s
-1
 for k2, and from 18.4 ± 0.1 s
-1 
to 9.2 ± 1.2 s
-1
for k3).
 
For PRE-II adding 
polyamine had only minor effects, slightly decreasing k1 and k3 and having little effect on 
k2. Added polyamine also increased the percentage of Group I traces from 29.8 % to 37.7 % 
for PRE-I and from 19.0 % to 25.1 % for PRE-II (Table 4.6).  
In summary, added polyamine stabilized high FRET states in PRE I and II by both 
reducing the transition rate from High to INT and increasing the portion of tRNA starting 
translocation from a high FRET state.  
4.2.6 Antibiotics effect on EF-G:tRNA FRET interaction  
Many biochemical and structural studies have revealed that a diverse array of 
antibiotics function during translocation to inhibit protein synthesis. Fusidic acid (FA) 
binds to Domains G, II and III of EF-G, prevents EF-G conformational changes 
following GTP hydrolysis, but does not inhibit translocation (Gao et al., 2009). Viomycin 
(VIO) decouples the movements between EF-G and the A-site tRNA, blocking the 
effective translocation of the A-site tRNA and stabilizing the ribosome in both ratcheted 
and unratched states (Ermolenko et al., 2007; Peske et al., 2004; Stanley et al., 2010; 
VAZQUEZ et al., 1977). Spectinomycin (Spc) binds to helix 34 of the small subunit 
head domain on the ribosome and inhibits translocation after GTP hydrolysis and Pi 
release (Munro et al., 2010; Peske et al., 2004). 
4.2.6.1 Viomycin perturbs EF-G:tRNA FRET state transitions 
PRE-I and II interactions with EF-G
Cy3
 were carried out in the presence of 100 µM 
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VIO under standard experimental conditions. The FRET distribution was shifted to 
higher values on VIO addition with peak values of 0.27 ± 0.01, 0.42 ± 0.01 for PRE-I 
[compare Fig 4.23, middle left (+VIO) with Fig. 4.21B (-VIO)] and 0.31 ± 0.01, 0.52 ± 
0.02 for PRE-II [compare Fig 4.23, middle right (+VIO) with Fig. 4.21E (-VIO)]. 
Previous studies suggest that VIO blocks translocation of the A-site tRNA to the P site 
and stabilizes tRNAs in both A/A classic and A/P hybrid states. Therefore, the 0.27 and 
0.42 FRET states are attributed to the EF-G:A/P tRNA and EF-G:A/A tRNA structures 
for PRE-I. Similarly, 0.31 and 0.52 FRET states are attributed to the EF-G:A/P tRNA and 
EF-G:A/A tRNA structures for PRE-II . In the absence of VIO, FRET conversions from 
High to INT and to Low efficiencies were observed. Added VIO suppressed these FRET 
conversions, demonstrated by both synchronization analysis and ΔFRET distribution. 
Postsynchronized analysis showed constant values for both pre and post synchronization 
traces, indicating that there were no FRET efficiency changes during the entire residence 
time of EF-G on the ribosome (Fig 4.24 A, B). Similarly, added VIO completely 
suppressed Group I traces as plotted in Fig 4.24 C, D.   
The same experiments were repeated under different buffer conditions described 
above (Section 4.2.5.2). Adding polyamine at 15 mM Mg
2+
 led to an increases in the 
fraction of PRE complex in the high FRET state (E ≈ 0.5) which was more pronounced 
for PRE-II than for PRE-I, suggesting that high Mg
2+
 and polyamine concentrations 
stabilize a classic-like state (Fig 4.23). To sum up, these findings together revealed that 
EF-G:A/A site tRNA revealed a high FRET value ~ 0.5, and EF-G:A/P hybrid tRNA 
showed an intermediate FRET value ~ 0.3, while the low FRET state (0.23 for PRE-I and 
0.26 for PRE-II ) was not observed in the presence of VIO. This indicates that low the 
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FRET state observed in the absence of antibiotics is attributable, at least in part, be 
contributed by tRNAs in the late steps of translocation, which were not populated in the 
presence of VIO. 
4.2.6.2 Spectinomycin (Spc) inhibits complete translocation  
PRE-I and II interactions with EF-G
Cy3
 were repeated in the presence of 5 mM Spc. 
Added Spc suppressed the population of traces showing a complete FRET change as 
what was observed with no antibiotics, but still allowed some FRET changes. In the 
presence of Spc, the FRET distribution was shifted to lower values compared to that seen 
with added VIO and shifted to higher values compared to the experiments lacking 
antibiotic, with peak values of 0.19 ± 0.01 and 0.38 ± 0.02 for PRE-I, and 0.23 ± 0.01 and 
0.45 ± 0.01 for PRE-II (Fig 4.25). This indicated that Spc hindered translocation in a later 
step compared to VIO, in accord with published results (Pan et al., 2007, Munro et al., 
2010). Interestingly, with Spc, we captured a smaller FRET change, demonstrated by 
synchronization analysis, and the transition was a one step process with no intermediate 
FRET state observed. Also, Group I traces were observed in ΔFRET distribution but the 
population was smaller compared to that in the absence of antibiotics (Fig 4.26 B, D and 
Fig 4.14 A, C). Taken together, these data suggested that Spc allowed the initial EF-G to 
engage in the GTPase activation center and A-site tRNA conformational change, but 
inhibited a later step of translocation. Similar global fitting analysis was applied here to 
the traces with large FRET change. Two FRET states were obtained for both PRE-I and 
PRE-II complexes. For the PRE-I complex, transition rate constants from the High (0.53 
± 0.01) to the Low FRET state (0.26 ± 0.01) and from Low FRET state to dissociation are 
5.7 ± 0.2 s
-1 
and 3.3 ± 0.1 s
-1
, respectively. Similar results were calculated for PRE-II, 
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with efficiencies for both FRET states equal to 0.53 ± 0.01 and 0.27 ±0.01 and transition 
rates of 5.7 ± 0.1s
-1
 and 4.5 ± 0.1 s
-1
 (Fig 4.27). The results suggest that in the presence of 
Spc, the lowest FRET state, which was observed in the absence of antibiotic, was not 
populated, and that EF-G dissociated from an intermediate state, with a FRET value 
similar to that of a hybrid state, without catalyzing the complete translocation.  
4.3 Discussion  
Comparing our results with previous smFRET studies using labeled EF-G 
smFRET studies have the potential to elucidate reaction mechanism by identifying 
the important intermediates that may be too short-lived or weakly populated to be 
detected in the ensemble FRET measurements. Since 2007, several smFRET studies have 
been published focusing on different aspects of the role of EF-G in translocation. Wang in 
our group first reported smFRET studies measuring FRET between position 231 in the G’ 
domain of EF-G, which is far from residue 693, the labeling position most utilized in our 
work, and the NTD of L11 (C38) on a ribosome engaged in poly Phe synthesis, showing 
that two FRET states can be identified, with efficiencies of 0.3 and 0.6 respectively 
(Wang et at., 2007). However, due to the low time resolution of the experiment, no dwell 
time or transition rates were reported in this work. In 2010, Munro et al. reported another 
smFRET work of translocation. Cy3 labeled tRNA
fMet 
(U8) and Cy5 labeled L1 (S55C) 
construct were used to study the formation of the unlocked state. Cy3-fMet-Phe-tRNA
Phe 
(U47) and Cy5-EF-G were used to study the EF-G interaction with the A site tRNA. But 
in this work, EF-G was enzymatically labeled via the Sfp phosphoantetheinyl transferase 
reaction to a peptide (12 aa in length) fused at the C terminus. As a result, the dye could 
be far away from EF-G protein, making questionable utilizing the FRET signal to 
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monitor the relative movements between EF-G and A-site tRNA. This work focused on 
the ribosome spontaneous movement which results in an unlocked state, suggesting that 
this intrinsic conformational change of the ribosome determines the rate of translocation. 
They observed FRET between EF-G and the A-site tRNA with a dwell time of 385 ms, 
which matches the dwell time of total FRET events in our work (424 ± 9 ms, PRE-I; 457 
± 8 ms, PRE-II). However, at the time resolution used in Munro’s work, transition rates 
between FRET states could not be accurately determined (Munro e al., 2010). Chen et al. 
(2013) correlated the composition and conformation of the ribosome during translocation 
and focused on elucidating the ratcheting and back ratcheting motions of the ribosome by 
using Cy3 labeled 30S and quencher labeled 50S. They reported dwell times for 
translocation of 122 ms at 5 mM Mg
2+
 increasing to 270 ms at 15 mM Mg
2+
, somewhat 
shorter than our results for translocation. However, in their measurement, dwell time is 
based on measuring multiple cycles of translocation. In contrast, our result is obtained 
from the first round of translocation, which is believed to be longer than translocation 
occurring in the later cycles (Chen et al., 2011b). The most recently published EF-G 
translocation work (Salsi et al., 2014) followed the movement of Domain IV on EF-G 
(either position 538 or 541) by measuring FRET between labeling sites on Domain IV of 
EF-G and small ribosomal protein S12, which is the only protein located at the subunit 
interface near the A-site. By comparing FRET measured in the presence of different 
antibiotics which are believed to stabilize either PRE or POST complexes, this work 
describes a nice picture of EF-G Domain IV moving toward the A-site to facilitate the 
movement of peptidyl-tRNA from the A site to the P site. However, due to weak EF-G 
binding, all the results are obtained with antibiotics FA and/or VIO, no real-time 
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translocation with dwell times and transition rates characterized.  
Here, we monitor FRET between fluorophores attached to EF-G
693
 and ribosome 
protein L11 or the A site tRNA to directly observe the relative distance changes between 
EF-G:L11 and EF-G:tRNA. Our work provides the first good estimation of translocation 
kinetics with rate constants of each transition accurately determined and coupled 
movements between EF-G:tRNA and EF-G:L11.  
EF-G:L11 shows constant FRET during translocation 
For the EF-G:L11 pair, constant FRET was obtained for both a N-terminal domain 
(NTD) labeled residue (C38) and a C-terminal domain (CTD) labeled residue (C87). L11 
has a flexible structure with a linker region that is composed of two proline amino acids. 
A comparison between EF-G bound ribosome with EF-G free ribosome structures reveals 
that the NTD of L11 undergoes a large conformational change and large rearrangements 
upon EF-G binding, with the EF-G binding regions on the NTD and the CTD moving 
toward each other (Wimberly et al., 1999; Agrawal et al., 2001). In addition, during 
translocation, Domains III-V of EF-G are believed to undergo large distance 
displacements (Agirrezabala et al., 2009; Tourigny et al., 2013; Zhou et al., 2013), 
Despite these results from structural studies, we observe no FRET efficiency changes 
between EF-G and either NTD or CTD labeled L11 during the entire occupancy of EF-G 
on the ribosome, as demonstrated by synchronization analysis. This implies that L11 
internal conformational changes that are induced by EF-G binding occur prior to 
translocation, and that, during translocation, either L11 moves together with EF-G or that 
the labeled positions of EF-G (CTD) and L11 do not move, which seems less likely. 
Group I traces measure the translocation trajectory 
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A significant fraction of traces for the EF-G:tRNA FRET pair, denoted Group I 
traces, showed decreased FRET efficiency during translocation and had a longer EF-G 
residence time on the ribosome than traces showing little FRET change (Fig 4.9, Fig 
4.10). We propose that the FRET efficiency changes in Group I traces reflect changes in 
EF-G:tRNA distance during translocation, based on the following considerations. EF-
G
693-Cy3
 is active in translocation confirmed by fluorescence increase of prf labeled tRNA 
programmed at the ribosomal A-site (Fig 3.5). The residence time of EF-G
693-Cy3
 for 
Group I traces is similar to the overall rate of translocation measured in rapid kinetic 
ensemble experiments, considering a) the measured ensemble rate constant in this work 
at 2 µM EF-G concentration is 2.5 ± 0.6 s
-1 
for EF-G
693-Cy3 
mutant and the measured EF-
G residence time of Group I in smFRET is ~0.5 s, corresponding to a rate constant of 2 s
-
1
; b) the Km for EF-G in Pan et al. (2007) is ~ 1.14 - 1.6 µM, so the saturated ensemble 
rate would be about 4.5 s
-1
; c) the smFRET experiments are performed at 21 
o 
C and the 
ensemble experiments are performed at 25 
o 
C. Increasing the temperature by 4 ° C, it is 
likely to raise the smFRET rate by 1.5 - 2 fold which is about 3 - 4 s
-1
, and matches the 
results of ensemble measurements both in our work and Pan’s work in 2007. 
EF-G interactions with POST were also studied. PRE complex (about 10 ~ 30 nM) 
was pre-incubated with fully active wild type EF-G (~ 3 µM) to form the POST complex. 
The direct comparison of ΔFRET distributions between EF-G:POST and EF-G:PRE 
suggests that, unlike in PRE complex, Group I traces are not present in POST complex 
(Fig 4.14). The result is further supported by the postsynchronization analysis as a 
constant FRET efficiency is obtained (Fig 4.13 C, F), suggesting that there are no relative 
distance changes between EF-G and POST complex bearing Cy5 labeled tRNA in the P 
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site. This result suggests that Group I traces report on those A-site tRNAs which undergo 
translocation to the P site.  
This suggestion is further supported by results that measure PRE complex 
interactions with EF-G in the presence of viomycin (VIO) or spectinomycin (Spc). VIO is 
a cyclic peptide antibiotic that binds at the 16S and 23S ribosomal RNA interface and 
inhibits translocation by stabilizing tRNAs in the A and P sites (Modolell et al., 1977), 
while allowing both EF-G binding and fast GTP hydrolysis (Ermolenko et al., 2007, 
Stanley et al., 2010). Translocation is completely inhibited by 100 µM VIO, the 
concentration used in our experiment. The ΔFRET distribution of PRE bearing Cy5 
labeled A-site tRNA in the presence of VIO shows that Group I traces are fully 
suppressed (Fig 4.24), indicating that Group I traces are attributable to translocation of 
the A-site tRNA to the P-site. Spc binds to h34 of 30S neck region and disturbs 
translocation by inhibiting swivelling of the head of the 30S subunit, but does not block 
the movements of tRNAs in 50S subunit (Pan et al., 2007). In our experiments, Spc 
suppresses the population of traces showing a complete FRET change. Moreover, global 
fitting of the results with PRE-II clearly show that, in the presence of Spc, good fits can 
be obtained by using a two-state model (Fig 4.27), while without Spc, a three-state model 
is required for a good fit (4.17). This result suggests that, with Spc, EF-G dissociates in 
an intermediate state without finishing catalyzing the complete translocation process. 
This conclusion is in agreement with Pan et al. (2007) who reported that Spc stabilizes a 
kinetically competent intermediate state of EF-G induced translocation, with puromycin 
activity falling between that of PRE and POST complexes. Combining all the 
aforementioned evidence leads to the conclusion that Group I traces arise from A-site 
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tRNA translocation. 
Translocation kinetics of EF-G:tRNA 
Unlike EF-G:L11 which shows a constant FRET value during the whole EF-G 
duration on the ribosome, EF-G:tRNA interaction possesses heterogeneous properties. 
The previous view raised by Gonzalez and coworkers in 2008 suggested that EF-G only 
binds to the hybrid state of tRNAs and shifts the equilibrium of the ribosome to the 
ratcheted state. In 2011, Chen et al. demonstrated that EF-G binds to both rotated and 
non-rotated states of the ribosome, by studying the tRNA: tRNA FRET and tRNA:L11 
FRET. This idea was later confirmed by Chen et al. (2013) as EF-G binding to both 
rotated and nonrated states was observed with Cy3 labeled 30S and quencher labeled 50S.  
In our work, by measuring the dynamics of FRET interaction between the EF-
G:tRNA pair, we are able to directly characterize how EF-G samples tRNAs states. The 
initial FRET distribution is broad and implies that EF-G samples tRNAs in various states 
located along the translocation trajectory. To further understand what these FRET states 
structurally correspond to, the EF-G:tRNA FRET pair is studied under 100 µM VIO 
which traps tRNAs in both classic and hybrid states with a higher portion staying in the 
hybrid state in the TAM
15
 buffer used in this work (unpublished results from Chunlai 
Chen). It reveals that FRET between EF-G and classic or hybrid tRNAs are 0.42 ± 0.01 
and 0.27 ± 0.01 for PRE-I and 0.52 ± 0.02 and 0.31 ± 0.01 for PRE-II, respective (Fig 
4.23, middle). The initial FRET distributions (Fig 4.11, left) suggest that EF-G could 
sample tRNAs in both classic and hybrid states with Val-tRNA preferring the classic state 
and Phe-tRNA preferring to stay in the hybrid state.   
EF-G can catalyze translocation of both classic and hybrid state tRNAs. Group II 
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traces, which our results suggest include hybrid state tRNAs, show a FRET efficiency 
which is close to that seen for EF-G:P-site tRNA FRET (Fig 4.13 A, D). This explains 
why a significant portion of EF-G:tRNA FRET pairs corresponding to tRNAs 
translocating from hybrid states, show no large FRET changes during translocation. On 
the other hand, Group I traces, which we assign to translocation events starting from the 
classic state, show large FRET changes during translocation. Specifically, the PRE-II 
complex has an initial FRET efficiency of 0.49 ± 0.01, proceeds to 0.31 ± 0.01 to 0.26 ± 
0.01. For PRE-I, the intermediate and final states have similar FRET efficiencies. 
However, based on the PRE-II results, we used  a three-state model to give a good fit to 
our results, showing FRET values proceeding from 0.47 ± 0.01 to 0.25 ± 0.01 to 0.24 ± 
0.01. These results suggest that EF-G:tRNA FRET proceeds from classic to hybrid to 
POST-like FRET. The transition from hybrid state to POST-like state is the rate limiting 
step, but proceeds with only a small FRET change, whereas the transition from classic 
state to hybrid state is not rate limiting but shows a large FRET change. While Group I 
traces are made up mostly of translocation events that start with A-site tRNAs in a classic 
state, Group II traces reflect a more complex mixture of states, containing unproductive 
bindings as well as translocation events starting from hybrid states. If the transition from 
hybrid state to POST-like state is the rate-limiting step as observed in Group I, 
translocation events in Group II should present a longer dwell time than non-productive 
binding events. The dwell time of translocation events with an initial FRET value of 0.35 
to 0.27 and final FRET of 0.27 to 0.21 in Group II was analyzed. The average dwell time 
of this group for PRE-I and PRE-II are 670 ± 43 ms and 630 ± 30 ms (Fig 4.18, A), 
respectively, which are considerably longer than the dwell times of the total Group II 
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populations (374 ± 13 ms and 434 ± 10 ms, respectively, Fig 4.10 B, D), confirming the 
notion that FRET conversion from hybrid state to POST-like state is the rate determining 
step.  
Combining all the aforementioned results, we propose a kinetic model of EF-G 
catalyzed translocation. EF-G samples both classic and hybrid state tRNAs. EF-G 
binding to the classic state shows a high FRET efficiency, and then tRNAs quickly move 
to the hybrid states revealing an intermediate FRET with EF-G. The transition from 
hybrid state constitutes the rate-limiting step for translocation with a rate constant about 
10 fold slower than the transition rate from classic state to hybrid state. After hybrid state 
tRNA translocating to the P-site, EF-G quickly dissociates from the ribosome (Fig 4.28). 
On the other hand, the inter-domain movements of L11 occur before translocation, and 
during translocation L11, if it moves at all, moves together with the C-terminal domain of 
EF-G, showing no relative distance changes.   
4.4 Conclusion 
A simultaneous increase of Cy3 and Cy5 fluorescence intensities was observed for 
two FRET pairs, indicating that EF-G binds to the ribosome in a conformation revealing 
detectable FRET with both L11 and tRNA. For the EF-G:L11 FRET pair, a constant 
FRET value was obtained over the entire EF-G residence time for both N-terminal and C-
terminal labeled L11. In contrast, a decreasing FRET efficiency was observed for EF-
G:tRNA interaction. Our data provides evidence that tRNAs behave heterogeneously 
during translocation. We are able to formulate a detailed kinetic scheme for translocating 
complexes that show large negative FRET efficiency changes, suggesting that EF-
G:tRNA FRET proceeds from High to INT to Low FRET values. The transition from INT 
140 
 
to Low is the rate-limiting step with a small FRET change, whereas the transition from 
High to INT is rapid and displays a large FRET change. Both high concentration of the 
next ternary complex (500 µM) and high Mg
2+ 
with polyamine favor the High FRET state. 
By comparing the FRET efficiencies obtained with VIO, we propose that High, INT and 
Low FRET states correspond to peptidyl-tRNAs in A/A, A/P and near P-site like states as 
translocation proceeds.  
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Scheme 4.1 EF-G catalyzed translocation of A, P site tRNAs to P, E sites. Distinct 
tRNAs and ribosome states are labeled: State 7, PRE complex with tRNAs in their classic 
states (A/A, P/P);  State 8, PRE complex in an intermediate state of ratcheting, with 
tRNAs in A/A, P/E sites; State  9: PRE complex with a larger relative rotation between 
50S and 30S and tRNAs in A/P, P/E sites; State 10: PRE complex with EF-G bound in 
GTP form; State 11: PRE complex with EF-G bound in GDP·Pi form; 0 state, POST 
complex with P/P, E/E site tRNAs (Frank and Gonzalez, 2010). 
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Figure 4.1 Cartoon of single molecule experimental setup. PRE complex containing 
tRNA
Cy5 
or L11
Cy5
 was attached to the slide surface via a single biotin labeled mRNA. 
Then Cy3 labeled EF-G was injected into the system. A 532 nm laser was illuminated to 
excite Cy3 fluorophore. 
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Figure 4.2 Representative FRET traces of PRE-L11
Cy5
:EF-G
693-Cy3
 pair. Experiment 
was performed in TAM
15 
buffer with 100 nM next TC. Cy3 fluorescence (Green) and Cy5 
fluorescence (blue) showed a simultaneous increase for all FRET events. The initial 
appearance and final disappearance of FRET are indicated by black dashed lines.  
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Figure 4.3 FRET analysis of EF-G
693-Cy3
:L11
Cy5
. EF-G
693-Cy3
 interactions with L11
87-Cy5
 
(top) or L11
38-Cy5 
(bottom) were studied in TAM
15 
buffer with 100 nM next TC. A, C. 
FRET efficiency distributions are fitted by Gaussian function y=y0 + (
                   
      
 
  
      
   
 
). 
B, D. Dwell time distribution is fit by single exponential decay y = Aexp(-kt). 
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Figure 4.4 FRET state analysis of EF-G
693-Cy3
:L11
Cy5
. EF-G
693-Cy3
 interaction with 
L11
87-Cy5
 (top) or L11
38-Cy5 
(bottom) was studied in TAM
15 
buffer with 100 nM next TC. 
A, D. Postsynchronized traces are obtained by aligning all FRET events at the beginning 
(black) or at the end (red) and plotted as a function of time. B, E. FRET events which last 
longer than 6 frames (210 ms, 35 ms per frame) are selected. The first and last three 
frames are averaged separately, defined as initial and final FRET. The differences 
between final and initial FRET are calculated and delta FRET distributions are plotted. C, 
F. Initial and final FRET are plotted as a transition density map with the number of events 
in each region indicated.  
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Figure 4.5 Structure of pretranslocation complex. A. 70S ribosome with tRNAs bound 
in classical A/A and P/P states with FA and mRNA. B. Translocation intermediate 
complex, containing ap/ap and pe/E site tRNAs, EF-G mRNA and FA (Zhou et al., 2014).  
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Figure 4.6 Representative FRET traces of PRE
tRNA-Cy5
:EF-G
693-Cy3
 pair. Experiment 
was performed in TAM
15 
buffer with 100 nM next TC. Cy3 fluorescence (green) and Cy5 
fluorescence (blue) showed a simultaneous increase for all FRET events. The initial 
appearance and final disappearance of FRET are indicated by black dashed lines.  
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Figure 4.7 FRET analysis of EF-G
693-Cy3
:PRE
tRNA-Cy5
. EF-G
693-Cy3 
interactions with 
PRE-I
tRNA-Cy5
 (top) or PRE-II
tRNA-Cy5
 (bottom) were studied in TAM
15 
buffer with 100 nM 
next round TC. A, C. FRET distribution plot and two peak values are fitted to a Gaussian 
function. B, D. Dwell times are each fit by a single exponential decay.  
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Figure 4.8 Synchronization analysis of EF-G
693-Cy3
:PRE
tRNA-Cy5
. EF-G
693-Cy3
 
interaction with PRE-I
tRNA-Cy5 
(left) or PRE-II
tRNA-Cy5 
(right) for total events was studied 
in TAM
15 
buffer with 100 nM next round TC. Postsynchronized traces are obtained by 
aligning all FRET events at the beginning (black) or at the end (red) and plotted as a 
function of time. 
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Figure 4.9 FRET state analysis of EF-G
693-Cy3
:PRE
Cy5
. EF-G
693-Cy3
 interaction with 
PRE-I
tRNA-Cy5
 (top) or PRE-II
tRNA-Cy5
 (bottom) was studied in TAM
15 
buffer with 100 nM 
next round TC. FRET events which last longer than 6 frames (210 ms) are selected. The 
first and last three frames are averaged separately, defined as initial and final FRET. A, D. 
Delta FRET distribution of EF-G:tRNA. The differences between final and initial FRET 
are calculated and delta FRET distributions are plotted. B, E. Initial and final FRET are 
plotted relative to each other. C, F. Initial and final FRET values are plotted as two-
dimensional transition density contour maps. 
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Figure 4.10 FRET distribution and dwell time distribution of EF-G
693-Cy3
:PRE
tRNA-
Cy5
. EF-G
693-Cy3
:PRE-I
tRNA-Cy5
 (top) or EF-G
693-Cy3
:PRE-II
tRNA-Cy5
 (bottom) was studied in 
TAM
15 
buffer with 100 nM next round TC. Dwell time distributions of traces of Group I 
(red), II (green) are fitted by a single exponential decay. A, B. FRET distribution of 
Group I (red) and Group II (Green) of PRE-I. C, D. FRET distribution of Group I (red) 
and Group II (Green) of PRE-II. 
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Figure 4.11 Initial and Final FRET distributions of EF-G
693-Cy3
:PRE
tRNA-Cy5
 pair. EF-
G
693-Cy3
:PRE-I
tRNA-Cy5
 (top) and EF-G
693-Cy3
:PRE-II
tRNA-Cy5
 (bottom) were studied under 
TAM
15 
buffer with 100 nM next round TC. Percentages of two FRET states are labeled 
separately in red (cutoff FRET value: E=0.3 for PRE-I and E=0.4 for PRE-II). Fitted 
FRET peak values are labeled in black.  
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Figure 4.12 Initial FRET distributions of EF-G
693-Cy3
:PRE
tRNA-Cy5
 for Groups I and 
II. EF-G
693-Cy3
:PRE-I
tRNA-Cy5 
(top) and EF-G
693-Cy3
: PRE-II
tRNA-Cy5
 (bottom) were studied 
in TAM
15 
buffer with 100 nM next round TC. Distribution of initial FRET values for 
Groups I and II traces are plotted with peak values labeled separately. The detailed fitting 
results, including standard deviations of the peak values and percentages of high FRET 
state are listed in Table 4.1. 
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Complex  
Fitted Peak of Initial 
FRET distribution 
aσ(SD) b High FRET  
PRE-I 
MVF 
Total 
Peak1=0.23±0.01
c
 
Peak2=0.42±0.01 
 1= 0.06 
 2= 0.17 
55% 
Group I 
Peak1=0.37±0.01 
Peak2=0.52±0.01 
 1= 0.06 
 2= 0.14 
73% 
Group 
II 
Peak1=0.22±0.01 
Peak2=0.40±0.02 
 1= 0.06 
 2= 0.16 
32% 
PRE-II 
MFK 
Total 
Peak1=0.27±0.01 
Peak2=0.45±0.04 
 1= 0.08 
 2= 0.18 
30% 
Group I 
Peak1=0.41±0.01 
Peak2=0.63±0.06 
 1= 0.10 
 2= 0.18 
41% 
Group 
II 
Peak1=0.26±0.01 
Peak2=0.41±0.04 
 1= 0.08 
 2= 0.17 
20% 
 
Table 4.1 FRET result summary of EF-G
693-Cy3
:PRE
tRNA-Cy5
. Results of initial FRET 
distributions of EF-G
693-Cy3
:PRE-I
Cy5
 and EF-G
693-Cy3
:PRE-II
Cy5
 are summarized. The 
experiments were performed under TAM
15 
buffer with 100 nM next round TC. The initial 
FRET information of total events, Group I and Group II are summarized separately. 
a 
SD of FRET distribution  
b 
The intersect FRET value of the two Gaussian fitted curve (E = IS) is obtained. High 
FRET percentage is calculated by using the number of events (E > IS) divided by the 
number of total events. 
c 
Standard error of the fitted peak value  
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Figure 4.13 FRET analysis of EF-G
693-Cy3
:POST
tRNA-Cy5
. EF-G
693-Cy3
 interaction with P 
site fMet-Val-tRNA
Val-Cy5 
(top) or fMet-Phe-tRNA
Phe-Cy5
 (bottom) in TAM
15 
buffer was 
studied in the absence of next TC. A, D. FRET distributions are fitted by Gaussian 
function. B, E. Dwell times are fitted by a single exponential decay. C, F. 
Postsynchronized traces are obtained by aligning all FRET events at the beginning (black) 
or at the end (red) and plotted as a function of time. 
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Figure 4.14 Comparison of ΔFRET distribution between PRE and POST. FRET 
events which lasted longer than 6 frames are selected. The first and last three frames are 
averaged separately, defined as initial and final FRET, respectively. The differences 
between final and initial FRET are calculated and ΔFRET distributions are plotted. A. 
ΔFRET distribution of EF-G: PRE-I
tRNA-Cy5
. B. ΔFRET distribution of EF-G: POST-I
tRNA-
Cy5
. C. ΔFRET distribution of EF-G: PRE-II
tRNA-Cy5
. D. ΔFRET distribution of EF-G: 
POST-II
tRNA-Cy5
. 
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Figure 4.15 Dwell time distributions of high FRET traces (E > 0.4) in Group II. EF- 
G
693-Cy3
:PRE-I
Cy5 
(left) and PRE-II
Cy5 
(right) were studied in TAM
15 
buffer with 100 nM 
next round TC. Dwell time distributions are each fitted by a single exponential y = Aexp(-
kt). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
158 
 
 
 
 
Figure 4.16 Synchronization analysis of EF-G
693-Cy3
:PRE-I
tRNA-Cy5
. EF-G
693-Cy3
 
interaction with PRE-I
tRNA-Cy5 
was performed in TAM
15 
buffer with 100 nM next round 
TC. Post-synchronization traces are fitted by a two-state model (left) or a three-state 
model (right).  
 
 
 
 
 
 
 
 
Figure 4.17 Synchronization analysis of EF-G
693-Cy3
:PRE-II
tRNA-Cy5
. EF-G
693-Cy3
 
interaction with PRE-II
tRNA-Cy5 
was performed in TAM
15 
buffer with 100 nM next round 
TC. Post-synchronization traces are fitted by a two-state model (left) or a three-state 
model (right).  
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Figure 4.18 Dwell time distribution of certain traces in Group II. EF-G
693-Cy3
:PRE-
I
tRNA-Cy5 
(left) and PRE-II
tRNA-Cy5 
(right) were obtained in TAM
15 
buffer with 100 nM next 
round TC. Traces with initial FRET (0.35 to 0.27) and final FRET (0.27 to 0.21) in Group 
II are selected. Dwell time distributions of these traces are fitted by a single exponential y 
= Aexp(-kt). 
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Delta FRET cutoff 
values 
PRE-I 
<-0.10 <-0.12 <-0.14 <-0.16 <-0.18 <-0.2 
Number of events 2359 2075 1845 1638 1452 1296 
Percentage 
 
100% 88% 78% 69% 62% 55% 
1
Rate constant 
(Global fitting) 
k1=18.1±0.4 
k2=1.8±0.1 
k3=18.4±1.8 
k1=22.1±0.9 
k2=1.8±0.1 
k3=8.9±0.8 
----- ----- ----- 
k1=22.4±1.2 
k2=1.8±0.1 
k3=6.4±0.6 
FRET Efficiency 
F1=0.47±0.01 
F2=0.25±0.01 
F3=0.24±0.01 
F1=0.49±0.01 
F2=0.27±0.01 
F3=0.24±0.01 
----- ----- ----- 
F1=0.54±0.01 
F2=0.27±0.01 
F3=0.22±0.01 
Delta FRET values 
 
>0.1 >0.12 >0.14 >0.16 >0.18 >0.20 
Number of events 522 346 229 155 110 67 
Ratio 100% 66% 44% 30% 21% 13% 
 
Table 4.2a Global fitting results summary using different ΔFRET cutoff values of 
PRE-I. EF-G
693-Cy3
 interaction with PRE-I
tRNA-Cy5 
and 100 nM next TC was studied in 
TAM
15 
buffer. 
1
Global fitting results are based on traces with decreased FRET changes 
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Delta FRET cutoff 
values 
PRE-II 
<-0.12 <-0.14 <-0.16 <-0.18 <-0.2 
Number of events 1207 1017 865 730 610 
Percentage 
 
100% 84% 72% 60% 50% 
1
Rate constant 
(Global fitting) 
k1=24.4±1.1 
k2=1.6±0.1 
k3=12.6±1.1 
   
k1=23.1±1.2 
k2=1.6±0.2 
k3=10.4±0.5 
FRET Efficiency 
F1=0.49±0.1 
F2=0.31±0.1 
F3=0.26±0.1 
   
F1=0.53±0.01 
F2=0.33±0.01 
F3=0.28±0.01 
Delta FRET values 
 
>0.12 >0.14 >0.16 >0.18 >0.20 
Number of events 481 345 252 184 134 
Ratio 100% 72% 52% 38% 28% 
 
Table 4.2b Global fitting results summary using different ΔFRET cutoff values of 
PRE-II. EF-G
693-Cy3
 interaction with PRE-II
tRNA-Cy5 
and 100 nM next TC was studied in 
TAM
15 
buffer. 
1
Global fitting results are based on traces with decreased FRET changes 
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Figure 4.19 FRET distribution of EF-G
693-Cy3
:PRE
tRNA-Cy5 
under different next TC 
concentrations. EF-G
693-Cy3
 interaction with PRE-I
tRNA-Cy5 
(top) and PRE-II
tRNA-Cy5 
(bottom) was studied in TAM
15 
buffer with 0, 100, 500 nM next TC. FRET distribution is 
plotted and two peak values are fitted by Gaussian function. The detailed fitting results, 
including standard deviations of the peak values and the percentage of high FRET state 
are listed in Table 4.3. 
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Complex  
Fitted Peak of Total 
FRET distribution 
aσ(SD) 
b
High FRET 
percentage 
PRE-I 
MVF 
0 
Peak1=0.18±0.01
c
 
Peak2=0.36±0.02 
 1= 0.07 
 2= 0.16 
22% 
100
 
Peak1=0.18±0.01 
Peak2=0.37±0.02 
 1= 0.07 
 2= 0.17 
20% 
500 
Peak1=0.18±0.01 
Peak2=0.40±0.01 
 1= 0.07 
 2= 0.19 
41% 
PRE-II 
MFK 
0 
Peak1=0.21±0.01 
Peak2=0.35±0.04 
 1= 0.08 
 2= 0.14 
27% 
100
 
Peak1=0.22±0.01 
Peak2=0.36±0.03  
 1= 0.08 
 2= 0.15 
19% 
500 
Peak1=0.23±0.01 
Peak2=0.45±0.02 
 1= 0.09 
 2= 0.20 
30% 
 
Table 4.3 Summary of FRET distributions of EF-G
693-Cy3
:PRE
tRNA-Cy5
 at different 
next TC concentrations. The experiments were performed under TAM
15 
buffer with 0, 
100, 500 nM next round TC.  
a 
SD of FRET distribution  
b 
The intersect FRET value of the two Gaussian fitted curve (E = IS) is obtained. High 
FRET percentage is calculated by using the number of events (E > IS) divided by the 
number of total events. 
c 
Standard error of the fitted peak value  
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Complex  TC 
Concentration 
Dwell time (ms)  dTransition rate (s-1 ) 
k
1 
 k
2
 k
3
 
PRE-I 
MVF  
0 1
 aDw=386+8 bDw1=557+8  cDw2=336+9  18.7±0.5  1.8±0.1  18.6±2.0  
100 nM 1
 
Dw=424±9  Dw1=555±10  Dw2=374±13  18.1±0.4  1.8±0.1  18.4±1.8  
500 nM 1
 
Dw=199±3  Dw1=288±8  Dw2=185±3  15.7±1.2  1.8±0.1  38.6±18.7  
PRE-II  
MFK  
0 3
 
Dw=291±6  Dw1=394±14  Dw2=278±7  22.9±1.5  2.1±0.1  13.8±1.4  
100 nM 2 Dw=457±8  Dw1=573±21  Dw2=434±10  24.4±1.1  1.6±0.1  12.6±1.1  
 500 nM 2
 
Dw=250±4  Dw1=417±12  Dw2=229±4  12.8±0.5  1.5±0.1  20.9±3.6  
 
Table 4.4 Summary of kinetics of EF-G promoted translocation at different next TC 
complex concentrations. 
a
Dwell time of total events 
b
Dwell time of Group I traces 
c
Dwell time of Group II traces 
d
Transition rates are fitted by using the three FRET states model  
1 
Cognate Phe-tRNA
Phe 
2 
Cognate Lys-tRNA
Lys 
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Figure 4.20 Global fitting of synchronization traces at different next TC complex 
concentrations. FRET between EF-G693-Cy3 and PRE-I
tRNA-Cy5 
(top) or PRE-II
tRNA-Cy5 
(bottom) in TAM15 buffer with 0, 100 or 500 nM next round TC. Fitting results are listed 
in Table 4.4.  
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Figure 4.21 FRET distribution of EF-G
693-Cy3
:PRE
tRNA-Cy5 
under different buffer 
conditions. FRET results between EF-G
693-Cy3
 and PRE-I
tRNA-Cy5
 (top) or PRE-II
tRNA-Cy5
 
(bottom) in WB buffer, TAM
15 
buffer and Polyamine buffer with 100 nM next round TC 
are studied. FRET distribution is plotted and two peak values are fitted by Gaussian 
function. The detailed fitting results, including standard deviation of the peak values and 
percentages of high FRET state are listed in Table 4.5. 
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Complex  
Fitted Peak of Total 
FRET distribution 
aσ(SD) 
b 
High FRET 
percentage 
PRE-I 
MVF 
WB 
Peak1=0.21±0.01
c 
Peak2=0.40±0.02 
 1= 0.09 
 2= 0.17 
41% 
TAM
15 
Peak1=0.18±0.01 
Peak2=0.37±0.02 
 1= 0.07 
 2= 0.17 
20% 
Polyamine 
Peak1=0.18±0.01 
Peak2=0.43±0.01 
 1= 0.08 
 2= 0.18 
67% 
PRE-II 
MFK 
WB 
Peak1=0.25±0.01 
Peak2=0.45±0.02 
 1= 0.09 
 2= 0.21 
18% 
TAM
15 
Peak1=0.22±0.01 
Peak2=0.36±0.03  
 1= 0.08 
 2= 0.15 
19% 
Polyamine 
Peak1=0.21±0.01 
Peak2=0.40±0.03 
 1= 0.08 
 2= 0.18 
22% 
 
Table 4.5 Summary of FRET distributions of EF-G
693-Cy3
:PRE
tRNA-Cy5 
at different 
buffer conditions. The experiments were performed in WB buffer, TAM
15 
buffer and 
Polyamine buffer with 100 nM next round TC.  
a 
SD of FRET distribution  
b 
The intersect FRET value of the two Gaussian fitted curve (E = IS) is obtained. High 
FRET percentage is calculated by using the number of events (E > IS) divided by the 
number of total events. 
c 
Standard error of the fitted peak value  
 
 
 
 
 
 
 
 
 
 
 
 
 
168 
 
Complex  Buffer  Dwell time (ms)  dGroup I 
ratio 
eTransition rate (s-1 ) 
k
1 
 k
2
 k
3
 
PRE-I 
MVF  
WB  aDw=204±3 bDw1=275±3  cDw2=186±4 26.1% 21.6±1.1  3.9±0.1  12.6±1.3  
TAM
15
  
Dw=424±9  Dw1=555±10  Dw2=374±13 29.8% 18.1+0.4  1.8±0.1  18.4±1.8  
Polyamine  Dw=359±8  Dw1=679±26  Dw2=286±7 37.7% 10.2±0.5  1.1±0.3  9.2±1.2  
PRE-II  
MFK  
WB  Dw=266±3  Dw1=322±7  Dw2=255±3  18.9% 21.5±0.8  4.0±0.1  11.2±0.8  
TAM
15
  
Dw=457±8  Dw1=573±21  Dw2=434±10  19.0% 24.4±1.1  1.6±0.1  12.6±1.1  
Polyamine  Dw=509±8  Dw1=596±20  Dw2=479±6  25.1% 16.6±0.5  1.9±0.1  8.5±0.4  
        
Table 4.6 Summary of kinetics of EF-G promoted translocation at different buffer 
conditions. 
a
Dwell time of total events 
b
Dwell time of Group I traces 
c
Dwell time of Group II traces 
d
Percentage of Group I is calculated by using the number of traces from Group I divided 
by the number of total events 
e
Transition rate constants are fitted by the three-state model. 
 
 
 
 
 
169 
 
 
 
Figure 4.22 Global fitting results of postsynchronized traces at different buffer 
conditions. FRET results between EF-G
693-Cy3
 and PRE-I
tRNA-Cy5
 (top) or PRE-II
tRNA-Cy5
 
(bottom) in WB buffer, TAM
15
 buffer or polyamine buffer with 100 nM next round TC 
are fitted separately. Detailed fitting results are listed in Table 4.6. 
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Figure 4.23 FRET distribution of EF-G
693-Cy3
:PRE
tRNA-Cy5
 with VIO. EF-G
693-Cy3 
interaction with PRE-I
tRNA-Cy5
 (left) or PRE-II
tRNA-Cy5
 (right) in different buffer conditions 
with 100 nM next round TC and 100 µM VIO. FRET distributions are plotted, with two 
major peaks indicated in the Figures. The detailed fitting results, including standard 
deviation of the peak values and the percentages of high FRET states are listed in Table 
4.7. 
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Complex Buffer FRET Peaks 
a 
Dwell time 
b   (SD) 
c 
High FRET 
percentage 
PRE-I 
MVF 
WB 
Peak1=0.33±0.01
d 
Peak2=0.45±0.03 
Dw=275±3 
 1= 0.10 
 2= 0.15 
54% 
TAM
15
 
Peak1=0.27±0.01 
Peak2=0.42±0.01 
Dw=550±10 
 1= 0.08 
 2= 0.14 
46% 
Polyamine 
Peak1=0.34±0.02 
Peak2=0.49±0.14 
Dw=359±4 
 1= 0.12 
 2= 0.15 
54% 
PRE-II 
MFK 
WB 
Peak1=0.28±0.01 
Peak2=0.45±0.02 
Dw=266±3 
 1= 0.09 
 2= 0.17 
37% 
TAM
15
 
Peak1=0.31±0.01 
Peak2=0.52±0.02 
Dw=235±3 
 1= 0.11 
 2= 0.20 
44% 
Polyamine 
Peak1=0.32±0.01 
Peak2=0.53±0.01 
Dw=298±4 
 1= 0.09 
 2= 0.20 
52% 
 
Table 4.7 Summary of FRET distributions of EF-G
693-Cy3
:PRE
tRNA-Cy5
 with VIO. 
FRET between EF-G
693-Cy3
 and PRE-I
tRNA-Cy5
 or PRE-II
tRNA-Cy5
 are studied under 
different buffer conditions with 100 nM next round TC and 100 µM VIO. 
a 
Dwell time of total events 
b 
SD of FRET distribution  
c 
High FRET percentage is calculated by using the number of events (E > 0.4) divided by 
the number of total events 
d 
Standard error of the fitted peak value  
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Figure 4.24 VIO suppresses FRET conversions. A, B. Postsynchronized traces under 
standard conditions in the presence of 100 µM VIO are obtained by aligning all FRET 
traces at the beginning (black) or at the end (red) and plotted as a function of time. C, D. 
ΔFRET distribution of EF-G
693-Cy3
:PRE-I
tRNA-Cy5
 (left) and EF-G
693-Cy3
:PRE-II
tRNA-Cy5
 
(right) in TAM
15 
buffer with 100 µM VIO. FRET events which last longer than 6 frames 
are selected. The first and last three frames are averaged separately, defined as initial and 
final FRET, respectively. The differences between final and initial FRET are calculated 
and delta FRET distributions are plotted. 
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Figure 4.25 FRET distribution of EF-G
693-Cy3
:PRE
tRNA-Cy5
 with Spc. EF-G
693-Cy3
 
interaction with PRE-I
tRNA-Cy5
 (top) and PRE-II
tRNA-Cy5
 (bottom) under TAM
15
 buffer with 
100 nM next round TC and 5mM Spc. A, C. FRET distributions are plotted with two 
major peaks. B, D. Dwell time distributions are each fitted by a single exponential y = 
Aexp(-kt). The detailed fitting results, including standard deviations of peak values and 
the percentages of high FRET state are listed in Table 4.8. 
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Complex Buffer 
Fitted Peak of Total 
FRET distribution 
aσ(SD) bHigh FRET ratio 
PRE-I 
MVF 
TAM
15 
Peak1=0.19±0.01
c 
Peak2=0.38±0.02 
 1= 0.07 
 2= 0.17 
51% 
PRE-II 
MFK 
TAM
15
 
Peak1=0.23±0.01 
Peak2=0.45±0.02 
 1= 0.08 
 2= 0.20 
32% 
 
Table 4.8 Summary of FRET distributions of EF-G
693-Cy3
:PRE
tRNA-Cy5
 with Spc. 
FRET between EF-G
693-Cy3
 and PRE-I
Cy5
 or PRE-II
Cy5
 is obtained under TAM
15
 with 100 
nM next round TC and 5 mM Spc. 
a 
SD of FRET distribution  
b 
The intersect FRET value of the two fitted Gaussian curves (IS) is obtained. High FRET 
percentage is calculated by using the number of events (E > IS) divided by the number of 
total events. 
c 
Standard error of the fitted peak value  
 
175 
 
 
 
Figure 4.26 FRET state analysis of EF-G
693-Cy3
:PRE
tRNA-Cy5
 with Spc. FRET between 
EF-G
693-Cy3
 and PRE-I
tRNA-Cy5
 (top) or PRE-II
tRNA-Cy5
 (bottom) is obtained under TAM
15
 
buffer with 100 nM next round TC and 5mM Spc. A, C Postsynchronized traces are 
calculated by synchronizing all FRET events at the beginning (black) or at the end (red) 
and plotted as a function of time. B, D FRET events which last longer than 6 frames are 
selected. The first and last three frames are averaged separately, defined as initial and 
final FRET, respectively. The differences between final and initial FRET values are 
calculated and delta FRET distributions are plotted. 
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Figure 4.27 Global fitting results of postsynchronized traces of EF-G
693-Cy3
:PRE
tRNA-
Cy5
 with Spc. EF-G
693-Cy3
 interactions with PRE-I
tRNA-Cy5
 (left) and PRE-II
tRNA-Cy5
 (right) 
were studied in TAM
15
 buffer, 100 nM next round TC and 5 mM Spc. 
 
 
 
 
 
 
Figure 4.28  Kinetic models of EF-G catalyzed translocation.  
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CHAPTER V SMFRET STUDY OF BIFUNCTIONAL 
RHODAMINE LABELED EF-G 
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Abstract 
Elongation factor G (EF-G) catalyzes translocation of mRNA, A- and P-site bound 
tRNAs on the ribosome during the polypeptide elongation cycle. Previous studies show 
that EF-G has significant conformational flexibility with different conformations 
observed for EF-G·GTP and EF-G·GDP forms (Agirrezabala et al., 2009). Upon binding 
to the ribosome, EF-G undergoes large conformational changes as it transitions from 
bound EF-G·GTP to bound EF-G·GDP·Pi and to bound EF-G·GDP that include both 
distance displacement and orientation changes. To understand how these two different 
movements occur on the ribosome, bifunctional rhodamine labeled EF-G derivatives 
(BR-EF-G) were utilized to compare the timing of changes in EF-G orientation on the 
ribosome, as measured by single molecule polarized total internal reflection fluorescence 
(polTIRF) microscopy (Chen et al., manuscript in preparation) with changes in EF-
G:tRNA FRET efficiency measurement, presented below. In our work, Phe-tRNA
Phe
 was 
labeled with Cy5 and six EF-G derivatives were labeled with a bifunctional 
tetramethylrhodamine (BR). Four of the six mutants showed measurable BR:Cy5 FRET, 
with dwell times of  150 - 350 ms, depending on which mutant was used. A major FRET 
change during EF-G occupancy of the ribosome was observed for only one BR-EF-G, as 
determined from synchronization analysis, FRET distributions, and transition heat 
contour maps. Interestingly, for the four BR-EF-Gs showing FRET, FRET changes 
during EF-G occupancy were larger if the BR group was located closer to the EF-G hinge 
region, suggesting that parts of Domain IV of EF-G, which penetrate to the decoding 
region of the ribosome, move together with the A-site tRNA during translocation.  
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5.1 Introduction 
EF-G
.
GTP first binds to the GTPase activation center (GAC) of a pretranslocation 
(PRE) complex, followed by a fast GTP hydrolysis (k = 170 s
-1
). The tip of Domain IV on 
EF-G is believed to penetrate to the A-site during translocation.  At the same time, the 
interactions of EF-G with tRNAs and mRNA are retained to help to maintain the reading 
frame (Pulk et al., 2013; Tourigny et al., 2013; Zhou et al., 2013). The translocation 
movements of tRNA and mRNA occur at the same rate and according to the most recent 
research, this movement is also coupled with the back ratcheting of the ribosome (Chen 
et al., 2013a). As the EF-G.GDP form has a much lower affinity to the ribosome, after Pi 
release, EF-G
.
GDP dissociates from the ribosome spontaneously (Rodnina et al., 1997). 
The conformational changes during EF-G residence on the ribosome can be described as 
a hinge-like motion of Domains III, IV and V relative to Domains I and II, directly 
confirmed by the structural results (Fig 5.1).  
In Chapter 4, we identified time-dependent FRET changes between EF-G
693 
and the 
A-site tRNA or L11 during translocation, which revealed important insights regarding the 
dynamics of distance changes between one position on C-terminal domain (CTD) of EF-
G (N693C-EF-G) and the D-loop of tRNA (position 16/20) during translocation. Here, 
we extended such measurements to six different BR-labeled EF-G derivatives. The 
results obtained provide a more comprehensive view of relative EF-G:tRNA motion 
during translocation, and ultimately will be useful in comparing the timing of changes in 
EF-G:tRNA distance to changes in EF-G orientation on the ribosome during translocation. 
The latter, which is carried out using single molecule polarized total internal reflection 
fluorescence (polTIRF) microscopy, employs the same six BR-labeled EF-G derivatives 
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(Chen et al., manuscript in preparation). These derivatives are designed to diminish the 
free rotation of the dye relative to EF-G. For this purpose, two engineered cysteines (Cys) 
located within the same -helix seven residues apart are cross-linked with BR (Fig 5.2).  
5.2 Results 
5.2.1 The design of the experiment 
PRE-II complex containing Cy5 labeled Phe-tRNA
Phe
, hereinafter denoted PRE-II
Cy5
, 
was prepared as described (Section 2.2.4.4) and attached to the slide surface via a 5’ and 
3’ double biotin labeled mRNA (MFV) to restrict ribosome free rotation (Fig 5.3, Fig 5.4). 
To keep the results of polTIRF and smFRET-TIRF comparable to one another, the 
standard buffer condition in our lab (TAM
15 
buffer) was used. Also, 20 nM next TC (WT-
Val-TC) and 10 nM Cy5-Phe-TC were added to reduce the likelihood of EF-G binding to 
the POST complex and carry out multiple rounds of translocation. All experiments were 
performed at 21 °C with a frame rate of 10 ms/frame.  
5.2.2 EF-G mutant selections 
Six BR-EF-G derivatives which showed full translocation activity (Chen et al., 
unpublished results) were screened for FRET with the A-site Cy5 labeled tRNA, 
including BR-EF-G
429-436 
(Domain III), BR-EF-G
630-637 
(Domain V), BR-EF-G
467-474 
(Domain III), BR-EF-G
555-562
 (Domain IV), BR-EF-G
599-606 
(Domain IV) and BR-EF-
G
692-699
(CTD). The latter four all gave FRET with the A-site bound fMet-Phe-tRNA
Phe 
(Cy5) and were selected for further studies. Each of the labeled sites fell within -helices 
that were solvent-exposed and contained amino acids that were not strongly conserved.  
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5.2.3 Characterization of the EF-G:tRNA FRET interactions 
5.2.3.1 FRET efficiency distributions and BR-EF-G dwell times  
For each of the four BR-EF-Gs giving FRET with the A-site bound fMet-Phe-
tRNA
Phe 
(Cy5), binding to PRE-II
tRNA-Cy5
 led to a simultaneous increase of BR and Cy5 
fluorescence. FRET efficiency distributions (Fig. 5.5) were fitted with Gaussian function 
and all BR-EF-G dwell times (Fig 5.6) were fitted with a double exponential decay. 
FRET efficiencies were fitted by two major peaks except for BR-EF-G
599-606 
as only one 
peak was obtained. Among these four EF-G derivatives, FRET efficiencies were largest 
for BR-EF-G
599-606 
and lowest for BR-EF-G
555-562
. FRET efficiencies of BR-EF-G
467-474 
and BR-EF-G
692-699
 were similar but a high FRET proportion was more prominent in BR-
EF-G
692-699
 mutant. BR-EF-G
467-474
 and BR-EF-G
555-562
 showed comparable FRET dwell 
time with values of τ1= 33 ± 9 ms, τ2= 123 ± 8 ms and τ1= 16 ± 2 ms, τ2= 182 ± 3 ms, 
respectively, whereas τ2 for EF-G
692-699 
was much longer with a value of 335 ± 9 ms. The 
differences in dwell times among different EF-G derivatives are likely due to the position 
where the dye is attached and all of the dwell time obtained in this work is similar to 
previous characterized dwell time of translocation (Chen et al., 2013a; Munro et al., 
2010). 
5.2.3.2 Characterization of BR-EF-G:tRNA FRET efficiency change  
Following the logic employed in analyzing the interaction of EF-G
693-Cy3
 with PRE-I 
and PRE-II (Section 4.2.4.3), we utilized synchronization analysis (Fig 5.7), ΔFRET 
distribution (Fig 5.8) and transition heat contour maps (Figure 5.9) to determine whether 
BR-EF-G:tRNA FRET efficiency showed changes during translocation. 
Postsynchronized traces of both BR-EF-G
467-474 
and BR-EF-G
692-699
 presented a small 
182 
 
FRET change, while the other two mutants only had one constant FRET value over the 
entire FRET duration. ΔFRET distributions were plotted, and although the majority of the 
events still showed no significant FRET changes, for BR-EF-G
692-699
, a certain proportion 
of events was observed located in x < 0 region with a negative FRET change (left side of 
the dashed line in Fig 5.8 D). In contrast, this population was not prominent in BR-EF-
G
467-474 
mutant, likely due to only a low proportion of traces with large FRET changes. As 
discussed in Chapter 4, the FRET events of BR-EF-G
692-699 
mutant were further 
segmented into two groups to study the heterogeneity of EF-G:tRNA interactions. We 
denoted the group of traces with large decreased FRET (ΔFRET < - 0.2) for the BR-EF-
G
692-699
:PRE-II
tRNA-Cy5
 FRET pair as Group I. All the other traces were placed in Group II 
(ΔFRET > - 0.2). The dwell time averaged 408 ± 19 ms for Group I and 372 ± 10 ms for 
Group II (Fig 5.10). This small difference is not as large as what was obtained for EF-
G
Cy3-693 
(543 ± 19 ms for Group I and 434 ± 10 ms for Group II, Section 4.2.4.3).  
5.2.3.3 Initial and Final FRET distributions for the BR-EF-G
692-699
:tRNA pair 
We next examined the distributions of initial and final FRET values for the BR-EF-
G
692-699
:tRNA pair, which were calculated as the average values of the first three and last 
three frames of the FRET events, respectively (Fig 5.11). A clear decrease was observed 
for the final FRET as compared to the initial FRET efficiencies, with FRET values of 
0.27 ± 0.01 and 0.47 ± 0.01 for initial FRET shifting to 0.23 ± 0.01 and 0.37 ± 0.04 for 
final FRET. Also, the initial FRET distribution was broader compared to the final FRET 
distribution. Detailed analysis was applied to postsynchronized traces to characterize the 
kinetics of tRNA translocation  
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5.2.3.4 Translocation kinetics of Group I for the BR-EF-G
692-699
:tRNA pair 
Following the procedure described in Section 4.2.4.7, we fit the postsynchronized 
traces in Group I to characterize the kinetics of BR-EF-G
692-699
 catalyzed translocation. 
Global fitting was applied to postsynchronized traces using two-state or three-state 
models (Fig 5.12). A better fit to the raw data was obtained using the three-state model. 
Accordingly, the results obtained from the three-state model will be used for the later 
discussion. 
The fitted results showed that in Group I, FRET events started with a high FRET 
value of 0.53 ± 0.01, proceeded via an intermediate FRET of 0.28 ± 0.01, and finally 
disappeared with a low FRET of 0.24 ± 0.01, corresponding to a distance change from 
about 52Å to 62 Å and then to 64 Å.  The transitions from 0.53 to 0.28, 0.28 to 0.24, and 
0.24 to zero proceeded with rate constants of 45.5 ± 1.7 s
-1
, 2.5 ± 0.1 s
-1
, and 24.8 ± 2.2  
s
-1
 (Table 5.3). These results are similar to what we found for EF-G
Cy3-693
 catalyzed 
translocation (Section 4.2.4.7 - FRET states: 0.49, 0.31, 0.26; rate constants 24.4 ± 1.1 s
-1
, 
1.6 ± 0.1 s
-1
, 12.6 ± 1.1 s
-1
), although the rate constants for BR-EF-G
692-699 
are 1.5 - 2 
times larger. The slower rate constants for EF-G
Cy3-693
 might be due to interaction of the 
singly tethered Cy3 dye with the ribosome. The double tethered BR dye would be 
expected to interact much less with the ribosome. The smallest rate difference between 
the two labeled EF-Gs is in the rate limiting step, which is accompanied by only a small 
FRET change. This step, which presumably involves large movements of tRNA and/or 
mRNA but only shows a small relative FRET change between labeled positions on EF-G 
and the A-site tRNA, might be less influenced by differences in dye-ribosome interaction. 
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5.2.3.5 FRET and BR placement within EF-G 
The results presented in Fig 5.13 could be used to address the question of how the 
extent of negative FRET change correlated with the position of BR cross-linking to the 
EF-G molecule. For each BR-EF-G, the measured variable D, defined as the number of 
traces showing a ≥ 0.2 decrease in FRET efficiency minus the number of traces showing 
a ≥ 0.2 increase in FRET efficiency, was divided by the total number of FRET recordings 
(T) (Table 5.4). This results in the following ordering of the percentage of net negative 
FRET changes: EF-G
692-699
 (CTD) > BR-EF-G
467-474 
(Domain III) > EF-G
599-606 
(Domain 
IV) or  BR-EF-G
555-562 
(Domain IV), supporting the conclusion that negative FRET 
changes were larger if the BR group was located closer to the EF-G hinge region.   
5.3 Discussion 
In Chapter 4, we proposed a kinetic model of EF-G:tRNA interaction during 
translocation with the FRET efficiencies and rate constants of each state characterized for 
the first time. This model suggests that EF-G:tRNA FRET proceeds from High to INT to 
Low FRET, which correspond to FRET values of EF-G:tRNA pair when tRNAs are in 
classic, hybrid or POST-like states. This kinetic model is further confirmed by analyzing 
post-synchronized FRET between the A-site tRNA and bifunctional rhodamine labeled 
EF-Gs(BR-EF-Gs) located at the IV:V interface. The global fitting results of post-
synchronized FRET of BR-EF-Gs:tRNA suggest that the FRET efficiency starts with a 
high FRET value, and proceeds to an intermediate value, to a low FRET value. Similar as 
what was obtained in Chapter 4, the transition rate from INT to Low is the rate limiting 
step, while only a small FRET change occurs during this process. However, the transition 
rates of BR-EF-Gs:tRNA pair are comparably faster ( ~ 2 fold ) than those of Cy3-EF-
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G:tRNA (Table 5.1, Table 4,4). This difference could be due to the difference in the 
labeling strategies. The BR dye on EF-G is more restricted and has less freedom of 
rotational movements. In contrast, Cy3 dye is only singly attached to EF-G. When it is 
tethered onto the ribosome, more contacts could be formed between the dye and 
ribosomal proteins or rRNAs, which are likely to extend EF-G lifetime on the ribosome.   
Both postsynchronization analysis and delta FRET distributions (Fig 5.7, Fig 5.8) 
show that larger changes in FRET efficiency are found when the BR group is located 
closer to the EF-G hinge region (Agirrezabala et al., 2009; Agrawal et al., 1998; Frank 
et al., 2007; Valle et al., 2003) about which Domains III-V move relative to Domains I 
and II, than when the BR group is in a part of Domain IV that extends into the A-site 
decoding center. During translocation, both A-site tRNAs and Domain IV of EF-G are 
believed to undergo large distance displacements in the decoding center (Agirrezabala et 
al., 2009). Our present results of FRET changes detected by BR-EF-Gs and previous 
structural information about the large distance displacements of tRNA and EF-G together 
suggest that Domain IV, which extends into the decoding center, moves together with the 
A-site tRNA during translocation. Thus, we detect no relative movement between 
Domain IV of EF-G and the A-site tRNA during translocation. In contrast, other parts of 
EF-G which are located closer to the hinge region, do not undergo such large movement. 
The resulting large distance changes between those domains and peptidyl-tRNA during 
translocation result in the significant FRET efficiency changes we observe during 
translocation.  
 
 
186 
 
5.4 Conclusion 
By using bifunctional tetramethylrhodamine labeled EF-G derivatives, restricting the 
free rotation of dye attached to EF-G, we were able to study the relative movements 
between EF-G and the A-site peptidyl-tRNA. Our data suggest that during EF-G 
catalyzed translocation, some parts of Domain IV of EF-G move together with the 
peptidyl-tRNA, so that the EF-G:tRNA FRET efficiency doesn’t change (Fig 5.2). In 
contrast, when the BR group is located closer to the EF-G hinge region, at which position, 
Domains III, IV and V undergo a large movement relative to Domains I and II during 
translocation (Agirrezabala et al., 2009), FRET efficiency decreases, consistent with a 
growing distance between those parts of EF-G and peptidyl-tRNA.  
Fitting results by using two-state or three-state models suggest that an intermediate 
state existed in our BR-EF-G:Cy5-tRNA FRET interaction. The fitted rate constants of 
BR-EF-G
692-699 
are larger than those for EF-G
Cy3-693
. This is likely due to the free rotation 
of the fluorophore in EF-G
Cy3-693
, which could, by forming contacts with parts of the 
ribosome, extend EF-G lifetime on the ribosome. The smallest rate difference between 
the two labeled EF-Gs is in the rate limiting step which only shows a small EF-G:tRNA 
FRET change, suggesting that tRNA and mRNA movement at the decoding center may 
occur at this stage.  
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Figure 5.1 Comparison of structural changes observed in EF-G [from (Agirrezabala, 
et al., 2009)]. The conformations observed in EF-G/eEF2 by means of cryo-EM 
(ribosome-bound forms) and X-ray crystallography (in solution) can be summarized as 
follows: EF-G in complex with GTP in solution (red), before interacting with the 
ribosome, as seen in the crystal structure of the EF-G analog EF-G-2 (PDB code: 1WDT). 
EF-G•GTP•ribosome conformation was determined by cryo-EM using the non-
hydrolyzable GTP analog GDPNP (PDB code: 1PN6). The conformational changes in 
ribosome-bound EF-G, upon GTP hydrolysis, are likely similar to those described for 
eEF2•80S complexes in Taylor et al. (2007). A comparison of the complexes before 
(yellow) and after GTP hydrolysis (blue, PDB code: 2P8Y). Conformational changes of 
EF-G•GDP from the ribosome-bound conformation (blue), determined by cryo-EM (PDB 
code: 2P8Y), to the solution structure (pink), determined by X-ray crystallography (PDB 
code: 1EFG), include a movement at the tip of domain IV by ~43 Å. A comparison of the 
GDP-bound conformation (pink) of EF-G with the GTP-bound conformation (red) 
reveals a shift at the tip of domain IV of the factor by ~25 Å. The presence of GTP also 
reveals an ordered Switch I loop and a different conformation of the Switch II loop. 
Altogether, these rearrangements likely are the basis of a much higher affinity of the 
pretranslocational ribosome for the GTP-bound conformation of EF-G.  
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Figure 5.2 Carton figures of EF-G and cross-linked bifunctional rhodamine. EF-G 
(red), A-site tRNA (purple) and P-site tRNA (yellow). Mutated sites on EF-G are 
identified by amino acid number and domain labeled.  
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Figure 5.3 Cartoon of the single molecule experiment setup of BR-EF-G. Cy5 labeled 
PRE complex with tRNA
Cy5 
was attached to the slide surface via a double biotin labeled 
mRNA. Then bifunctional rhodamine labeled EF-G was injected into the system. A green 
laser (532 nm) was illuminated to excite rhodamine fluorophore directly. 
 
 
 
 
 
 
     Nucleotide spacer       StrongSD         Spacer  Start    F        V        F      V          F        V         
         
5’ biotin- G UUA AUA AGG AUA CAU ACU AUGUUC  GUG  UUC GUG  UUC GUG  -biotin 3' 
 
Figure 5.4 T   5’ and 3’ d u l   i tin la  l d RNA u  d in t i     k.  
 
 
 
PEG 
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Figure 5.5 FRET distribution of BR-EF-G:PRE-II
tRNA-Cy5
. Sample was prepared in 
TAM
15 
buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-Phe-TC and 
1mM GTP.  FRET efficiency distributions are fitted by Gaussian function: 
y= y0 + (
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Figure 5.6 FRET dwell time distribution of BR-EF-G:PRE-II
tRNA-Cy5
. Sample was 
prepared in TAM
15 
buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-Phe-
TC and 1mM GTP.  Dwell time distribution is fitted by double exponential decay: 
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EF-G derivative 
(Domain) 
 
 
Mutant sites FRET efficiency High 
FRET 
percentage 
FRET  dwell time 
(ms) 
Peak 1 Peak 2  t1 t2 
BR-EF-G467-474 
(III) 
 
D467C,K474C, C114D, 
C266A, C397S 
0.17 ± 20.01 
(10.08) 
0.29 ± 0.01 
(0.17) 
0.26 33 ± 9 123 ± 8 
BR-EF-G555-562 
(IV) 
 
K555C, K562C, C114D, 
C266A, C397S 
0.14 ± 0.01 
(0.06) 
0.28 ± 0.02 
(0.13) 
0.24 17 ± 2  162 ± 3 
BR-EF-G599-606 
(IV) 
 
I599C, K606C, C114D, 
C266A, C397S 
0.33 ± 0.01 
(0.16) 
---- ---- 46 ± 5 248 ± 10 
BR-EF-G692-699 
(CTD) 
 
S692C, I699C, C114D, 
C266A, C397S 
0.20 ± 0.01 
(0.09) 
0.31 ± 0.01 
(0.15) 
0.48 52 ± 9 334 ± 15 
 
Table 5.1 FRET distributions and dwell time of BR-EF-Gs:PRE-II
tRNA-Cy5
 FRET 
pair. Sample was prepared in TAM
15 
buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 
10 nM Cy5-Phe-TC and 1 mM GTP at 21 
o 
C. 
1
 SD of FRET distribution 
2
 Standard error of the fitted peak 
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Figure 5.7 Postsynchronized analysis of BR-EF-G:PRE-II
tRNA-Cy5
. Sample was 
prepared in TAM
15 
buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-Phe-
TC and 1mM GTP. Postsynchronized traces are obtained by aligning all FRET events at 
the beginning (black) or at the end (red) and plotted as a function of time. 
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Figure 5.8 ΔFRET di t i uti ns of BR-EF-G:PRE-II
tRNA-Cy5
. Sample was prepared in 
TAM
15 
buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-Phe-TC and 1 
mM GTP. The initial and final FRET are calculated as the averaged results of the first 
three frames and last three frames, respectively. ΔFRET distribution is plotted with a bin 
size of 0.02.  
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Figure 5.9 Transition density contour map of BR-EF-G:PRE-II
tRNA-Cy5
. Sample was 
prepared in TAM
15 
buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-Phe-
TC and 1mM GTP. The initial and final FRET are calculated as the averaged results of 
the first three frames and last three frames, respectively. Initial and final FRET values are 
plotted as two-dimensional transition density contour maps. 
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Figure 5.10 Dwell time distributions of Groups I and II traces. Sample was prepared 
in TAM
15 
buffer and contained BR-EF-G
692-699
, 10 nM Cy5-Phe-TC, 20 nM WT-Val-TC 
and 1mM GTP. Dwell time distributions of Group I and Group II were each fitted by a 
single exponential decay.  
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Figure 5.11 Initial and final FRET distributions. Sample was prepared in TAM
15 
buffer 
and contained BR-EF-G
692-699
, 10 nM Cy5-Phe-TC, 20 nM WT-Val-TC and 1mM GTP. 
The initial and final FRET are calculated as the averaged results of the first three frames 
and last three frames, respectively. Initial and final FRET distributions are plotted with a 
bin size of 0.02. The proportion of FRET events on each sides of the dashed line are 
indicated in red. The detailed fitting results, including standard deviation of the peak 
value and percentage of high FRET state are listed in Table 5.2. 
 
 
 
 
Complex Buffer 
Fitted Peak of Total 
FRET distribution 
aσ(SD) 
b
High FRET 
percentage 
PRE-II MFK 
Initial FRET 
TAM
15 
Peak1=0.27±0.01 
Peak2=0.47±0.02 
 1= 0.12 
 2= 0.14 
19% 
PRE-II MFK 
Final FRET 
TAM
15
 
Peak1=0.23±0.01 
Peak2=0.37±0.04 
 1= 0.07 
 2= 0.09 
38% 
 
Table 5.2 Statistics of fitted FRET peaks of BR-EF-G:PRE-II
tRNA-Cy5
. Sample was 
prepared in TAM
15 
buffer and contained BR-EF-G
692-699
, 10 nM Cy5-Phe-TC and 20 nM 
WT-Val-TC. 
a
SD of FRET distribution 
b
The intersect FRET value of the two fitted Gaussian curves (IS) is obtained. High FRET 
percentage is calculated by using the number of events (E > IS) divided by the number of 
total events 
c
Standard error of the fitted peak 
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Figure 5.12 Global fitting results of Group I traces of BR-EF-G:PRE-II
tRNA-Cy5 
pair. 
Sample was prepared in TAM
15 
buffer and contained BR-EF-G
692-699
, 10 nM Cy5-Phe-TC, 
20 nM WT-Val-TC and 1mM GTP. Postsynchronized traces are obtained by aligning all 
FRET traces at the beginning (black) or at the end (red) and plotted as a function of time. 
Both two-state (A) and three-state (B) models are applied. Detailed fitting results are 
listed in Table 5.3.  
 
 
 
 
 
 
Complex 
BR-EF-
G
692-699 
PRE-
II
tRNA-Cy5 
 
Buffer 
Fitting 
model 
Transition rate (s
-1 
) FRET state 
k
1
 k
2
 k
3
 E1 E2 E3 
TAM
15
 Two state 26.2±0.7 1.6±0.1 ----- 0.54±0.01 0.25±0.01 ----- 
TAM
15
 Three state 45.5±1.7 2.5±0.1 24.8±2.2 0.53±0.01 0.28±0.01 0.24±0.01 
 
Table 5.3 Global fitting results of Group I traces of BR-EF-G:PRE-II
tRNA-Cy5 
pair. 
Sample was prepared in TAM
15 
buffer and contained BR-EF-G
692-699
, 10 nM Cy5-Phe-TC, 
20 nM WT-Val-TC and 1mM GTP.  Fitting results of two-state and three-state models are 
listed.  
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Figure 5.13 Initial and final FRET distributions of BR-EF-G:PRE-II
tRNA-Cy5 
pair. 
Sample was prepared in TAM
15 
buffer and contained BR-EF-Gs, 10 nM Cy5-Phe-TC, 20 
nM WT-Val-TC and 1mM GTP.  The initial and final FRET was calculated as the 
averaged results of the first three frames and last three frames respectively. Initial and 
final FRET distributions are plotted with a bin size of 0.02. 
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PRE-II  BR-EF-G
467-474 
(III)
 
 
BR-EF-G
555-562
 
(IV) 
 
BR-EF-G
599-606 
(IV) 
 
BR-EF-G
692-699 
(CTD) 
 
Total events (T) 759 3716 1527 1702 
Number of events  
ΔFRET < - 0.20 
 
55  115 138  191 
Number of events  
ΔFRET > + 0.20 
 
20 57 100 62 
Difference in 
number  
of events (D) 
35 58 38 129 
Percentage 
(D/T) 
4.6%  1.5%  2.4%  7.6%  
 
Table 5.4 Stati ti al  tudi    f ΔFRET of BR-EF-G:PRE-II
tRNA-Cy5 
pair. Sample was 
prepared in TAM
15 
buffer and contained BR-EF-Gs, 10 nM Cy5-Phe-TC, 20 nM WT-Val-
TC and 1mM GTP. The first three frames and last three frames are averaged separately, 
defined as initial and final FRET. The difference between final and initial FRET is 
denoted ΔFRET. 
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